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Abstract 
Modulation of neutrophil degranulation by hypoxia 
Kim Hoenderdos 
Neutrophils are key effector cells of the innate immune system. They employ a number of 
powerful ‘weapons’ to eliminate pathogens, including an array of destructive proteins 
packaged into distinctive granule subsets. In addition to their microbicidal activity, these 
granule proteins are capable of causing substantial tissue damage if inappropriately 
deployed.  To mitigate against this possibility, most physiological stimuli induce minimal 
extracellular degranulation. Sites of inflammation and infection are usually hypoxic, and 
it has been shown that oxygen depletion compromises neutrophil function by impairing 
the generation of reactive oxygen species and hence bacterial killing.  
The key finding reported in this thesis is that hypoxia substantially increases the release 
of all neutrophil granule subsets, as measured by the release of (active) hallmark proteins 
(elastase, myeloperoxidase, lactoferrin and matrix metalloproteinase-9). In consequence, 
supernatants from hypoxic neutrophils induced substantially more damage to lung 
epithelial cell layers than supernatants from neutrophils cultured under normoxic 
conditions; this damage was protein- and protease-dependent. This pattern of damage was 
seen consistently across lung adenocarcinoma-derived epithelial cells, primary 
immortalised lung epithelial cells, and primary human bronchial epithelial cells grown in 
physiological air-liquid interface culture. Surprisingly, the mechanism of hypoxia-
augmented degranulation was found to be independent of protein synthesis and 
specifically, of the transcription factor HIF-1α (the ‘master-regulator’ of hypoxic 
responses); thus, hypoxia did not affect mRNA transcript or protein abundance of the 
major granule components, and hypoxia mimetics failed to recapitulate the phenotype. 
Inhibition of the key pathways known to be involved in neutrophil degranulation, 
including, phosphatidylinositol 3-kinase and phospholipase C, but not calcium flux 
prevented augmented granule release under hypoxia 
In conclusion, hypoxia induces a destructive neutrophil phenotype, with increased release 
of multiple histotoxic proteases. This may contribute to tissue injury and disease 
pathogenesis in a range of clinically important conditions. 
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1. Introduction 
1.1 The immune system 
The immune system protects the body from invading pathogens and consists of a range of 
physical barriers and cellular components. These barriers are provided by the skin, the 
low pH of the stomach, the mucous membranes of the gut and the muco-ciliary escalator 
in the lungs. Besides comprising a physical barrier, the skin and epithelial surfaces of the 
gut and lungs also secrete a range of anti-microbial peptides. The second component of 
the immune system is comprised of two constituent parts, namely the innate and the 
adaptive immune systems. To function effectively these systems need to distinguish 
between harmful pathogens (‘non-self’) and the body’s own tissues and proteins (‘self’). 
The innate immune system provides an immediate, but non-specific response through the 
recognition of non-self proteins called pathogen-associated molecular patterns (PAMPS), 
which leads to the activation of range of immune cells through Toll-like receptors 
(TLRs). Immune cells that play an important role in the innate immune system include 
phagocytic cells like macrophages and neutrophils, which ingest and kill invading 
pathogens, and natural killer (NK) cells, whose main role is to identify and destroy 
infected host cells. Dendritic cells reside in the physical barriers exposed to the external 
environment such as skin, gut and lung epithelial surfaces; they are the interface between 
the innate and adaptive immunity, and process foreign antigen to present to adaptive B 
and T lymphocytes. The adaptive immune system is capable of mounting a very specific 
response through this precise and tailored recognition of pathogens, leading to antibody 
production and cytotoxic T cell responses. This is a slower process than the innate 
response, but the specific generation of immunological memory results in a faster 
response when the same pathogen is subsequently encountered
1
.  
 
1.2 Neutrophils 
Neutrophils (Figure 1.1) play a key role in the innate immune response as “first 
responders” in instances of pathogen invasion or damage. They are the most abundant 
white blood cell present in the circulation (54-62% of the leukocyte differential count
2
) 
and have two important roles in the defence against microbial invasion; immune 
surveillance and the elimination of micro-organisms. This is reflected in their 
development, abilities and lifespan.   
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Figure 1.1 The neutrophil structure and phagocytic capacity 
A. Cytospin of isolated human neutrophils stained with May/Grünwald/Giemsa (x40 
magnification). B. Confocal immunofluoresence image (x63) of neutrophils stained for 
the nucleus (blue, DAPI) the azurophil granules (red: goat IgG antibody and Alexa Fluor 
488 – donkey anti-goat IgG) and actin (green: rhodamine-phalloidin). C. Electron 
microscope image of a neutrophil, highlighting the many intracellular granules; * indicate 
electron dense (Myeloperoxidase (MPO) positive) granule # indicate the electron light 
(MPO negative) granules (x3500). D. Confocal immunofluoresence image of a neutrophil 
that has phagocytosed Ph-Rhodo-labelled S. Aureus (red), (nucleus blue, DAPI) x63 with 
6x zoom (images taken from my own experiments). 
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Neutrophils are one of the three types of granulocytes (with eosinophils and basophils) 
that develop in the bone marrow, with 1-2x10
11
 cells generated per day
3
. Under normal 
conditions only a small percentage of the total neutrophils resident in the bone marrow 
are released into the circulation, where they have a very short half-life and are rapidly 
cleared by macrophages in the reticulo-endothelial system
4,5
. During inflammation, the 
production of neutrophils increases and both mature and immature neutrophils are 
released into the circulation to boost the available circulating pool. Their role in immune 
surveillance requires neutrophils to move quickly; they are the most motile cells in the 
body
6
 and purposeful or directional motion (chemotaxis) enables them to home in on their 
prey. To enable these responses they express a large range of cell surface receptors 
involved in the reaction to microbial invasion; these include receptors for the recognition 
of microbial structures, those allowing the detection of soluble chemoattractants, those 
responsible for recognising an inflammatory environment and those involved in 
activation of the adaptive immune system
7
. 
To avoid non-specific activation, circulating neutrophils are relatively quiescent cells. 
However, neutrophils can be converted to a substantially more aggressive phenotype by a 
process called priming, as shown by Forehand et al.
8
. Neutrophil priming has been 
studied extensively and it has been shown that a range of inflammatory mediators, 
including TNF-α9, GM-CSF10, platelet activating factor (PAF)11 and lipopolysaccharide 
(LPS)
12
 can induce this state of pre-activation. Besides having a direct effect on cell 
polarisation, deformability
13
 and integrin/selectin expression
14
, priming enables an 
increased activation-mediated oxidative burst (up to 20 fold
12
), degranulation response
15
 
and lipid mediator (e.g. leukotriene B4 and arachidonic acid) release
16,17
. Priming is a 
relatively quick process, which occurs within seconds to minutes, depending on the 
ligand
14
. It has been suggested that neutrophil priming occurs in the circulation as a first 
step in neutrophil recruitment and precedes extravasation and activation at the site of 
infection
18
. 
 
1.2.1 Neutrophil recruitment 
Neutrophils are recruited rapidly to sites of infection or inflammation, through a number 
of steps (Figure 1.2), guided by signals generated by microbes and host cells such as 
tissue macrophages. Neutrophils are present in the circulation in two pools; a freshly 
circulating vascular pool and a marginating pool that consists of granulocytes 
1. Introduction 
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Figure 1.2: Neutrophil recruitment and function 
Upon pathogen recognition, neutrophils are recruited rapidly to sites of infection, guided 
by signals generated by the microbes and resident tissue macrophages. Circulating, un-
activated neutrophils “roll” along the endothelial cells surface (1), patrolling for signs of 
damage/infection. The rolling, transient contact with the endothelial cells involves P-
selectin and E-selectin interactions with L-selectin and P-selectin ligand-1 (PSGL-1) on 
the surface of neutrophils. After “capture” of the neutrophil the next step is firm adhesion 
(2); β2-integrins interact with intracellular adhesion molecule (ICAM)-1 and ICAM-2. 
The final step in neutrophil recruitment is migration towards the site of inflammation 
following a chemo-attractant gradient. Neutrophils cross the endothelial cell layer (3) and 
then migrate through the basal membrane. Neutrophil granule proteases play an important 
role in the latter process as they are capable of breaking down components of the basal 
membrane such as collagen and laminins. When the neutrophils reach the site of infection 
(4) they phagocytose pathogens, degranulate and undergo apoptosis or netosis. Apoptotic 
neutrophils are taken up by macrophages. (Adapted from Borregaard et al.
19
)  
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transiently arrested in sinusoids of the liver and spleen
20
. Circulating, non-activated 
neutrophils “roll” along the endothelial cell surface, patrolling for signs of 
damage/infection. The transient, rolling contact with endothelial cells involves the 
interaction of P- and E-selectins with L-selectin (CD62L) and P-selectin ligand-1 (PSGL-
1) on the surface of neutrophils
21,22
. Upon contact with inflammatory stimuli, many cell 
surface receptors involved in neutrophil recruitment are up-regulated; P-selectin 
expression increases within minutes after stimulation with thrombin or reactive oxygen 
species (ROS)
23
 and E-selectin expression increases after 1 to 2 hours of stimulation with 
IL-1, TNF-α or LPS. If the interactions between the selectins and their ligands are 
sufficient, the rolling neutrophil becomes ‘captured’. 
After capture of the neutrophil, the next step is firm adhesion. In this step β2-integrins 
play an important role, particularly CD11a/CD18 (LFA-1) and CD11b/CD18 (Mac-1)
21
. 
CD11a/CD18 interacts with intracellular adhesion molecules ICAM-1 and ICAM-2, 
while CD11b/CD18 interacts with a larger range of receptors including ICAM-1, ICAM-
2, fibrinogen and complement fragment iC3b. Further activation is mediated through 
neutrophil chemokine receptors
24
, which bind ligands secreted or presented by endothelial 
cells
25,26
, such as IL-8, and platelet activating factor (PAF). Upon activation by these 
chemo-attractants or contact with activated epithelium, neutrophils switch from a rounded 
to a polarised morphology, forming cells with a clear leading edge and a distinct rear 
(uropod). The establishment of a leading edge is controlled by G-protein coupled 
receptors through a complex signalling cascade; phosphoinositide 3-kinase (PI3K) 
generates the second messenger phosphatidylinositol (3,4,5)-trisphosphate (PIP3) from 
phosphatidylinositol (4,5)-bisphosphate (PIP2); PIP3 accumulates at the leading edge and 
induces the activation of Rho GTPases and the polarisation of F-actin
27,28
. 
The constant generation of an F-actin mesh pushes the neutrophil forwards, while the 
uropod detaches following degradation of PIP3 (by the phosphatases PTEN and SHIP), 
and the engagement of RhoA/Rock dependent signalling, leading to actin-myosin 
contraction (Figure 1.3). The final step in neutrophil recruitment is migration towards the 
focus of inflammation following a chemo-attractant gradient. Neutrophils can cross the 
endothelial cell layer by passing directly through an individual endothelial cell or by para-
cellular migration, squeezing between cells. Migration is mediated by the integrins 
CD11a/CD18 and CD11b/CD18 on the neutrophil cell surface, and their ligands ICAM-1 
and ICAM-2 on the endothelium (reviewed by Pick et al.
29
). 
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Figure 1.3: Leading edge formation in the neutrophil 
Upon activation by chemoattractants or by contact with activated epithelium, neutrophils 
change from a rounded morphology to a polarised “activated” state. Activated neutrophils 
undergo shape change to generate more elongated cells with a clear leading edge and a 
distinct rear end (uropod). Activation of the cognate GPCR by fMLP leads to the 
dissociation of the G protein into α- and βγ-subunits, which activate PI3Kγ. PI3Kγ 
generates the second messenger phosphatidylinositol (3,4,5)-trisphosphate (PIP3) from 
phosphatidylinositol (4,5)-biphosphate (PIP2), and PIP3 accumulates at the leading edge 
to induce the local activation of Rho GTPases (particularly Rac) and polarisation of F-
actin
27,28
. The constant generation of an F-actin mesh pushes the neutrophil forward, 
while the uropod detaches due to PTEN/SHIP degradation of the second messengers PIP3 
and RhoA/Rock dependent signalling leading to actomyosin contraction, again pushing 
the neutrophil forward. 
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Once they have crossed the endothelium, neutrophils must migrate through the basal 
membrane. Neutrophil granule proteins play an important role in this process as they 
contain proteases capable of breaking down components of the basal membrane such as 
collagen and laminins
30
. Both MMP-9 and neutrophil elastase (NE) have been shown to 
play a role in migration through basement membranes and ECM breakdown; in vitro 
work has shown that MMP-9 is needed for migration through Matrigel and amnion 
membranes
31
 and Llewellyn-Jones et al.
32
 showed that connective tissue degradation can 
be reduced by the serine protease inhibitor α1AT, suggesting a possible role for NE. 
Despite the presence of abundant protease inhibitors in the extra-cellular space, NE is still 
capable of degrading ECM for two main reasons. Firstly, secreted NE has been shown to 
bind to the neutrophil plasma membrane locally via a charge-dependent mechanism
33
, 
making it inaccessible to the tissue inhibitors. Secondly, the formation of shielded peri-
cellular micro-environments, in which NE molecules greatly outnumber the opposing 
protease inhibitors, can protect NE and allow substantial but localised tissue breakdown 
(‘quantum proteolysis34,35) 
 
1.2.2 Neutrophil intracellular bacterial killing 
Once at the site of infection, neutrophils fulfill their second role, namely the elimination 
of micro-organisms (Figure 1.4). Neutrophils have a large arsenal of “weapons” they can 
employ against pathogens. They are extremely effective phagocytes, being able to ingest 
an opsonized particle within 20 seconds
36
. After pathogen engulfment, the phagosome 
matures through fusion with a range of vesicles present in the cytosol, acquiring 
machinery to kill the ingested pathogen. Inside the phagosome, the environment is 
rendered hostile to the pathogen by the secretion of bactericidal proteins and proteases 
and by a series of redox reactions including the production of reactive oxygen species 
(ROS) by the NADPH oxidase complex. Upon neutrophil activation, the cytosolic 
components of the NADPH complex (p40
phox
, p47
phox
, p67
phox 
and p21
rac
) translocate to 
the plasma or phagosome membrane and interact with the membrane-associated 
cytochrome b558. The assembled NADPH oxidase complex then catalyses a sequence of 
reactions, culminating in the formation of hydrogen peroxide (H2O2). Catalysed by 
myeloperoxidase (MPO) from the azurophilic granules, and in the presence of halide 
ions, H2O2 is then converted into hypohalous acids. These and other products of the 
oxidative burst are effective anti-microbial agents but can also cause tissue damage; they  
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Figure 1.4: Neutrophil oxygen-dependent bacterial killing 
After Fc receptor or complement receptor-assisted phagocytosis of pathogens, the 
phagosome matures through fusion with a range of vesicles present in the cytosol, 
acquiring the machinery to kill the ingested pathogen. Upon phagocytosis, the cytosolic 
components of the NADPH complex (p40
phox
, p47
phox
, p67
phox 
and p21
rac
) translocate to 
the phagosomal membrane and assemble with cytochrome b558. The resulting activated 
NADPH oxidase complex catalyses a sequence of reactions through which hydrogen 
peroxide is formed. Hydrogen peroxide, catalysed by myeloperoxidase (MPO) from the 
azurophilic granules and in the presence of halide ions, is then converted into hypohalous 
acids, which are highly effective anti-microbial agents. The neutrophil granules also play 
a role in ROS-independent bacterial killing as they contain a range of bactericidal 
proteins.  
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activate pro-collagenases, pro-gelatinases
37
 and induce the production of cholesterol 
chlorohydrins
38,39
. The importance of the respiratory burst is epitomised by patients with 
chronic granulomatous disease (CGD). Neutrophils from these patients migrate and 
phagocytose normally but fail to mount a respiratory burst due to a defect in one of the 
components of the NADPH oxidase. This impairs intracellular bacterial and fungal 
killing, especially of Staphylococcus spp and Aspergillus spp, leading to recurrent 
infections and early death
40
.  
In addition to the NADPH oxidase, the neutrophil possess several granule populations 
which contain a range of bactericidal proteins (Table 1.1) that play a key role in bacterial 
killing, as discussed in detail in section 1.3. Segal et al.
36
 postulate that instead of MPO 
and ROS production being the primary killing systems they have been thought to be, they 
help create conditions in the phagosome conducive to microbial killing and digestion by 
enzymes released into the phagomsome from the cytoplasmic granules.  
 
1.2.3 Neutrophil extracellular traps 
An additional, recently discovered mechanism of bacterial killing is the formation of 
neutrophil extracellular traps (NETs, Figure 1.5
41,42
). NETs consist of de-condensed 
strands of DNA coated with proteins from the nucleus, cytosol and granules. Urban et 
al.
43
 identified 24 different proteins present on NETs including histones, defensins, 
elastase, lactoferrin and cathepsin G. NET formation is characterised by the loss of 
intracellular membranes before the integrity of the plasma membrane is compromised and 
ruptures, ejecting chromatin and attached proteins into the extracellular space as NETs. 
The main functions of NETs are to trap microbes, prevent dissemination of infection, and 
inactivate virulence factors. NETs capture microbes via a charge reaction, although some 
pathogens have evolved either a capsule structure or an alteration of surface charge that 
prevents binding to NETs
44
. Proteases presented by NETs such as elastase and cathepsin 
G can inactivate bacterial virulence factors
41
. NETs also contain anti-microbial proteins 
including defensins and lactoferrin, which can kill or inhibit bacteria. The importance of 
NETs is illustrated by Li et al. 
45
, who showed that mice deficient in NET formation were 
more susceptible to necrotising fasciitis induced by group A streptococci then wild type 
(WT) mice. However, like many components of the immune system, aberrant activation 
can cause damage.  For example, NETs have been implicated in auto-immunity; Systemic 
Lupus Erythematosus (SLE) patients make antibodies against histones and neutrophil  
1. Introduction 
 
 
26 |  
 
 
 
 
Figure 1.5: NETs 
A. Neutrophil extracellular traps (NETs) are characterised by long strands of DNA (blue) 
decorated with the granular protein, neutrophil elastase (red). Immunofluorescence 
image, Magnification= 40x. Adapted from Carmona-Rivera
46
. B. Scanning electron 
microscope image showing blankets of NETs after 4 hours of PMA (200 nM) treatment 
(B :This imags was prepared and is shown by courtesy of Daniel Storisteanu). 
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proteins, and their neutrophils have been shown to be more prone to forming NETs
47
. 
NETs have also been suggested to play a role in cystic fibrosis (CF); Manzenreiter et al.
48
 
found that NETs are present in sputum from CF patients and their presence can contribute 
to the viscosity of CF sputum.  
 
1.2.4 Role of neutrophils in disease: a double-edged sword 
Neutrophils are expertly equipped to carry out their role, as illustrated by the 
susceptibility of patients with neutrophil defects such as congenital neutropenia or 
chronic granulomatous disease to severe and recurrent infections
36,49
. Neutropenia is more 
commonly due to chemotherapy, and these patients are likewise highly susceptible to 
sepsis
50
. Neutrophils are professional phagocytes designed to phagocytose and eliminate 
pathogens rapidly, however in the context of adhesion or integrin activation, if they do 
not not encounter pathogens within a short time frame (in vitro this is 15-45 minutes), 
they may release large amounts of reactive oxygen species into the extracellular space
51
. 
This, combined with the release of granule proteins, causes localised tissue damage which 
again can be beneficial: it leads to the trapping of pathogens in a ‘toxic soup’ (pus), 
collagen disassembly which improves neutrophil-pathogen contact, and the collapse of 
lymphatics and capillaries therefore cutting off pathogen escape routes
37,51,52,53
.  
Besides fighting infection, neutrophils have been shown to play an important role in 
wound healing; patients with neutropenia
54
 or those with defective neutrophil adhesion 
experience poor wound healing
55
. However, neutrophil function must be tightly 
controlled to prevent inappropriate or excessive damage. Aberrant or over-activation of 
neutrophils has been related to a range of inflammatory diseases such as rheumatoid 
arthritis (RA), where neutrophils have been implicated in joint damage. A mouse model 
of RA shows a correlation between the earliest signs of ankle joint inflammation and the 
presence of neutrophils in the synovial tissue
56
 and neutrophils have been found in high 
numbers in the synovium during the initial stages of RA
57
. 
Another example of a disease process in which neutrophils have a detrimental effect is 
cancer. Several mouse models have shown that neutrophils modulate the tumour micro-
environment to promote tumour progression, through promoting angiogenesis via the 
release of vascular endothelial growth factor, and by promoting tumour cell motility, 
migration and invasion
58
. Fridlender et al.
59
 show that tumour associated neutrophils 
(TANs) can acquire a pro-tumour phenotype (similar to M2 macrophes), largely driven 
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by TGF-β. Upon TGF-β blockade, neutrophils acquire an antitumor phenotype to become 
“N1” TANs (similar to M1). This paradigm suggests that TANs are a double-edged 
sword, capable of being pro- or anti-tumourigenic, depending on the tumor 
microenvironment. N2 neutrophils express higher levels of CXCR4, VEGF, MMP-9 and 
arginase, supporting carcinogenesis, angiogenesis and immune suppression.
60
 Tumour 
invasion requires the degradation of extracellular matrix (ECM), which neutrophils are 
capable of either directly by the release of granule proteins including elastase, cathepsin 
G, MMP-8 and MMP-9, or indirectly by activating MMP-2 and thereby promoting the 
invasion of tumour cells
61,62
  
Additionally, neutrophils have been implicated in a range of inflammatory lung diseases 
such as chronic obstructive pulmonary disease (COPD). This disease is characterised by 
aberrant and persistent inflammation leading to severe damage both to the airways and 
the lung parenchyma. Neutrophils are the most abundant cells found in the bronchial wall 
and lumen of COPD patients
63,64
 and their presence correlates with the decline in lung 
function characteristic of this relentlessly progressive disease
65
. Neutrophil granule 
proteins, otherwise important in fighting infection, have been heavily implicated in 
causing tissue damage in COPD; circulating levels of NE have been shown to increase 
during exacerbations
66
 and alveolar NE (as measured in bronchoalveolar lavage fluid 
(BALF)) is related to disease severity
67
.  
Thus while the neutrophil plays an essential role in host defence, it also plays a 
pathogenic role in many diseases. In the next section neutrophil degranulation, which has 
many important physiological functions but also the capacity to cause substantial tissue 
injury, will be discussed. 
 
1.3 Neutrophil granules: development and function 
Granule contents play a role in almost every step of the neutrophil inflammatory 
response, from the initial endothelial capture and extravasation to bacterial killing and 
modulating the inflammatory response at the site of infection. Thus neutrophil granules 
not only contain anti-microbial proteins and proteases, but are also a store of NAPDH 
oxidase components, receptors for endothelial adhesion molecules, extra-cellular matrix 
proteins and soluble inflammatory mediators, as summarised in Table 1.1. Degranulation 
can be induced by a range of ligands, including fMLP and PAF
68–70
; the degranulation 
response is very rapid, starting 30-40 seconds after stimulation with fMLP
71
.   
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Table 1.1: Contents of neutrophil granules 
This table summarises the major contents of each granule type, divided into membrane 
and intracellular components. The granule membranes contain essential components for 
neutrophil activation and recruitment (CD11b and fMLP-R), ROS dependent intracellular 
bacterial killing (cytochrome b558) and lysosome acidification (ATP-pump), which are 
highlighted in blue. The granule matrix contains many key components for extravasation 
(gelatinases) and bacterial killing (lactoferrin, MPO and NE) highlighted in red. (Adapted 
from Borregaard et al.
19
).  
Secretory vesicles Gelatinase granules Specific granules Azurophil granules 
Membrane Membrane Membrane Membrane 
• Alkaline phosphatase  
• C1q-R 
• CR1 
• Cytochrome b558 
• CD10, CD11b, CD13,   
CD14, CD16, CD45 
• DAF 
• fMLP-R  
• SCAMP 
• U.kinase-type 
plasmasminogen 
activator R.  
• V-type H+-ATPase  
• VAMP-2 
 
• CD11b, CD15 
• Cytochrome b558 
• Diacylglycerol-
deacylating enzyme  
• fMLP-R  
• SCAMP 
• U.kinase-type 
plasmasminogen 
activator R.  
• VAMP-2 
• V-type H+-ATPase  
 
• CD11b, CD15, CD66, 
CD67  
• Cytochrome b558 
• fMLP-R  
• Fibronectin-R  
• G-proteinα-subunit 
• Laminin-R  
• NB 1 antigen 
• 19-kD 155 protein  
• Rap1, Rap2 
• SCAMP 
• Thrombospondin-R  
• TNF-receptor  
• Urokinase-type  
plasminogen activator R 
•  VAMP-2 
• CD63, CD69 
• V- type H+-ATPase  
 
Matrix Matrix Matrix Matrix 
• Plasma binding 
proteins  
 
• Acetyltransferase  
• β2Microglobulin 
• Gelatinase 
• Lysozyme  
 
• β2 Microglobulin 
• Collagenase  
• Gelatinase 
• hCap-18 
• Histaminase  
• Heparanase  
• Lactoferrin 
• Lysozyme  
• NGAL 
• Urokinase-type 
plasminogen activator R 
• Sialidase  
• SGP28 
• Vitamin B12 –binding 
protein  
 
• Acid β-glycero-
phophatase  
• Acid muco 
polysaccharide  
• α1—antitrypsin  
• α-Mannosidase  
• Azurocidin/CAP37/  
• Bacterial perm.  
increasing protein  
• β/Glycerophosphatas
e  
• β/Glucuronidase  
• Cathepsins  
• Elastase 
• Lysosyme  
• Myeloperoxidase 
• Proteinase-3 
• Ubiquitin-protein  
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Neutrophil granules are bounded by a phospholipid bilayer membrane and possess an 
intracellular matrix incorporating proteins destined for delivery to the phagosome or for 
exocytosis
72
. There are four granule subsets that can be classified according to their 
contents: primary (azurophil) granules, secondary (specific) granules, tertiary (gelatinase) 
granules and secretory vesicles. However, this classification is not precise, as granules are 
formed continuously from the early promyelocyte stage until nuclear segmentation (Table 
1.2). Granulopoeisis involves budding of vesicles from the Golgi network and their fusion 
to form early stage granules
73,74
. Borregaard et al.
75
 and others 
76,77
 showed that the 
granule content depends on the changing transcriptional profile as neutrophil 
development proceeds, and if the bio-synthetic window of a granule protein is changed it 
will be incorporated into a different granule types
78
. Since the expression of granule 
proteins occurs as a continuum rather than in a distinct quantal fashion, there is some 
overlap in protein content
72
. The azurophil granules are formed first, in the promyelocyte 
stage
79
, the specific granules in the myelocyte and metamyelocyte stages, and gelatinase 
granules in the band cell and segmented cell stage
70,74
. The secretory vesicles are last to 
be formed and appear in segmented neutrophils
80
 (Table 1.2). Once maturation is 
complete, it is thought that no further granule proteins are produced; Fouret et al. showed 
that mature neutrophils do not contain mRNA transcripts for myeloperoxidase (MPO), 
lactoferrin or NE. 
Granule subsets differ not only in their protein content but also in the timing of their 
release; the secretory vesicles, which play a role in the earliest phases of the neutrophil 
response, are released first. Tertiary, secondary and primary granules are progressively 
less prone to mobilise to the cell surface (a control mechanism, which reduces the 
likelihood of extra-cellular release of the potentially destructive serine proteases). This 
hierarchical mobilisation of neutrophil granule populations can be reproduced in vitro by 
inducing progressive elevations of intracellular calcium
81
, suggesting that activation of 
phospholipase C may be important in controlling this response. The primary (azurophil) 
granule is preferentially targeted to the emerging phagosome, a process dependent on the 
microtubule network
82
 and on the small GTPase Rac
83
 The precise molecular mechanisms 
providing this fine control of granule deployment are not fully understood, but are likely 
to involve differential granule expression of soluble N-ethylmaleimide-sensitive 
attachment protein receptor (SNARE) proteins and differences in SNARE complex  
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Table 1.2: Neutrophil granules develop at different stages during neutrophil 
maturation 
The formation of granules occurs sequentially, during neutrophil maturation in the bone 
marrow. Granulopoiesis starts in early promeyelocytes; the azurophil granules are formed 
first, in this promyelocyte stage. The peroxidase-negative granules, which include the 
specific and gelatinase granules, are formed next. The specific granules are formed in the 
myelocyte and metamyelocyte stages and the gelatinase in the band cell and segmented 
cell stages. The secretory vesicles are the last to be formed and appear in segmented, 
mature neutrophils. 
  
 Developmental stage Granule population 
 
Myeloblast  
 
Promyelocyte Azurophilic granules 
 
Myelocyte 
Specific granules 
 
Meta myelocyte 
 
Band cell Gelatinase granules 
 
Mature neutrophil Secretory vesicles  
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formation
84
. This targeted and timed release profile is essential for optimal neutrophil 
function and to minimise tissue damage
72,52
.  
 
1.3.1 Secretory vesicles 
The secretory vesicles are the last to be formed during neutrophil development and are 
the most readily exocytosed, for example following contact with inflamed endothelial 
surfaces or exposure to priming agents. They contain a reservoir of membrane-associated 
receptors such as integrins (CD11b/CD18) and fMLP receptors (table 1.1), which 
facilitate the earliest phases of the neutrophil-mediated inflammatory response, in 
particular the recruitment of these cells to the inflammatory focus
85,86
. The mobilisation 
of secretory vesicles is accompanied by L-selectin shedding on the surface of neutrophils 
and this allows the neutrophil to establish firm contact with the activated vascular 
endothelium. Secretory vesicles only contain a few intra-vesicular components, which are 
mostly plasma proteins, suggesting that they are formed by endocytosis
87
. 
 
1.3.2 Gelatinase granules  
The gelatinase granules are the next most readily exocytosed granule population after the 
secretory vesicles. This reflects their function as a reservoir of matrix degrading enzymes 
(gelatinases) and membrane receptors (CD11b/CD18) required for neutrophil 
extravasation and migration through the tissues. In vitro experiments have shown that 
gelatinase activity is essential for neutrophil migration through Matrigel and amniotic 
membranes
88
. Matrix metalloproteinase 9 (MMP-9 or gelatinase B) is the predominant 
component of gelatinase granules. MMP's are stored as inactive pro-forms and undergo 
proteolytic activation after exocytosis. Together with other MMP's, MMP-9 is capable of 
degrading major structural components of the extracellular matrix, including collagen, 
laminin and gelatin, thereby facilitating neutrophil extravasation and migration, but also 
conferring the potential for tissue injury
30,89,90
. In a recent study into the role of  
intravenous salbutamol in the treatment of ARDS, an increase in BALF MMP-9 level at 
day 4 correlated with reduced extravascular lung water
91
, suggesting a possible role for 
MMP-9 in injury repair. However, excessive release of MMP-9 (or other 
metalloproteases) in most settings is associated with tissue damage. Increased expression 
of MMP-2 and MMP-9 in tumours has been associated with the progression of ovarian  
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cancer
92
 and has been shown to play a role in breast tumour growth. Additionally MMP-9 
has been shown to disrupt vascular integrity and to induce leukocyte migration in an 
ischaemia/reperfusion liver injury model; MMP-9 knockout mice are protected from liver 
injury with reduced leukocyte infiltration, pro-inflammatory cytokine expression and 
liver necrosis
93
. Furthermore increased MMP-9 levels have been associated with tissue 
damage in a range of inflammatory lung disease such as COPD
94
 and acute lung injury 
(ALI)
95,96
, as discussed in more detail in Section 1.4. In tissues such as the lung, tissue 
inhibitors of metalloprotease (TIMPs) 1-4 are present, and can limit the damage caused 
by these MMPs; an imbalance between TIMPs and neutrophil proteases is a feature of 
several inflammatory lung diseases, including ARDS
97
.  
The gelatinase granules also contain cytochrome b558
98
, the major membrane component 
of the NADPH oxidase, responsible for most of the proton pump activity of the 
assembled complex 
99
. Thus fusion of tertiary granules with the phagosome is essential 
for phagosome acidification and intracellular ROS production. The gelatinase granules 
contain another ion-transporter: natural resistance-associated macrophage protein 1 
(Nramp 1), which also locates to the phagosome membrane and transports divalent 
cations so as to deprive micro-organisms of metals such as Fe
2+
, Mn
2+
 and Zn
2+
 
100
. 
A rare disease called Specific Granule Deficiency (SGD) illustrates the importance of the 
gelatinase and specific granules. Neutrophils from these patients have abnormal bi-lobed 
nuclei, and lack expression of both specific and gelatinase granule proteins. This leads to 
an inability to infiltrate tissues, and defects in chemotaxis, receptor upregulation and 
impaired bactericidal activity
101
. SGD is an inherited disorder, which causes patients to 
suffer severe and recurrent infections
54,102,103
 and at least in some patients, reflects loss-
of-function mutations in the C/EBP factor gene which regulates the transcription of the 
relevant granule proteins. 
 
1.3.3 Specific granules  
The specific granules have some overlap in granule contents with the gelatinase granules 
(for example, both contain cytochrome b558) but have a different function; in particular, 
they play an important antimicrobial role
104–106
. Lactoferrin is the principal constituent of  
specific granules
107,108
. It is a member of the transferrin family of iron-binding proteins 
and impairs bacterial growth by the sequestration of iron 
109
. It is also capable of binding  
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to bacterial cell membranes via an N-terminal amphipathic α-helical region, causing 
irreversible membrane damage and cell lysis
110
. It has anti-microbial activity against a 
broad spectrum of gram-positive and gram-negative bacteria. Lactoferrin has recently 
been suggested to be a specific biomarker of cystic fibrosis pulmonary exacerbations
111
; 
however, as other granule proteins including NE are also implicated in these episodes, 
this probably reflects neutrophil activation and degranulation in general rather than a 
process specific to lactoferrin. 
Besides lactoferrin, the specific granules contain other bactericidal components including 
hCAP-18, a cathelicidin peptide that exerts antimicrobial effects against both gram-
negative and gram-positive bacteria and can induce chemotaxis of neutrophils, monocytes 
and T-cells. Another antimicrobial peptide present in the specific granules is neutrophil 
gelatinase-associated lipocalin (NGAL)
70,112
. This peptide can bind MMP-9, protecting it 
from degradation, but also plays a role in iron-depletion by means of its ability to 
sequester ferric-siderophore complexes
113
. In addition to its presence in neutrophil 
granules, NGAL is also produced by a variety of normal, inflamed and neoplastic 
tissues
114,115
. Urinary NGAL has been shown to be a sensitive and specific biomarker of a 
range of renal diseases such as acute renal injury
116
 and the interstitial nephritis associated 
with IgA nephropathy
117
. NGAL has also been suggested to be a key player in a range of 
different cancer types; its proposed functions range from inhibiting apoptosis (of thyroid 
cancer cells), invasion and angiogenesis (of pancreatic cancer) to increasing proliferation 
and metastasis (of breast and colon cancer) as reviewed in Chakraborty et al.
118
  
 
1.3.4 Azurophilic granules 
Azurophil granules are the last granules to be released and require the most potent stimuli 
(such as cytochalasin B, which is not a physiological compound) to induce major 
degranulation into the external milieu, although less potent stimuli may trigger a more 
limited release. Instead they are directed preferentially to fuse with phagosomes that 
contain engulfed pathogens
68,81
.  
Azurophil granules are defined by the presence of MPO, a 150 kDa microbicidal 
haemoprotein. MPO reacts with H2O2, a product of the neutrophil respiratory burst, to 
increase its toxic potential. Through oxidation of chloride, tyrosine and nitrite, the H2O2-
MPO system induces formation of hypochlorous acid and a number of other reactive 
intermediates, which can attack the surface membranes of microorganisms
119
. Besides 
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playing a role in bacterial killing, MPO has also been shown to modulate the immune 
response; El Kebir et al.
120
 have shown that MPO rescues human neutrophils from 
constitutive apoptosis and prolongs their lifespan, potentially delaying the resolution of 
inflammation. Furthermore it has been shown that MPO can disrupt endothelial cell (EC) 
function through β2-integrin-dependent neutrophil-EC contact, which mediates MPO 
transfer from neutrophils to ECs
121
; this process has been shown to play a role in 
atherosclerosis and vasculitis. MPO has also been associated with oxidative damage in a 
range of diseases including Parkinson’s disease122, diabetes mellitus123 and COPD124,125. 
In contrast to its pro-inflammatory functions, MPO can also dampen the inflammatory 
response by suppressing dendritic cell activation, function and migration
126
.  
Azurophil granules also contain serine proteases including NE, cathepsin G and 
proteinase 3. These proteases play an important role in the non-oxidative pathway of 
intracellular and extracellular pathogen destruction
127
. In the phagolysosome they 
contribute to microbial killing together with the NADPH oxidase system, which produces 
abundant reactive oxygen species to optimise protease activity
36
. Whilst redundancy of 
the serine proteases offers some protection from individual deficiencies, mice lacking NE 
and/or cathepsin G show enhanced susceptibility to bacterial infection
128,129
, fungal 
infection
130
, and mycobacterial infection
131
. Of particular relevance to the work described 
in this thesis, Reece and colleagues showed that serine protease activity plays an 
important role in the control of Mycobacterium tuberculosis in hypoxic lung granulomas 
in mice. Finally, mutations in the human elastase gene (ELANE) cause cyclical or severe 
congenital neutropenia syndromes, but the mechanism seems to relate to defective protein 
folding or processing
132
.   
Recently it has been shown that serine proteases, especially NE, also have regulatory 
functions during inflammation. Demonstrated functions include the release of active 
cytokines from their inactive precursors, the proteolytic cleavage/inactivation of active 
cytokines, proteolysis of cell surface bound cytokines and the activation of specific cell 
surface receptors, including Proteinase-activated receptors (PARs) and Toll-Like 
Receptor 4 (TLR4)
133
 (full list of NE targets can be found in the appendixes, section 8.1).  
Mihara et al.
134
 have shown that that both NE and Proteinase-3 can cleave the endothelial 
proteinase-activated receptor (PAR)-1 leading to impaired endothelial barrier integrity, 
and promoting neutrophil infiltration. Furthermore, NE has been shown to modulate the 
expression and activity of important inflammatory cytokines such as TNFα and G-CSF135 
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in the context of Pseudomonas aeruginosa-induced pneumonia. However, it is important 
to note that most of our knowledge of how NE regulates these targets comes from in vitro 
studies, and further studies are needed to assess the role of NE in the modulation of 
inflammation in vivo.  
Mice lacking NE are protected from lung injury in some models
136
, but the efficacy of 
neutrophil elastase inhibitors in human disease has been disappointing
137
. Neutrophil-
derived proteases have been implicated in the pathogenesis of CF (reviewed by Griese et 
al.
138
) and 90% of the elastolytic activity in CF sputum has been attributed to NE
139
, but 
again targeted therapeutic intervention has been unsuccessful
140
. Perhaps as a safety 
measure against over–activity of the serine proteases, the azurophil granules also contain 
a powerful endogenous anti-protease, alpha 1-antitrypsin (α1AT). This promiscuous 
inhibitor can bind and inhibit not only elastase, but also a range of other serine proteases. 
The majority of circulating α1AT is released by the hepatocyte; it is present in circulation 
at 1.5-3.5 g/L
141
. In patients with α1AT- deficiency low circulating serum levels of α1AT, 
leads to early onset and severe smoking-related pulmonary emphysema
142
. This is partly 
due to damage caused by over-activity of NE in the absence of an inhibitor as discussed 
further in section 1.5.1.  
Besides α1AT, other important endogenous serine protease inhibitors include secretory 
leukocyte protease inhibitor (SLPI) and elafin. SLPI can inhibit the serine proteases 
cathepsin G and NE, but not PR3. It can be found in all body fluids including bronchial 
secretions but the highest concentrations of SLPI are present in the upper airways. It is 
also produced by phagocytes including monocytes and neutrophils
143
 and, due its low 
molecular weight, it has unique access to the space between adherent neutrophils and the 
ECM, protecting it from degradation
144
. Elafin inhibits serine proteases PR3 and NE, but 
not Cathepsin G. It is mainly present in the skin, but like SLPI can also be found in 
bronchial secretions, produced by Clara cells and type II pneumocytes
143
. 
Further constituents of the azurophil granules include the α-defensins, which are small 
antimicrobial peptides with activity against a range of bacteria, fungi, enveloped viruses 
and protozoa
145,146
. They function by forming transmembrane pores
147
, and upon release 
into the extracellular matrix are able to induce chemotaxis of monocytes, CD4
+
 and CD8
+ 
T-cells
148
. Thus in summary, azurophil granule contents are essential for killing a range of 
pathogens but also contribute to tissue injury, with a particular predilection for lung 
damage.  
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1.4 Lung epithelial dysfunction and damage  
Neutrophil granule proteins have been strongly associated with lung epithelial cell 
damage and dysfunction. An example of the severe damage that can be caused by 
neutrophil degranulation is supplied by Soehnlein et al.
149
; they shown that a protein (M1) 
released by Streptococcus pyogenes induces degranulation of all neutrophil granule 
subsets by forming complexes with fibrinogen that bind to β2-integrins, resulting in acute 
lung injury in mice. Thus the respiratory epithelial surface is a highly relevant model in 
which to study the damaging effects of neutrophil granule proteins. 
 
1.4.1 Structure of the respiratory tract 
The lung epithelium is a complex system lining the airway spaces, which changes 
composition along the lungs to fulfil its functions including gas exchange, hydration, 
muco-ciliary clearance and host defence. The respiratory system extends from the nasal 
cavities to distal bronchia and alveoli structures and can be divided into two sections; the 
“Upper Respiratory Tract” and the “Lower Respiratory Tract”. The upper respiratory tract 
includes the nostrils, nasal cavities, pharynx, epiglottis and larynx
150
. The lower 
respiratory tract consists of the trachea, bronchi bronchioles and alveoli. The upper 
respiratory tract, trachea and large bronchi are lined with respiratory epithelium 
consisting of pseudo-stratifed columnar, ciliated epithelium with mucus-secreting goblet 
cells (discussed in more detail below). As bronchi progressively decrease in size, there is 
a gradual transition to ciliated simple columnar and finally simple cuboidal epithelium 
and an accompanying decrease in the number of goblet cells. In areas subjected to 
abrasion (eg. pharynx), respiratory epithelium is replaced by stratified squamous 
epithelium. Gas exchange occurs in the alveolus which consists of 3 cell types; type I 
pneumocytes which are simple squamous cells covering most of the alveolar wall, and 
type II pneumocytes which are cuboidal cells that produce surfactant 
151
. By acting to 
reduce the surface tension of the fluid lining the alveolar surface, surfactant helps to 
prevent collapse of the alveoli; surfactants are also responsible in part for the regulation 
of gas exchange
152
. The third cell type in this compartment is the alveolar macrophage, 
which is a resident phagocyte and scavenges particulates and micro-organisms. Adjacent 
alveoli form sandwich-like inter-alveolar septa consisting of the epithelial lining of the 
alveoli on each side and a thin layer of loose connective tissue between. This connective  
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tissue layer contains the extensive network of pulmonary capillaries, a few fibroblasts, 
some reticular fibres and numerous elastic fibres. This part of the lung is also known as 
the interstitium, and is affected in a number of inflammatory and fibrosing 
conditions
153,154
. Due to the lack of supporting cartilage and their small size, bronchioles 
are vulnerable to blockage and collapse. For example; in chronic bronchitis 
hypersecretion of mucus may lead to bronchiolar blockage
155
. 
 
1.5 The airway epithelium 
The airway epithelium contains a number of morphologically different cell types, which 
can be divided into three categories according to their function; basal cells, secretory cells 
and ciliated cells
156
. Basal cells are present throughout the large (50%) and small airways 
(81%) and can differentiate into secretory or ciliated cells
157
. Within the epithelium, basal 
cells are the only cells attached to the basement membrane, forming a scaffold for the 
other cells. They are able to release a number of bioactive molecules including neutral 
endopeptidase, 15-lipoxygenase products and cytokines
157
. Goblet cells are the main 
secretory cells present in the lung epithelium. They secrete mucin granules to form a 
mucus layer covering the epithelium, which traps foreign particles in the airway 
lumen
158,159
. This mucous layer is present in the airway from the trachea to the 
bronchioles. In normal, “healthy” airways there is a perfect balance between mucus 
production and clearance; in contrast, goblet cell hyperplasia can lead to excessive mucus 
production and has been associated with diseases like chronic bronchitis and asthma
160
.  
Another type of secretory cells found in the small airway, Clara cells, contain electron 
dense granules and play a role in the regulation of bronchial epithelial integrity and 
immunity
161
. Clara cells produce protease inhibitors such as the SLPI
162
 and have been 
shown to produce p450 mono-oxygenases, which can metabolise xenobiotic compounds 
such as the aromatic hydrocarbons present in cigarette smoke
163
. Ciliated cells 
differentiate from basal cells, and are the most prominent cell type present in the upper 
airway epithelium accounting for approximately 50% of all epithelial cells in this region.  
They have around 300 cilia per cell and contain many mitochondria to supply the energy 
for their main function, namely muco-ciliary clearance
156
. 
The muco-ciliary escalator provides a semi-permeable barrier that prevents most 
pathogens from penetrating the airway surface but still allows for the exchange of 
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nutrients and gas. It is highly effective as around 90% of inhaled particles including 
bacteria and viruses are cleared of the lungs via this route 
164
.  
The main components of the secreted mucous are the large, highly charged mucin 
molecules MUC5B and MUC5AC, which cross-link to form a viscoelastic gel to 
contribute to airway defence
165
. The mucus contains approximately 200 other proteins 
including antimicrobial compounds such as defensins, lactoferrin, lysozyme, nitric oxide, 
cytokines and anti-oxidants
166
. All inhaled particles interact with the lung epithelium and 
it is normally very effective in eliminating any “threats”. However, if this layer of 
defence is breached the epithelium is able to signal efficiently to immune cells as a 
variety of them reside within this layer, including mast cells, macrophages, dendritic cells 
and neutrophils
167
 (Figure 1.6). 
 
1.5.1 Role of neutrophil proteases in airway epithelial injury and lung disease 
The lung epithelium responds to infectious or inflammatory insults via stimulation of 
pattern recognition receptors (PRRs) such as Toll-like receptors (TLRs), leading to the 
release a range of inflammatory mediators including IL-1β and IL-8, which are both 
neutrophil chemo-attractants. The presence and actions of a range of immune cells 
present in, or adjacent to, the delicate epithelial cell lining can be either beneficial or 
detrimental; although they can respond quickly to limit infection, aberrant activation 
and/or function can cause substantial damage. 
In chronic inflammatory lung diseases such as COPD, CF and asthma, goblet cell 
hyperplasia is a common finding and is thought to contribute to the productive cough 
associated with these diseases
160
; NE is the archetypal neutrophil protease that has been 
shown to induce goblet cell hyperplasia
168
 and also to increase the expression of MUC5 
and other mucins
169,170
. Whilst other aspects of neutrophil biology such as ROS may 
contribute to epithelial damage and dysfunction, the following discussion focuses on the 
role of neutrophil-derived proteases in this setting. 
 
1.5.1.1 Role of NE in airway epithelial injury and lung disease 
Although NE and other neutrophil proteases have an important role in neutrophil-
mediated bacterial and fungal killing, they can also directly damage the ECM; NE and 
MMP-9 are capable of degrading almost every ECM component including collagen,  
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Figure 1.6: The lung epithelium in health and disease 
Healthy airways are protected from infection by the innate immune system; bacteria are 
cleared by the muco-ciliary escalator, by the action of anti-bacterial peptides, and by 
resident phagocytes. Pathogens which evade these first-line defences are ingested and 
killed by recruited neutrophils, which then undergo apoptosis and efferocytosis, 
controlling infection and limiting inflammation. In the inflamed airway (‘disease’), 
pathogens trigger the release of chemo-attractants, promoting the recruitment of 
neutrophils and other inflammatory cells. Although there is increased neutrophil 
infiltration, local or systemic hypoxia impairs bacterial killing and increases the release of 
proteases, resulting in muco-ciliary dysfunction and cellular and tissue injury. Finally, the 
pro-inflammatory state is perpetuated by increased neutrophil lifespan secondary to 
hypoxia and inflammatory cytokines. ECM: extra cellular matrix, EC: epithelial cell.  
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fibronectin, proteoglycans, heparin, and cross-linked fibrin
171
. Stockley et al.
172
 have 
shown that neutrophils moving in close proximity to ECM degrade it en passant, and that 
this degradation can be reduced but not abolished by α1-antitrypsin32.The inability of 
naturally occurring protease inhibitors to prevent NE-dependent damage completely has 
been attributed to a number of factors. One such factor is the phenomenon of quantum 
proteolysis, which refers to the fact that NE molecules vastly outnumber inhibitor 
molecules in the immediate peri-cellular zones
34
. Another suggested mechanism is that 
upon degranulation, serine proteases bind to the neutrophil cell surface, and these bound 
proteases are remarkably resistant to protease inhibitors, a finding that has been attributed 
to steric hindrance
33,173
.  
The installation of elastase in the lungs of experimental animals (usually porcine 
pancreatic elastase, but the model is phenocopied when human NE is used) induces 
emphysema in a dose-dependent fashion
174,175
. Likewise, transgenic mice lacking NE are 
protected from cigarette smoke-induced emphysema
136
. This evidence, together with the 
observation that in humans, α1-AT deficiency predisposes to early onset emphysema
176
 
led to the protease:antiprotease imbalance hypothesis of COPD
177
, which proposes that 
alveolar and interstitial tissue destruction is driven by excessive proteolysis. In healthy 
individuals α1-AT is produced in abundance by hepatocytes; in individuals with α1-AT 
‘deficiency’, α1-AT polymers accumulate in the ER of hepatocytes and secretion is 
impaired, which leads to the observed reduction in circulating protein; when this is 
combined with the recruitment of neutrophils into the bronchi and interstitium by 
cigarette smoke, failure of local pulmonary elastase inhibition results in smoking-induced 
lung tissue destruction and early emphysema
178
. Therapeutic replacement (or 
‘augmentation’) of α1-AT in this disease has been shown to improve some parameters 
such as radiological disease progression; however to date, robust evidence of clinical 
benefit from augmentation therapy is lacking. This may reflect under-powering of trials, 
the initiation of augmentation therapy at too late in the disease process, or it may indicate 
that the pulmonary disease seen in α1-AT deficiency is not caused by a lack of functional 
α1-AT alone.  
In addition to its elastolytic activity, NE has a range of immune-modulatory effects. It has 
been shown to cleave critical components of the bronchial defences, such as the C3Bi 
opsono-phagocytic receptor CR1
179
 and immunoglobulins
180
, reducing the ability of the 
airway tissue to retain sterility in diseases such as cystic fibrosis. Additionally, NE has 
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been shown to degrade short palate, lung, and nasal epithelial clone 1 (SPLUNC1), which 
destroys its natural antimicrobial activity. NE-dependent SPLUNC1 degradation 
increased the non-typeable haemophilus influenza (NTHi) load in human airway 
epithelial cells, and SPLUNC1 KO mice had a higher bacterial load in the lungs then WT 
mice. Furthermore, SPLUNC1 is reduced in the lungs of COPD patients, potentially 
increasing airway susceptibility to infection
181
.  
Perhaps as a consequence of its immune-modulatory functions and its ability to degrade 
ECM components, NE has been implicated in a range of inflammatory diseases. For 
example, inhibition or lack of NE has been shown to reduce neutrophilic infiltration in 
neutrophil-mediated injury models such as ischaemia-reperfusion injury
182
, endotoxin-
induced lung injury
183
 and ventilator-induced lung injury
184
. Lack of NE significantly 
reduced airway neutrophilia, mucin expression, goblet cell metaplasia, and distal airspace 
enlargement in a mouse model of cystic fibrosis
185
. NE contributes to the progression of a 
range of cancers by enhancing tumour invasion and metastasis
186,187
. Together, these data 
indicate that the modulation of NE secretion and function may be a promising target for 
therapeutic intervention. A recent Phase II study of AZD9668, a newly developed oral 
NE inhibitor, in patients with bronchiectasis, reported some improvement in lung 
function, with a trend towards a reduction in sputum inflammatory biomarkers
188
. 
However the improvements were small, indicating that inhibition of NE alone might not 
be enough to prevent inflammation and further damage, and that other neutrophil-derived 
products may contribute to disease pathogenesis.  
 
1.5.1.2 Role of MPO in airway epithelial injury and lung disease 
The presence of MPO defines the azurophil granule population, and its heme moiety is 
responsible for the green colour of secretions rich in neutrophils, such as pus and sputum. 
It is also expressed (to a lesser degree) by monocytes and macrophages.  Like NE, MPO 
has been associated with tissue damage in a range of diseases and disease processes; for 
example, elevated leukocyte and blood MPO levels have been associated with the 
presence of coronary artery disease
189
, and MPO-directed autoantibodies are associated 
with a range of vasculitis
190
, in particular granulomatosis with polyangiitis (formerly 
known as Wegener’s granulomatosis). MPO, together with other circulating neutrophil 
degranulation products, has been suggested to be a possible biomarker in CF
111
, and MPO 
presented on the surface of NETS has been associated with Pseudomonas-induced airway 
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damage
191
. Serum MPO levels are associated with rapid lung function decline and poorer 
cardiovascular outcomes in COPD patients
192
 and 3-Chlorotyrosine, a specific product of 
MPO oxidative activity, was shown to be upregulated in COPD sputum
193
. Late 
intervention with the MPO inhibitor AZ1 in a guinea pig cigarette smoke exposure model 
of COPD stopped the progression of emphysema and small airway remodelling and was 
partially protective against pulmonary hypertension
125
. These studies suggest that the role 
of MPO in COPD warrants further investigation; however, as the authors note, positive 
findings in animal models of COPD have a disappointing record of failure in human 
disease
194
. 
Like NE, MPO has been shown to upregulate the inflammatory response directly; MPO 
internalised by endothelial cells leads to IL-6, IL-8, and ROS release
195,196
 (although 
others have shown that MPO can also inhibit IL-8 release by bronchial cells
197
). MPO is 
capable of inducing oxidative stress in inflammatory states, especially in the presence of 
cigarette smoke
38,198
, and neutrophil MPO content is increased in smokers
199
.  
 
1.5.1.3 Role of MMP-9 airway epithelial injury and lung disease 
MMP-9 is a component of the gelatinase granules and is capable of degrading major 
structural components of the ECM, including collagen, laminin, and gelatin, allowing 
neutrophil extravasation and migration
30,89,90
. However, indiscriminate MMP-9 release 
can also cause substantial damage. MMP-9 has been related to parenchymal destruction 
and lung function decline in both subclinical and established emphysema
200,201
. Other 
studies have shown MMP-9 to be elevated in the sputum of patients with COPD in 
comparison to healthy control subjects, and MMP-9 sputum levels were found to 
correlate with decreased lung function
94,202,203
. Because neutrophils do not synthesise the 
MMP-9 anti-protease TIMP-1, substantial and unrestrained release of this enzyme can 
occur
204
. Vlahos and colleagues
67
 demonstrated a major up-regulation of MMP-9 in the 
BAL fluid of patients with COPD and noted a striking correlation with disease severity 
(21-fold increase in MMP-9 activity in GOLD II versus GOLD IV disease); upregulation 
of NE was noted in the same samples, and it is noteworthy that NE can degrade TIMP-1, 
further promoting the action of MMP-9
205
.  
Thus there is abundant evidence that a range of neutrophil-derived proteases contribute to 
the pathogenesis of COPD and other inflammatory lung diseases and to the persistence of 
the inflammatory phenotype in these conditions.
94,199–202,206–210
 Therapeutic strategies to 
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control this aspect of neutrophil function may need to be directed at the broader spectrum 
of neutrophil-derived proteases rather than an individual target, and could be more 
beneficial if administered early in the course of disease before major irreversible tissue 
destruction occurs. Interventions aimed at limiting neutrophil degranulation would ideally 
target extracellular protease release and not inhibit the delivery of granules to the 
phagosome. 
 
1.6 Mechanisms of neutrophil degranulation 
The mechanisms of neutrophil degranulation are complex and only partially delineated 
(Figure 1.7). Different ligands have been shown to have different effects on 
degranulation; for example, stimulation with low nanomolar concentrations of the 
bacterial-derived tripeptide fMLP alone results in a rapid and almost complete discharge 
of secretory vesicles without significant release of the other granule populations
81
, whilst 
priming with agents such as TNFα augments granule release including the liberation or 
MPO from the azurophilic granules; stimulation with the pharmacological agent PMA 
(phorbol myristate acetate) alone leads to extensive release of gelatinase granules, 
moderate release of specific granules and low grade release of azurophil granules
68,70
.  
In general, exocytosis of the granules occurs in 4 steps; upon receptor stimulation 
granules are recruited from the cytoplasm to the target membrane (phagosome membrane 
or cell membrane). This process is dependent on actin cytoskeletal- and microtubule-
remodelling
211
. The next step is vesicle tethering and docking, followed by granule 
“priming” (ensuring rapid fusion) in which a reversible fusion pore structure develops 
between the granule on the target membrane, and the final step is the rapid fusion 
between the granule and target membrane
212
.  
Resting neutrophils contain a cortical actin ring that forms a barrier against granule 
docking and fusion; this is rapidly disassembled upon receptor ligation and exocytosis
212
. 
Jog et al.
213
 demonstrated that actin is associated with all granule subsets and that 
disruption of the actin cytoskeleton by latrunculin A or cytochalasin D led to enhanced 
basal and fMLP dependent degranulation, implying an active role for actin in granule 
exocytosis. Conversely tetracaine, which causes enhanced accumulation of F-actin in the 
periphery of fMLP-stimulated cells, inhibits degranulation
214
. It was postulated by Lacy 
et al.
212 
that cytoplasmic filamentous (F)-actin formation is required for primary granule 
exocytosis and that, as granules co-localise with polarised  
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Figure 1.7 Neutrophil signalling pathways involved in degranulation 
GPCR ligation results in signalling through the heterotrimeric G-proteins of the Gi/o 
family; activation leads to the dissociation of the GPCR-specific Gα subunit from the 
shared Gβγ dimer which triggers the activation of two signalling events: 1. Activation of 
PLCβ leads to diacylglycerol formation and hence activation of PKC, and to the 
hydrolysis of PIP2, generating IP3. Elevation of intracellular IP3 leads to an increase in 
intracellular Ca
2+
 release from the endoplasmic reticulum.  2. Activation of PI3Kγ 
induces the production of PIP3 by phosphorylation of PIP2. Ligation of integrins and of 
cytokine receptors induces activation of tyrosine kinases, leading to the activation of PLC 
and eventually to a rise in Ca
2+
 levels. PI3K activation is also mediated by integrin and 
cytokine receptor binding. 
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F-actin during activation, cytoskeletal remodelling triggers the formation of actin “tracks” 
to guide granules to the target membrane for exocytosis. As actin 
polymerisation/reorganisation plays an important role in not only degranulation but 
inmany features of neutrophil function, including migration and the ROS response, 
signalling pathways regulating these functions may overlap.  
 
1.6.1 Receptors regulating degranulation 
Neutrophils express a large range of cell surface receptors to sense damage or danger, 
including receptors for the recognition of microbial structures, receptors involved in 
activation of the adaptive immune system, and receptors involved in recognising an 
inflammatory environment (as summarised in Futosi et al.
7
). These receptors initiate a 
range of complex intracellular signalling pathways that lead to the induction of an 
appropriate spectrum of responses, including neutrophil chemotaxis, activation, 
phagocytosis, ROS production, degranulation, NET release, and cytokine release.  
The receptors present on the neutrophil surface can be divided into a number of classes; 
G-protein-coupled seven-transmembrane domain receptors (GPCRs), Fc-receptors, 
adhesion molecule ‘receptors’ such as integrins, cytokine receptors and pattern 
recognition receptors (Toll-like receptors and C-type lectins). Of these receptor classes, 
Fc receptors, integrins and GPCRs have been shown to induce neutrophil 
degranulation
215,216
. Fc-mediated neutrophil interaction with immune complexes has been 
shown to induce degranulation
217
 through Src family kinase signalling leading to a rise in 
intracellular calcium levels
215
. The combination of integrin-dependent neutrophil 
adhesion plus stimulation with inflammatory mediators also results in degranulation
218,219
. 
However, most of the research into the signalling pathways involved in degranulation has 
focussed on GPCR signalling. Neutrophils express a range of different GPCRs, including 
those that recognise chemokines and chemoattractants such as IL-8, platelet activating 
factor (PAF) and leukotriene B4, and those that recognise bacterial products (formyl-
peptide receptors). 
The archetypal ligand for the latter is the formylated tri-peptide fMLP, which is often 
used to interrogate neutrophil functional responses such as degranulation. GPCR ligation 
results in signalling through the pertussis toxin-sensitive heterotrimeric G-proteins of the 
Gi/o family; activation leads to the dissociation of the GPCR-specific Gα subunit from the 
shared Gβγ dimer and subsequent activation of various signal transduction pathways7.  
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It is currently thought that the majority of signal transduction in neutrophils occurs 
through the Gβγ dimer and not the Gα subunit220,221.   
 
1.6.2 Phospholipid and kinase signalling in degranulation 
Stimulation of GPCRs by IL-8 or fMLP leads to the dissociation of the Gβγ dimer from 
the Gx subunit, triggering activation of two phospholipid-based signalling cascades 
relevant to degranulation: firstly, the phosphoinositide 3-kinase (PI3K) pathway, which 
induces the production of phosphatidylinositol (3,4,5)-trisphosphate (PIP3) from 
phosphatidylinositol (4,5)-bisphosphate (PIP2)
222
 and secondly phospholipase C-β 
(PLCβ), which leads to both the activation of Protein Kinase C (PKC) isoforms (via the 
generation of diacylglycerol) and also to the hydrolysis of PIP2, generating inositol 1,4,5-
trisphosphate (IP3) and hence regulating calcium signalling
223,221
.  
That PI3K plays a fundamental role in degranulation is illustrated by a number of studies 
including that of Kampe et al.
224
, who showed that neutrophil degranulation in vitro can 
be inhibited by the PI3K-inhibitor Wortmannin, and also Fensome et al.
225
, who showed 
that PI3Kγ is required for granule exocytosis from permeabilised HL-60 cells, a 
neutrophil-like cell line. However, little data has been published regarding the precise 
PI3K-isoform controlling neutrophil degranulation, although of note PI3Kγ is known to 
specifically regulate mast cell degranulation
226
. Phospholipase D (PLD) has also been 
shown to influence neutrophil degranulation via the generation of phosphatidic acid 
(PA)
216,227
, although recently others have shown that PLD is entirely dispensable for 
neutrophil degranulation in mice
228
. Elevation of intracellular IP3 leads to an increase in 
intracellular Ca
2+
 by release of stores from the endoplasmic reticulum (ER)
229
. The 
important role of IP3 and the resultant rise in intracellular Ca
2+ 
in degranulation was 
supported by the work of Reeves et al.
230
 who found that recombinant SLPI inhibited 
fMLP-induced degranulation populations, and that this was restored by the incorporation 
of exogenous IP3 into electro-permeabilised cells. Ligation of integrins and of cytokine 
receptors activates tyrosine kinases leading to the subsequent activation of PLC and 
thence to a rise in Ca
2+
 levels
231,232
. 
 
1.6.3 Calcium signalling in degranulation 
Translocation and exocytosis of neutrophil granules requires an increase in intracellular 
Ca
2+
 
233,234
. Receptor ligation induces a rise in intracellular Ca
2+
 levels that is biphasic; 
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the first phase is secondary to Ca
2+
 release from IP3-sensitive intracellular stores such as 
the ER, and the second phase is due to Ca
2+
 influx from the extracellular space
235
. It has 
been found that the hierarchy of granule exocytosis is linked to the magnitude of increase 
in intracellular Ca
2+
 levels, with secretory vesicle release triggered by a minor increase, 
and a far more significant elevation being required to stimulate azurophil granule 
exocytosis
233,236
. A rise in Ca
2+
 can be induced by a number of stimuli, including ligation 
of GPCRs (e.g. those for fMLP/IL-8) and L-selectin and integrin engagement
233,237,238
.  
The specific target molecules influenced by Ca
2+
 transients in neutrophils are unknown, 
but potential candidates include annexins
239,240
, PKC
241
 and calmodulin
242
, all of which 
bind Ca
2+ 
to modulate their activities and are involved in the degranulation process. The 
role of calmodulin is supported by data from Nagaji et al.
243
, showing that a 
Ca
2+
/calmodulin-coupling inhibitor prevents MPO release.  Annexins are a group of 
phospholipid-binding proteins that mediate vesicle aggregation and membrane fusion 
when exposed to high concentrations of Ca
2+
 
244
. Several annexins have been identified in 
neutrophils and appear to promote a calcium-dependent fusion event in vitro, including 
annexin I
245
, annexin XI
246
 and lipocortin III
244
. Furthermore, Zou et al.
247
 show that 
stored-operated Ca
2+ 
entry plays a role in neutrophil polarisation by the downstream 
regulation of Akt and Src family kinases and Rho-family small GTPases including Rac. 
As actin polymerisation plays an important role in polarisation and in degranulation, 
cytoskeletal reorganisation may represent another route by which Ca
2+ 
modulates 
neutrophil function. 
 
1.6.4 Src family kinases in degranulation 
Tyrosine kinases, especially the Src family of non-receptor tyrosine kinases, have also 
been implicated in neutrophil degranulation, although the mechanism of tyrosine 
activation through GPCRs is poorly understood. 
Neutrophils express 3 members of the src tyrosine kinase family - Hck, Fgr and Lyn – all 
of which are activated by fMLP-GPCR ligation
248
; their inhibition (by Src family kinase 
inhibitor PP1) prevents the release of all granule subsets
249
. Research performed with 
Hck
-/-
Fgr
-/-
 double and Hck
-/-
Fgr
-/-
Lyn
-/- 
triple knockout neutrophils showed that 
deficiency in these kinases leads to a failure of granule release and also impaired ROS 
production in response to fMLP
249,249–251
. Src kinase deficiency also resulted in reduced 
activation of JNK (c-Jun N-terminal kinase) and p38 MAPK (mitogen-activated protein 
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kinase) and impaired activation of Rac, but did not affect Ca
2+ 
signalling, suggesting that 
these pathways may mediate parallel non-Ca
2+
-dependent events required for 
degranulation and/or the downstream effects of Ca
2+
. Further studies have shown that the 
different Src tyrosine kinases have a particular affinity for certain granule populations 
suggesting separate and regulated release of different granule populations; for example 
Fgr associates with the specific granules
252
, whereas Hck associates with the azurophil 
granules
253
.  
The Src family of tyrosine kinases has a number of known downstream targets, which 
affect degranulation; Hck and Fgr have been shown to regulate the activation of the Rho 
guanine exchange factor (GEF) Vav1 to signal through Rac, inducing actin 
polymerisation and ROS release
251
. Additionally, the Src family kinases have been shown 
to work upstream of p38 MAPK as Hck
-/-
Fgr
-/-
Lyn
-/- 
triple knockout neutrophils show 
reduced p38 MAPK activity and the p38 MAPK inhibitor SB203580 led to reduced 
azurophil and specific granule release
249,254
.  
Data from Simard et al.
255
 also support a role for p38 MAPK, but not ERK (extracellular 
signal-regulated kinase)1/2 in neutrophil degranulation. They showed that S100A9, a pro-
inflammatory protein present in the neutrophil cytosol (and also expressed by activated 
endothelial and epithelial cells), induced degranulation via a p38 MAPK-dependent 
pathway. Other cytoplasmic tyrosine kinases that are expressed in neutrophils and have 
been implicated in degranulation are Syk and PyK2 (proline rich kinase2). Syk works 
downstream of integrin signalling and is involved in actin and microtubulin 
polymerisation; Syk deficiency impairs integrin- and Fc-mediated receptor-mediated 
neutrophil activation resulting in defective adhesion, ROS production and 
degranulation
256
 and impaired neutrophil-dependent host defence in vivo
257
. Pyk2 is 
activated upon integrin ligation and subsequent association with Src family 
kinases
258
.Kamen et al.
259
 showed that Pyk2 participates in cell migration and 
degranulation, as Pyk2 deficient mouse neutrophils display impaired adhesion- dependent 
degranulation.  
Recently proteomic approaches have been employed to help identify the downstream 
targets of protein kinases including Hck and Fgr. Luerman et al.
260
, identified 
phosphoproteins that were associated with the gelatinase and specific granules after fMLP 
stimulation, supplying new candidates that may potentially play a role in degranulation 
including known regulators of vesicle trafficking. Several potential regulators of 
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membrane trafficking and exocytosis were identified in this screen, including N-
ethylmaleimide sensitive factor (NSF), small molecular weight GTPases, GTPase 
regulators and effectors, and proteins known to regulate cytoskeletal re-arrangement and 
stability. 
 
1.6.5 GTPase signalling in degranulation 
GTP-binding proteins act as molecular switches in processes such as cell survival, 
transcriptional regulation and vesicle trafficking, cycling between active (GTP-bound) 
and inactive (GDP-bound) states
229
, with their activity regulated by GEFs. Two GTP-
binding proteins (Rho and Rac) have emerged as major players in cytoskeletal re-
organisation, directed migration of neutrophils (chemotaxis) and degranulation
261,262
. Rac 
is present as 3 isoforms; Rac1, Rac2 and Rac3. Although both Rac1 and Rac2 are 
expressed in neutrophils, Rac2 predominates in human cells
263
, while mouse neutrophils 
also express Rac1 in addition to Rac 2. It has been shown that Rac2 plays an essential 
role in neutrophil degranulation; genetic deletion of Rac2 in mice affects cytoskeletal re-
organisation and leads to complete loss of azurophil granule release from murine bone 
marrow neutrophils 
83,264
.  
However, specific and gelatinase granule release is not altered in Rac2
-/- 
neutrophils; this 
suggests a non-redundant role for Rac2 in azurophil granule release only. It is possible 
that Rac1, which is present in mouse but not human neutrophils, supports specific and 
gelatinase granule release in this context, whilst Rac2 might still support such a function 
in human cells.A recent paper from Baier et al. 
265
 investigated the role of Rac1 and Rac2 
antigen-stimulated exocytosis in mast cells. Their data suggest that Rac isoforms play 
distinct roles in mast cell exocytosis, with Rac1 mediating membrane ruffling and Rac2 
signalling calcium influx. Rac2
-/- 
neutrophils have also been shown to exhibit impaired 
adhesion
266
, likely due to impaired Rac2-mediated actin re-organisation. Data produced 
by Mitchell et al.
267
 showed that fMLP-mediated azurophil granule release was enhanced 
by compounds such as Latrunculin B and Cytochalasin B, which mediate actin-
depolymerisation, but the opposite effect (reduced degranulation) occurred on F-actin 
stabilisation by Jasplakinolide or on inhibition of actin remodelling by the small molecule 
Rac inhibitor NSC23766.  
The exact signalling pathway(s) mediating Rac-dependent degranulation are still under 
investigation, but a number of possible downstream targets have recently been 
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identified
268,269
. For example, the GEF P-Rex-I is activated by PIP3 and regulates Rac 
directly
268
 and also indirectly by acting as a GEF for the upstream GTPase RhoG
269
. 
Although this pathway might link PI3K signalling to actin polymerisation via Rac, Welch 
et al.
270
 have also shown that P-Rex1 is not an essential regulator of neutrophil 
degranulation. p21-activated kinase (PAK) is a well-established Rac binding protein that 
is known to regulate the conformation of the actin cytoskeleton and hence motility of 
mammalian cells
271
. PAK is activated upon fMLP stimulation of neutrophils and 
accumulates at the actin-rich leading edge, thus implicating this serine/threonine kinase in 
Rac-dependent actin remodelling in this setting. PAK inhibition impaired neutrophil 
polarisation and directional migration towards an fMLP gradient, and was associated with 
dysregulated Ca
2+
 signalling
272
. A similar role for PAK in mast cells was found by Allen 
et al.
273
 who demonstrated importantly that PAK plays a role in mast cell degranulation 
through its effects on Ca
2+
 signalling and cytoskeletal remodelling.  
Together these data suggest a possible role for PAK in neutrophil degranulation, as mast 
cell signalling pathways has been shown to have some parallels with the analagous 
neutrophil pathways
274,275
. More recent proteomic studies (eg Eitzen et al.
276
) have 
identified further novel proteins that may play a role in Rac-mediated degranulation 
including actin remodelling proteins such as HSP60, the F-actin binding protein coronin-
1A, and the F-actin capping protein (CapZ-β); as yet however the relevance of these 
findings is unclear. Rho-family kinases such as Rac are mainly involved in the early 
phase of exocytosis that is dependent on actin cytoskeletal remodelling. Another family 
of GTPases - the Rab family - have been implicated in the more downstream aspects of 
exocytosis including vesicle transport and docking
277,278
. Chaudhuri et al.
279
 identified 3 
Rab GTPases that co-purify with neutrophil granules, namely Rab3, Rab4 and Rab5. The 
role for Rab3 and Rab4 in neutrophil degranulation is currently unknown, but Rab5a 
directs intracellular fusion of granules with pathogen-containing phagosomes
280
. 
Additional Rab isoforms mediate vesicle docking in other cell types including neural and 
endocrine cells (Rab3)
281,282
 and cytotoxic T-cells (Rab27)
283
. Thus a range of GTPases 
are involved in various steps of the degranulation signalling pathway, but more 
information is needed to elucidate their exact function(s) in the neutrophil. 
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1.6.6 SNAP/SNARE proteins in degranulation 
The pathways linking intracellular Ca
2+
 transients and degranulation are not fully 
understood, but are thought to involve SNAP receptor (SNARE) proteins, which are 
important in vesicle docking and fusion
284
. This system consists of the recognition of a 
membrane-bound ligand present in the granule membrane by a membrane-bound receptor 
on the target membrane
285
. A range of SNARE proteins have been identified in 
neutrophils, including vesicle-associated membrane protein-2 (VAMP-2), which is 
located on the membrane of secretory vesicles, gelatinase and specific granules
286
, 
syntaxin-4 and -6, which can be found at the plasma membrane
286,287
, and synaptosome-
associated proteins (SNAPs)-23 and 25, which are present mainly on the peroxidase 
negative granules (specific and gelatinase granules)
286,288,289
.  
Another SNARE protein found in neutrophils, syntaxin-11, is located predominantly on 
the azurophil granule membrane with some expression on the selective and gelatinase 
granules. The density of VAMP-2 corresponds to the hierarchy of degranulation, and 
antibodies against SNAP-23 and syntaxin-6 inhibit Ca
2+
-induced secretion of the specific 
granules and the azurophil granules respectively
289
. SNARE proteins have shown to 
interact with other proteins to regulate degranulation including SNARE-interacting 
Sec1/Munc18 family members. Brochetta et al.
290
 show that Munc18-2 and Munc18-3 are 
expressed by neutrophils, interact with SNARE proteins syntaxin-3 (Munc18-2) and 
syntaxin-4 (Munc18-3), and are associated with neutrophil granules. Both Munc18-2 and 
Munc18-3 can also be found in plasma membrane fractions and in the cytoplasm, where 
they associate with cytoskeletal elements. Upon stimulation both isoforms are 
redistributed to the granule and plasma membrane and Munc18-2 inhibition by antibodies 
blockes primary granule release
290
. Zhao et al.
291
 provided further evidence to support a 
role for Munc18-2 in neutrophil degranulation; they found that mutations in the Munc18-
2 gene cause the rare genetic disorder familial haemophagocytic lymphohistiocytosis 
(FHL) type 5, and lead to a profound defect of neutrophil granule mobilisation and 
consequently impaired bacterial killing.  
Thus there are still many gaps in our knowledge of the signalling pathways regulating the 
key neutrophil function of degranulation. There is evidence that both separate and 
overlapping pathways exist to control the release of the differing granule populations, and 
greater understanding of these details could provide ways to inhibit or promote the release 
of individual granule populations without affecting other neutrophil functions.  
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This could allow either novel investigative techniques and reveal new therapeutic 
avenues. 
 
1.7 Effects of cigarette smoke on neutrophils  
COPD is characterised by persistent local and systemic inflammation, leading to a 
progressive decline in lung function. Cigarette smoke (CS) is the main risk factor for the 
development of COPD, although the majority of smokers do not develop this disease. 
Even after smoking cessation patients with established COPD exhibit a continuous cycle 
of airway inflammation leading to ongoing decline in lung function
292
, indicating 
persistent activation of inflammatory cells. CS is a multicomponent mixture of gas-phase 
and particle-phase toxins with known immunomodulatory function, carcinogenic activity, 
and addictive activities. Components of CS include metals, volatile hydrocarbons, gas-
phase components such as carbon monoxide, polycyclic aromatic hydrocarbons (PAHs), 
acrolein, and reactive oxygen species. Since exposure of submerged culture cells to CS is 
difficult to achieve in the laboratory setting, cells are usually exposed to either CS extract 
(CSE, obtained by condensing CS in a cold trap) or CS medium (CSM), which is 
prepared by bubbling CS through a tissue culture medium; the content and properties of 
CSM and CSE may differ, perhaps giving rise to the rather surprising variability of results 
in the reported literature. 
As with the direct installation of NE, exposure of mice to CS recapitulates emphysema, 
and neutrophil recruitment is a key component of this model
293–295
. Since neutrophils are 
thought to play a key role in COPD pathogenesis, the direct effects of cigarette smoke on 
neutrophils has been investigated in vitro, albeit to a somewhat limited extent. Koethe et 
al.
296
 detected a priming effect of CSE on neutrophils, leading to increased NE release 
and ROS generation on stimulation with fMLP.  They also suggested that CSE induced an 
increase in fMLP receptor and integrin expression on the neutrophil membrane. In 
contrast to these results, Zappacosta et al.
297
 and Matthews et al.
298
 found a reduction in 
stimulated neutrophil ROS formation following CSM pre-incubation, whilst Mortaz et 
al.
299
 and Overbeek et al. 
300
 found that CSM induced the production of reactive oxygen 
species, IL-8, NE, MMP-2 and MMP-9 directly. The variability in these results may 
reflect significant inconsistencies in the methodology used, for example differing pre-
treatment times and the use of CSM or CSE; overall however the results suggest that 
cigarette smoke may induce a neutrophil phenotype that is detrimental to defence from 
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infection but which promotes tissue injury. These effects are similar to the effects of 
hypoxia; however the synergistic effects of hypoxia and cigarette smoke have not been 
previously investigated. 
 
1.8 Hypoxia  
1.8.1 Physiological and pathological hypoxia  
A range of oxygen tensions exist throughout the body even under physiological 
circumstances, ranging from 13 kPa in the arterial blood to 2.3 kPa in the spleen
301
, with 
even lower oxygen tensions of around 0.5-1 kPa in the skin 
302
, skeletal muscle
303
 and gut 
wall
304
 (Figure 1.8A). Different oxygen tensions exist even within a single organ such as 
the liver, from 0.13 kPa in the venous sinusoid to 8 kPa in the portal regions
305,306
. Cells 
present in the circulation such as leukocytes are exposed to oxygen tensions varying from 
around 13 kPa in the alveolar capillaries to approximately 5 kPa in mixed venous blood 
and venous capillaries. Upon migration to the lymphoid organs leukocytes may be 
exposed to oxygen tensions as low as 0.5 kPa 
307
. Although these oxygen tissues are 
extremely low, this cannot be called hypoxia as this is a normal physiological state for 
these cells and or organs. Generally hypoxia exsists because there is an insufficient 
supply of oxygen in relation to demand. Physiological hypoxia occurs when there is an 
inadequate supply of oxygen to the body as a whole as for example at high altitude.  
Pathological hypoxia occurs often at sites of infection and injury. Hypoxia in this setting 
can be caused by impaired blood flow, leading to a disruption of oxygen delivery, and/or 
by influx of inflammatory cells creating a situation where oxygen demand exceeds 
supply. Pathological tissue hypoxia (and in some situations systemic hypoxia) is a 
prominent feature in many disease states, and has been reported to have both positive and 
detrimental effects. Campbell and colleagues
308
 have shown that neutrophil-dependent 
depletion of oxygen is integral to and promotes the resolution of inflammation in a mouse 
colitis model. Additionally, there are data demonstrating that hypoxia with subsequent 
HIF-1α, stabilisation (section 1.8.3.1) plays an important role in wound healing309, 310,311. 
Whereas HIF-1α stabilisation promotes wound healing, HIF-2α deletion induced an 
accelerated rate of wound closure 
311
 
In the setting of liver transplantation, ischaemic pre-conditioning (10 min vascular 
clamping) prior to organ harvest improved biochemical markers of liver function and 
reduced liver donor cell apoptosis and transplant non-function
312
. Such ischaemic pre- 
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Figure 1.8: Hypoxia is present in physiological and pathological circumstances.  
A. A range of different oxygen tensions exist throughout the body under physiological 
circumstances; ranging from 13 kPa in the arterial blood to 6 kPa in the brain and 
substantially lower oxygen tensions of around 0.5-3 kPa in the skin, muscle and gut.  B. 
Axial and coronal PET-CT images of a human patient with pulmonary tuberculosis.  The 
presence of hypoxic areas (white areas, see arrows) is shown using the hypoxia tracer 
[
18
F] F-MISO (adapted from Belton et al.
313
) C. Local tissue hypoxia is present in 
inflammation as demonstrated in this image which shows a section of mouse lung 
infected with Aspergillus spp and stained for the pathogen (green), inflammatory cells 
(blue) and for hypoxic areas with hypoxyprobe-1 (red, adapted from Grahl et al.
314
).  
A  
 
B C 
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conditioning has been tested in other clinical settings and is thought to work by pre-
adapting the organ or tissue to hypoxia and hence reducing subsequent ischaemia-
reperfusion injury (reviewed by Brooks and Andrews
315
). Even more remarkably, brief 
cycles of ischemia and reperfusion in the arm or leg may protect the heart against injury 
following coronary artery occlusion and reperfusion, a phenomenon known as remote 
ischemic pre-conditioning. The mechanism by which this technique confers benefit is 
uncertain; whilst one group found that the value of remote ischaemia was dependent on 
HIF-mediated IL-10 transcription
316
, another group found that HIF up-regulation was not  
required
317
. In contrast, the physiological responses to hypoxia have been shown to be 
detrimental in other pathological settings. An example of this is tumour formation. 
Tumours are often hypoxic
318
 due to rapid cell proliferation and insufficient or 
disorganized neovascularisation and tumour hypoxia is associated with resistance to 
chemotherapy and tumour metastasis. HIF-1 regulates glycolysis and the pentose 
phosphate pathway, and these cellular metabolic pathways increase the antioxidant 
capacity of tumours, thereby countering the oxidative stress caused by irradiation. HIF-1 
upregulation further stimulates tumour cells to produce VEGF and other pro-angiogenic 
factors, which induce angiogenesis and protect the microvasculature from radiation-
induced endothelial apoptosis. 
Hypoxia has also been shown to play a role in a range of other diseases; it up-regulates 
RAGE receptor expression in murine and human cystic fibrosis and its expression is 
associated with infection related, lung disease severity
319
. Belton et al.
313
 show the 
presence of hypoxic areas in patients with Mycobacterium tuberculosis (MTB); this was 
demonstrated using PET-CT scanning and the hypoxia tracer [
18
F] F-MISO (Figure 18B); 
hypoxia potently upregulated MMP-1 in MTB-stimulated primary human monocyte-
derived macrophages and in respiratory epithelial cells, and these proteases may 
contribute to the tissue damage (cavitation) that is so characteristic of this infection.  
Others have shown that hypoxia induces an endothelial cell response similar to that seen 
in systemic inflammation, with upregulation of IL-1
320
, IL-6
321
, IL-8
322
, PAF and ICAM-
1 expression 
323,324
. Changes in oxygen tension and HIF activation have a profound effect 
on cell function as described below. However, hypoxia may also exert HIF-independent 
effects, and there is limited knowledge about primary human cell function under hypoxia, 
especially in relation to the immune system. This is of significance, since sites of 
infection and injury can be profoundly hypoxic. Hypoxia in this setting can be caused by 
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impaired blood flow, leading to a disruption of oxygen delivery, and/or by influx of 
inflammatory cells creating a situation where oxygen demand exceeds supply. An 
illustration of local hypoxia in the setting of inflammation is shown in Figure 1.8C; in this 
image
314
 a section of mouse lung infected with Aspergillus spp. has been stained for 
hypoxia with hypoxyprobe-1 (red); hypoxyprobe or pimonidazole is a commercial 
research tool that forms adducts within a cell at oxygen tensions lower than 1.3 kPa and 
labelled secondary antibodies to hypoxyprobe can then be used as a counter stain. Work 
by Niinikoski et al.
325
 further showed that the presence of bacterial infection causes 
additional wound hypoxia; whilst in uninfected wounds the oxygen tension rose from 0.9 
to 3.9 kPa during healing, in the infected wounds the oxygen tension dropped even 
further to near anoxic levels. Tissue hypoxia has also been demonstrated directly in 
humans in head and neck tumours by Rademakers et al.
326
, who injected subjects with 
pimonidazole prior to biopsy and showed co-localization of pimonidazole staining with 
HIF-1α stabilisation and a number of metabolic markers of hypoxia.  
Above examples are ways to measure the presence of “pathological hypoxia” in-vivo. The 
term hypoxia (In-vitro hypoxia or “experimental hypoxia”) as used in the literature 
generally indicates the use of  oxygen levels of approximately 1% O2 (±3 kPa) in the case 
of cell based work
327
 and around 15% O2 in case human volunteers
328
. However, as 
mentioned above these are oxygen tensions that immune cells like neutrophils encounter 
in physiological situations, so whether “experimental hypoxia” mimics “pathological 
hypoxia” is an important question. 
 
1.8.2 Cellular requirements for oxygen 
Oxygen is vital for cellular energy production and is utilised mainly though a metabolic 
pathway called oxidative phosphorylation, in which ATP is formed as a result of the 
transfer of electrons from NADH or FADH2 to O2 by a series of electron carriers in the 
mitochondria. Oxidative phosphorylation is highly efficient and generates 26 of the 30 
molecules of ATP that are formed when a single glucose moiety is completely oxidized to 
CO2 and H2O, and is the major source of ATP in aerobic organisms
329
. However, 
neutrophils contain relatively few mitochondria
330,331
 and due to the need to function at 
very low oxygen tensions have adapted to function predominantly (although not 
exclusively) by anaerobic metabolism
332
 in the form of glycolysis. During glycolysis, 
glucose or glycogen is converted into pyruvate by a range of enzyme-catalysed reactions. 
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This pathway is less efficient as the net gain is only 2 molecules of ATP. Key enzymes 
that play a role in glycolysis have shown to be upregulated under hypoxic conditions 
including glyceraldehyde-3-phosphate dehydrogenase
333,334
 and triose-phosphate 
isomerase-1
335
. 
 
1.8.3 Mechanism of oxygen sensing 
Due to the importance of oxygenation of tissues and the wide range of effects hypoxia has 
on cellular function, the human body has sensitive mechanisms in place to monitor 
oxygen tensions and induce appropriate responses at both systemic and cellular levels. An 
organ that plays an important role in oxygen tension in the body is the carotid body. This 
is a neural crest-derived, highly vascularised organ, located at the bifurcation of the 
carotid arteries, whose major function is to detect changes in blood oxygen tension. In the 
carotid body, low arterial blood oxygen tensions lead to inhibition of the K
+
 channels and 
hence glomus cell membrane depolarisation, resulting in Ca
2+ 
channel opening, increased 
cytosolic Ca
2+
 concentration and the release of transmitters such as catecholamines
336
; 
this results in respiratory and cardiovascular reflexes that attempt to restore oxygenation 
in the vital organs
337
. On a cellular level the HIF signalling pathway fulfils the role of 
oxygen sensing.  
 
1.8.3.1 Oxygen sensing–the prolyl-4-hydoxylase-HIF signalling pathway 
HIF transcription factors are crucial mediators of the cellular hypoxic response. They are 
heterodimers consisting of one of three major oxygensensitive HIF-α subunits (HIF-1α, 
HIF-2α or HIF-3α) and a constitutively expressed subunit HIF-1β (also known as aryl 
hydrocarbon receptor nuclear translocator or ARNT). Of the HIF-α subunits HIF-1α and 
HIF-2α are the most studied. Under normoxic conditions, HIF1/2A is continuously 
transcribed and translated to HIF-1/2α protein, which is rapidly hydroxylated and 
degraded by the ubiqutin-proteosome pathway, and hence normally present at very low 
levels. HIF-1α stability is regulated by the activity of a class of oxygen-, 2-oxoglutarate-, 
and iron-dependent enzymes known as the prolyl-4-hydroxylases or PHDs
338
. PHDs 
hydroxylate the two specific proline residues pro402 and pro564 within the oxygen 
degradation domain (ODD) of HIF-1α338,339. Hydroxylation of HIF-1/2α allows it to bind 
to the VHL (Von Hippel Lindau) tumour suppressor protein, that acts as a recognition 
component of the E3 ubiquitin ligase complex. Hydroxylated HIF-1/2α becomes 
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polyubiquitinated at three lysines in the central ODD domain and is hence directed to the 
26S proteosome for degradation
340
. The half-life of HIF-1α is <5 minutes in normoxic 
conditions
341. As intracellular oxygen levels drop below 200 μmol/L, or if iron levels 
become limiting, PHDs fail to hydroxylate the proline residues within ODD of HIF-1/2α. 
The un-hydroxylated protein is not a substrate for the ubiquitin ligase, and thus becomes 
stabilised and translocates to the nucleus. This oxygen-sensing mechanism is ubiquitous 
and, allows cells such as neutrophils to function effectively over a range of patho-
physiological oxygen tensions
342
 (Figure 1.9). 
A second protein regulating HIF-1/2α activity is Factor inhibiting HIF (FIH), which 
renders HIF-1α transcriptionally inactive by hydroxylation of asparagine 803, thereby 
inhibiting its interaction with co-activators p300 and CREB binding protein (CBP).  
Following hypoxic stabilisation, HIF-1/2α migrates to the nucleus, where it forms a 
heterodimer with HIF-1β. This heterodimer binds to specific DNA binding sites (A/(G) 
CGTG) called hypoxic response elements (HREs) located in the promoter regions of a 
large number of genes (a list of HIF targets is given in Appendix 2), inducing their  
transcription and modulating cell functions including cell migration, growth and 
apoptosis, energy metabolism, matrix and barrier function, and angiogenic signalling
343
.  
 
1.8.3.2 Effects of hypoxia and HIF on cell signalling 
The biology of HIF signalling has been investigated by both transgenic knockout (KO) 
and over-expression mouse models. Targeted homozygous inactivation of HIF-1/2α344,345 
or HIF-1β346 in the mouse is embryonically lethal, due to abnormal vascular development. 
Mice with heterozygous defects of HIF-1α have a reduced protective effect of hypoxic 
preconditioning in a model of cardiac ischemia
347
 (see above) and display very different 
carotid body neural activity and ventilatory adaptation to chronic hypoxia
348
. The role of 
HIF-1α in individual cell lineages has been explored using Cre-transgenics, and this 
approach  has demonstrated that in addition to hypoxia adaption, HIF-1α is required for 
normal physiological functions in a range of settings, in particular in the immune 
system
349,350
. Both of these studies show that HIF-1α deficient myeloid cells have 
profound defects in key effector functions including; adhesion, migration, chemotaxis, 
matrix invasion and bactericidal capacity. Peyssonnaux et al.
350
 also found that HIF-1α-
null neutrophils showed decreased enzymatic activity and protease content in comparison 
to WT neutrophils, while vHL-null neutrophils exhibited increased protease activity; this   
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Figure 1.9: Hypoxia inducible factor regulates most cell responses to hypoxia  
Classically, cells respond to changes in oxygen levels by means of hypoxia inducible 
factor (HIF)-mediated signalling. Under normal conditions the HIF-1α subunit is 
hydroxylated by the prolyl hydroxylases (PHD's).  This allows von Hippel-Lindau factor 
(VHL) to bind to HIF-1α, targeting it for degradation by the proteosome.  The PHDs 
exhibit reduced activity under hypoxic conditions, impairing VHL binding to HIF-1α. 
This allows HIF-1α to stabilize and migrate to the nucleus, where it forms a heterodimer 
with HIF-1β.  This heterodimer binds to hypoxic response elements (HREs) on a number 
of genes inducing their transcription.   
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is discussed in more detail below (section 1.8.5). The role of the HIF oxygen-sensing 
pathway in inflammation is supported further by a study of Walmsley et al.
351
 showing 
that PHD3-deficient mice subjected to acute lung injury have increased levels of 
neutrophil apoptosis and clearance.  However, PHD deficiency affected neutrophil 
apoptosis in the presence of preserved HIF transcriptional activity, indicating a likely 
specific function for PHD3 in regulating neutrophil apoptosis under hypoxic conditions.  
Pharmacological approaches can also be used to interrogate the HIF signalling pathway, 
in particular the use of HIF-1α stabilizers. There are 3 compounds that are widely 
employed; dimethyloxalylglycine (DMOG), desferrioxamine mesylate (DFO) and cobalt 
chloride (CoCl2). These compounds each work in a slightly different way but all lead to 
the stabilisation of HIF. DMOG is a 2-oxoglutarate analogue that acts as a competitive 
inhibitor of PHDs and FIH. DFO is an iron chelator, and chelation of Fe
2+
 bound to the 
active site of PHD inhibits its enzymatic activity. CoCl2 also works as an iron chelator, 
but has also been reported to bind to the PAS domain, blocking HIF-1α-pVHL binding 
and thereby increasing HIF-1α stability352. Work with these HIF-1α stabilizers and with 
transgenic mice has helped identify many HIF targets and functions, although much 
remains to be discovered. There are data, mainly in immune cells, linking some of the 
effects of HIF-1α to the NFκB pathway. NFκB is a family of dimeric transcription factors 
that play an important role in regulating cytokine production, cell proliferation, 
differentiation, adhesion, survival and apoptosis (as reviewed by Baeuerle et al.
353
). In 
resting cells NFκB is present in an inactive, IκB-bound form. NFκB activation is induced 
by ligands such as TNFα, which prompt the activation of the Iκκ complex and induce a 
phosphorylation-dependent degradation of IκB, allowing NFκB to migrate to the nucleus 
and activate target genes. Walmsley et al.
354
 have shown that the hypoxia-induced 
survival of neutrophils is mediated by HIF-1α dependent NFκB activation. Additional 
support for crosstalk between these pathways comes from Cockman et al.
355
 who showed 
that FIH can hydroxylate ankyrin repeats in p105 (NFκB1) and IκBα in an oxygen-
dependent manner, and Dyugovskaya et al. 
356, who show that NFκB plays an essential 
role in neutrophil survival after intermittent hypoxic exposure. Interestingly, Culver et 
al.
357
 demonstrated a HIF-independent mechanism of hypoxic NFκB activation, with 
hypoxic stress leading to IκB kinase activity through a calcium/calmodulin kinase 
dependent pathway. Hypoxia has also been shown to modulate a number of other key cell 
signalling molecules in vitro including p38 MAPK
358
, PKC, and Src family kinases
359
, 
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indicating that hypoxia can activate multiple stress-activated signalling pathways; much 
of this data is derived from studies on rat neural cells or rat cardiac myocytes. Of possible 
relevance to neutrophil degranulation, the GTPase Rac and the actin-binding protein 
Filamin A (FLNA) have recently been identified as hypoxia targets. Misra et 
al.
360
demonstrated that hypoxia increased localisation of Rac1 to the plasma membrane, 
leading to increased cell motility indicating a role in tumour metastasis. Although human 
neutrophils preferentially express Rac2, these GTPases have a high degree of sequence 
homology and many overlapping functions, hence this could be relevant to human 
neutrophil degranulation in the hypoxic setting. Filamin A (FLNA) is a large actin-
binding protein that is widely expressed, and stabilises 3-dimensional (3D) actin webs 
and links them to cellular membranes
361
. Zheng et al.
362
 showed that FLNA interacts with 
HIF-1α but not HIF-2α in melanoma cell lines, increasing nuclear localisation of HIF-1α.  
HIF-1α can also be activated in a hypoxia-independent manner, as shown by 
Peyssonnaux et al.
350
 using exposure of WT mouse monocytes to a range of pathogens 
and inflammatory agents such as LPS
363
.  On phagocyotosis of group A Streptococcus, 
Staphylococcus or Salmonella spp, macrophages upregulated HIF-1α expression to levels 
similar to those found under hypoxia. In addition, LPS induced HIF-stabilisation and 
downregulated PHD2 and PHD3 mRNA. These experiments indicate that HIF-1α 
regulates myeloid cell function in inflammation, not solely in the context of hypoxia.  
 
1.8.3.3 The roles of HIF-1α and HIF-2α in neutrophil function 
HIF-2α was identified in 1997364–366 and HIF-1α and HIF-2α can regulate the expression 
of many hypoxia-induced genes, although each HIF-α isoform has unique targets. Their 
stabilisation kinetics are also different; HIF-2α stabilisation is delayed, but more 
sustained in comparison to HIF-1α stabilisation. The biological actions of HIF-2α in 
response to hypoxia are distinct from those of HIF-1α (reviewed by Loboda et al.367). 
HIF-2α-mediated signalling is of particular importance in erythropoiesis368, iron 
homeostasis
309
, metabolism
369,370–372
, vascular permeability
373
, and tumour biology and 
angiogenesis (reviewed by Keith et al.
374
). The role of HIF-2α in immunity has been less 
extensively investigated than that of HIF-1α. However, Elks et al.375 showed that in a 
zebrafish model of TB, HIF-1α and HIF-2α in neutrophils have opposing effects on host 
susceptibility to mycobacterial infection via modulation of inducible nitric oxide synthase 
(iNOS) signalling at early stages of infection; stabilisation of HIF-1α or deletion of HIF-
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2α lead to increased levels of reactive nitrogen species and reduced the mycobacterial 
burden in this model. Thompson et al.
376
 have recently also delineated a role for HIF-2α 
in human neutrophil longevity. Neutrophils derived from 3 patients with gain-of-function 
mutations in HIF-2α, display a reduction in constitutive apoptosis, although HIF 
stabilizers were able to further delay apoptosis in these cells. Neutrophils from these 
patients showed increased HIF-2α target gene expression (VEGF, PAI1 and PHD3), but 
chemotaxis, respiratory burst and phagocytosis were unaffected. Finally, Thompson and 
colleagues showed that HIF-2α deficiency reduced neutrophilic inflammation, lung 
damage and vascular leak in a mouse model of LPS-mediated lung injury. These studies 
indicate that HIF-2α is emerging as an important regulator of neutrophil function and 
inflammation. Due to the temporal differences in expression of the two isoforms it is 
possible that HIF-1aα plays a major role in the initial stages of infection where as HIF-2α 
mainly plays a role modulating neutrophil function in the rsolution phase of the 
inflammation 
 
1.8.4 Neutrophil function under hypoxic conditions 
Neutrophils play an important function in the inflammatory response and their function is 
profoundly affected by hypoxia. Using a Cre-targeted myeloid HIF-1α knockout mouse, 
Cramer et al.
349
 removed the myeloid cells’ capacity to adapt to hypoxia, leading to a 
drop in the glycolytic capacity of these cells; this resulted in a substantial impairment of 
myeloid cell adhesion, migration and bacterial killing. Hypoxia has been shown to alter 
the phenotype and function of human neutrophils in vitro. Work by Mecklenburgh et 
al.
377
 demonstrated that neutrophil apoptosis was delayed by exposure to hypoxia or by 
iron chelation, suggesting an important role for HIF in determining neutrophil lifespan. 
Further work by Walmsley et al.
354
  confirmed a role for HIF-1α in this effect, since 
neutrophils derived from the HIF-1α conditional knockout mice described above showed 
increased apoptosis under conditions of hypoxia. 
McGovern et al.
327
 demonstrated that hypoxia affects neutrophil function as well as 
lifespan; hypoxia compromised the neutrophil’s ability to mount a respiratory burst in 
response to “primed stimulation” (GM-CSF/fMLP), stimulation (PMA), and even 
ingested particles (zymosan). As a consequence bactericidal capacity to S. aureus was 
also impaired. The impairment of bacterial killing was postulated to be due to a lack of 
molecular oxygen as a substrate for ROS production, since re-oxygenation of the cells 
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rapidly restored both the oxidative burst and killing of S. aureus. Of note, hypoxia did not 
prevent phagocytosis or shape change in response to IL-8, hence many neutrophil 
functions appear to be preserved or even augmented at low oxygen tensions. A recent 
paper from Shuang Ma et al.
378
 reported that hypoxia increased cell polarisation in 
response to fMLP in HL-60 cells (a neutrophil-like cell line) and that store-operated 
calcium entry plays a role in this process.  
 
1.8.5 Neutrophil degranulation under hypoxic conditions 
Knowledge of how hypoxia affects neutrophil degranulation is lacking. Published data 
from our laboratory
379
 suggested that NE release is increased under hypoxic conditions. 
Peyssonnaux et al.
350
 found a role for HIF-1α in the production of neutrophil granule 
proteases; HIF-1α-null neutrophils showed decreased enzymatic activity and protease 
content in comparison to WT neutrophils, while vHL-null neutrophils exhibited increased 
protease activity. However this might be caused by developmental differences, as 
neutrophil granules form during maturation in the profoundly hypoxic environment of the 
bone marrow, and others
380,381
 have shown that mature circulating neutrophils do not 
transcribe or translate mRNA for NE or other granule proteins. This probable 
developmental effect complicates the use of HIF-1α-null mouse neutrophils to study the 
role of HIF-1α in hypoxic degranulation. 
The effects of hypoxia on degranulation in other cell types have been studied in a little 
more depth. There is some evidence that hypoxia can induce mast cell granule 
release
382,383
, although others have suggested that this is an indirect effect, mediated by 
MCP-1 released from hypoxic alveolar macrophages
384
.  Others, like Pinskey et al.
385
 and 
Goerge et al. 
386
 have shown that hypoxia induces rapid endothelial cell degranulation. 
Hypoxic exposure led to exocytosis of endothelial cell Weibel-Palade (WP) bodies, 
releasing von Willebrand factor (vWF) and increasing expression of the adhesion 
molecule, P-selectin on the cell surface; Pinskey et al.
385
 postulated that endothelial WP-
body exocytosis occurs during hypothermic/hypoxic cardiac preservation, priming the 
vasculature to recruit PMNs during reperfusion.  
Thus the induction or augmentation of degranulation in other cell types under hypoxia, 
plus the preliminary data from McGovern et al.
379
 indicate that hypoxia may modulate 
neutrophil degranulation. The potential significance of such an effect to a range of disease 
processes including common and debilitating conditions such as COPD, led me to 
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hypothesise that hypoxia upregulates neutrophil degranulation, and that this is detrimental 
to the host in disease settings. 
 
1.9 Summary 
Neutrophils are key effectors of the innate immune system and have an array of 
“weapons” to eliminate pathogens, including abundant granules. These neutrophil 
granules contain proteins capable of causing substantial tissue damage. Neutrophil 
degranulation has been shown to be detrimental in a range of disease states, for example 
the smoking-related lung disease COPD. Neutrophil proteases such as NE, MPO and 
MMP-9 can degrade extracellular matrix proteins, and are implicated in the pathogenesis 
of emphysema. However, most physiological stimuli induce minimal extracellular 
degranulation. Signalling pathways regulating neutrophil degranulation are poorly 
understood, but include PI3K, PLC and calcium transients. Many tissues such as the skin 
and gut are hypoxic under physiological circumstances (physiological hypoxia), but sites 
of inflammation and infection can also be profoundly hypoxic (pathological hypoxia). 
Hypoxia affects neutrophil function, impairing the generation of reactive oxygen species 
and reducing bacterial killing. However, little is known about neutrophil degranulation 
under hypoxic conditions, and this will be the focus of my thesis. 
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2. Hypothesis & Aims 
 
2.1 Hypothesis 
Hypoxia induces a highly destructive neutrophil phenotype with an increased lifespan, a 
substantial reduction in oxidase-dependent bacterial killing and an increase in their ability 
to release granule proteins.  These effects are exacerbated by cigarette smoke. 
 
2.2 Specific aims 
1. To determine whether hypoxia up-regulates the secretion of NE either in 
isolation, or as part of a more generalised up-regulation of the neutrophil 
secretory repertoire. 
 
2. To investigate whether cigarette smoke and hypoxia act synergistically to 
modulate neutrophil degranulation. 
 
3. To explore the effects of hypoxia on neutrophil-mediated tissue injury. 
 
4. To determine the mechanism(s) whereby hypoxia modulates degranulation.
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3.  Materials and Methods 
3.1 Materials 
Amersham Biosciences (Buckinghamshire, UK): Percoll®, dextran 500 (mw 500,000, 
dissolved in sterile 0.9% saline (6% w/v) and stored at 4°C) 
AnaSpec EGT group: EGTA (tetrasodium salt, 10 mM) 
Baxter Healthcare (Berkshire, UK): Sterile 0.9% sodium chloride 
BD Biosciences (Embodegen, Belgium): Falcon polypropylene tubes (50 ml and 15 ml), 
50 ml syringes, Falcon flexible 96-well plates, Cellfix
TM
 
Cal Biochem: Pan PI3Kinhibitor (LY294002) 
Cell Signaling Technology®: cleaved caspase 3 rabbit monoclonal antibody, β-actin 
polyclonal antibody 
Dako:  goat anti-mouse horse radish peroxidase (HRP)-conjugated IgG 
Fisher Scientific (UK): Keratinocyte serum-free media (VX17005075) + 25 μg/ml bovine 
pituitary extract, 0.2 ng/ml rEGF, 250 ng/ml puromycin and 25 μg/ml G418. 
GE Healthcare (Little Chalfont, UK: ECL (Enhanced Chemiluminescence) system 
Hycult Biotechnology (Cambridgeshire, UK): lactoferrin ELISA 
Hospira Venisystems : sterile 19 gauge Butterfly needles 
Invitrogen: (Paisley, Scotland, UK): Hanks balanced salt solution (HBSS), 5-(and-6)-
chloro-methyl-2',7'-dichloro-dihydro-fluorescein-diacetate-acetyl-ester (CM-H2-DC-
FDA), secondary antibody (Alexa Fluor 488 – donkey anti-goat IgG), F-actin stain 
(rhodamine phalloidin), DAPI containing mountant (Gold anti-fade) 
Kentucky Tobacco Research & Development centre: 3R4F cigarettes 
Life Technologies (Paisley, UK):  Iscove's Modified Dulbecco's Medium (IMDM), 
Enzcheck Elastase assay kit, F-12K medium with 100 U/ml penicillin, 10 µg/ml 
streptomycin, 25 µg/ml amphotericin B (Invitrogen) and 10% fetal calf serum (GIBCO). 
Lonza (Berkshire, UK): human bronchial epithelial cells, bronchial epithelial growth 
media (BEGM)  
Martindale Pharmaceuticals Ltd (Essex, UK): sterile calcium chloride, sterile sodium 
citrate  
Merck Ltd.( Nottingham UK): May/Grünwald/Giemsa stain  
National Diagnostics (UK): Protogel (40%), stacking buffer, resolving buffer. 
Radiometer (Copenhagen, Denmark): ABL80 Basic automated blood gas machine and 
calibration reagents  
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R&D Systems (Oxfordshire, UK): human recombinant granulocyte macrophage colony-
stimulating factor (GM-CSF), MMP-9 ELISA Duoset kit, goat anti rabbit IgG-APC, 
phospho-kinase antibody array 
Ruskin Technologies, (Yorkshire, UK): Ruskin Invivo2 400 hypoxic chamber   
Santa Cruz Technology (Germany): neutrophil elastase goat polyclonal antibody, donkey 
anti-goat HRP-conjugated IgG 
Sigma-Aldrich, (Dorset, UK): cytochrome C from equine heart, phorbol 12-myristate 13-
acetate (PMA), superoxide dismutase (SOD) from bovine erthrocytes, phosphate buffered 
saline (PBS) with (PBS
+
) or without (PBS
-
) calcium chloride and magnesium chloride, 
dimethyl sulfoxide (DMSO), Trypan blue solution (0.4%), cytochalasin B, N-formyl-
methionyl-leucyl-phenylalanine (fMLP), tissue culture grade bovine serum albumin 
(BSA), Tween-20, Tri-reagent, U-73122 (phospholipase C and A2 inhibitor), trans-
styrylacetic acid (PAM inhibitor), poly-L-lysine solution, DMOG, DFO, hydrogen 
peroxide (30%), o-dianisidine dihydrochloride, TRI reagent
®
,  PAM inhibitor (4-phenyl 3 
butenoic acid), PLC inhibitor (U-73122), PI3Kγ inhibitor (AS605240), PI3Kδ inhibitor 
(IC87114), Thapsigargin, Cyclohexamide, Poly-L-lysine solution, glycerol-gelatin, 
lactate dehydrogenase (LDH), o-dianisidine dihydrochloride (DMB), Triton X-100, 
polyvinylidene fluoride (PVDF) membrane, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl 
tetrazolium bromide (MTT) 
Qiagen (Manchester, UK): primers for housekeeping genes B2M, 18S, granule proteins 
NE, MMP-9 and lactoferrin and for hypoxia targets BNIP and GLUT1 
VWR International (Leicestershire, UK): DPX mountant, methanol, Eppendorfs (Safe-
Lock micro test tube, PCR clean, 2 ml). 
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3.2 Neutrophil isolation  
Ethical permission for taking peripheral blood from healthy volunteers was obtained from 
the Cambridge Local Research Ethics Committee (REC reference 06/Q0108/281). 
Neutrophil isolations were performed under sterile conditions in a laminar flow cell 
culture hood (Microflow Class II cabinet). Sterile polypropylene tubes (Falcon) and 
reagents were used throughout. 
Neutrophils were isolated using dextran sedimentation followed by centrifugation over 
discontinuous plasma-Percoll® gradients. Blood was taken by venepuncture, performed 
by a qualified operator using a sterile 19 gauge Butterfly needle (Hospira Venisystems) 
and 50 ml Plastipak disposable syringes. The blood was carefully transferred into 50 ml 
tubes (Falcon) containing 4 ml of 3.8% sodium citrate, to a total volume of 40 ml. All 
subsequent steps were performed at 22°C, unless otherwise stated. The tubes were 
centrifuged at 310 g for 20 min, to yield platelet rich plasma (PRP) and pellets comprising 
red cells and leukocytes. The pellets were dextran-sedimented by the addition of 6% 
dextran-500 (2.5 ml/10 ml of cell pellet).  The volume was made up to 50 ml with pre-
warmed (37°C) sterile 0.9% saline (Baxter), carefully but thoroughly mixed, and allowed 
to stand for 30 min to allow erythrocyte sedimentation to occur. The PRP from the initial 
spin was used to make platelet poor plasma (PPP) and autologous serum; autologous 
serum was prepared by the addition of 220 μl of 10 mM CaCl2 to 10 ml of PRP and 
incubation at 37
ᴼ 
C, whilst PPP was prepared by centrifuging the remaining PRP at 1400 
g for 20 min. The pellet from this spin (containing the platelets) was discarded and the 
PPP retained. 
After erythrocyte sedimentation, the leukocyte-rich plasma (upper layer) was carefully 
aspirated from the red cell lower layer and centrifuged at 256 g for 5 min.  The pellet 
(containing mixed leukocytes) was gently re-suspended in 2 ml PPP and transferred to a 
15 ml tube (Falcon), where it was under-layered with 2 ml freshly prepared 42% Percoll® 
in the autologous PPP, which was then further under-layered with 2 ml of freshly 
prepared 51% Percoll® in PPP. Under-layering was performed using a glass pipette, 
which had been sterilised by autoclaving (240
ᴼ
C for 4 h). The gradients were centrifuged 
for 10 min at 150 g, with the brake and acceleration speed set to zero. The mononuclear 
cells remained at the top interface between the plasma and 42% Percoll® layer, with 
granulocytes cells (≥ 95% neutrophils) at the interface of the 42% and 51% layer 
Percoll® layers (Figure 3.1).  
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Figure 3.1: Neutrophil isolation using discontinuous plasma-Percoll® gradients  
Neutrophils were isolated from healthy volunteers using discontinuous Plasma-Percoll® 
gradients. A. Photograph of plasma-Percoll® gradients following centrifugation.  
Mononuclear cells comprise the top interface between the plasma and 42% Percoll® 
layer, with neutrophils at the interface of the 42% and 51% layer Percoll® layers. B. & C. 
are representative photomicrographs of cytospins from the upper mononuclear and lower 
neutrophil layers respectively (x40 magnification). 
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Each band was aspirated with a Pasteur pipette (Appleton Woods). The granulocyte pellet 
was washed once in PPP, once in phosphate buffered saline without Ca
2+
/Mg
2+
 (PBS
-
) 
and once in phosphate buffered saline with Ca
2+
/Mg
2+
 (PBS
+
), each time by spinning at 
256 g for 5 min. Using this method, the neutrophil isolate is >95% pure with less than 1% 
monocyte contamination. Cytospins were made by centrifugation in a Shandon Cytospin 
3 centrifuge (3 min, 300 rpm). To assess purity, the cells were fixed in methanol and 
subsequently stained with May/Grünwald/Giemsa (Figure 3.1). Cells were counted using 
light microscopy (Olympus CX31). 
 
3.3 Working under hypoxic conditions 
3.3.1 The hypoxic incubator 
An In-vivo 400 hypoxic incubator (Ruskin Technology, Figure 3.2A) was used to analyse 
the effects of hypoxia on neutrophil function. The gas levels in the hood are controlled by 
the Gas Mixer Q, which calibrates the O2 sensor automatically through a touch screen 
control. It controls O2 levels from 0.0% to 20.9% and CO2 from 0.0% to 30.0%; O2 and 
CO2 levels are programmable in 0.1% increments. The chamber is supplied with separate 
feeds of compressed air, nitrogen, carbon dioxide and 10% hydrogen/90% nitrogen. A 
palladium catalyst can be employed to create anoxic conditions. Thermostatic monitoring 
controls the temperature, and maximum humidity is limited by controlled condensation. 
Items can be placed in the chamber via a small mailbox on the side, which is flushed with 
nitrogen upon closure, thereby preventing re-oxygenation of the hypoxic chamber when 
adding or removing materials. The chamber contains standard electrical supply points for 
equipment (such as a micro-centrifuge and thermo-mixer) and the front is removable, 
thereby allowing equipment to be placed into the chamber when needed. The chamber is 
maintained at positive pressure above ambient levels and the control unit supplies an 
appropriate gas mix when the pressure falls. An important general issue is that it is the 
oxygen tension in the chamber that is being controlled directly, not the oxygen tension 
experienced by the cells placed within it, which are bathed in tissue culture media. All 
media to be used in any experimental setting were therefore placed in the hypoxic 
workstation to equilibrate for at least 3 h prior to use and analysed as documented below 
(section 3.3.2).  
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Figure 3.2: Working with the Invivo2 400 workstation  
A. Ruskinn Invivo2 400 workstation used to conduct all work under hypoxic conditions. 
B. Blood gas analyser from Radiometer used to check the pH, pO2 and pCO2.  C. Blood 
gas analyser readings (pH, pO2 and pCO2) of normoxic and hypoxic media from n>20 
experiments.  Results represent mean ± SEM. (A. Adapted from http://www.bioquip.com. 
B. Adapted from http://francais.radiometer.ch. 
  
A                                                                                                                                            
 
 B. 
 
 C 
 
 pH pO2 (kPa) pCO2 (kPa) 
Hypoxia 7.45 ±0.001 3.35 ± 0.14 4.19 ± 0.069 
Normoxia 7.40 ± 0.02 21.65 ± 0.49 4.30 ± 0.28 
 
B 
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3.3.2 Analysis of media pH, pO2 and pCO2  
An ABL80 Basic blood gas analyser (Radiometer, Figure 3.2B) was used to measure the 
gaseous partial pressures (pO2 and pCO2) and pH of the media encountered by cells. The 
ABL80 Basic measures pH, pCO2 and pO2 through a multi-use disposable sensor cassette 
containing a low volume, flow-through cell. The ABL80 basic has disposable solution 
packs, containing precision tonometered electrolyte solutions packaged in gas tight 
disposable pouches, to enable calibration. Quality control solutions (QC’s) were used 
before each experiment to ensure accurate function. 
Because of the expense and limited lifespan of the calibration and QC solutions, I 
analysed the media used in my experiments for periods of 2 months at regular intervals to 
ensure that the hypoxic chamber was delivering media with partial pressures of O2 of 3 
kPa and pH of 7.2-7.4. The optimum settings for the hypoxic hood to achieve the desired 
level of hypoxia in the tissue culture media were determined previously by Dr Naomi 
McGovern. Bicarbonate-buffered media, such Iscove’s modified Dulbecco’s medium 
(IMDM) required settings 5% CO2 and 0.8% O2, which, after a 3 h equilibration, gave 
media with a pH of 7.4 and an O2 partial pressure of approximately 2.92±0.29 kPa 
(Figure 3.2C). For phosphate-buffered media such as PBS the optimal hypoxic chamber 
settings were found to be 0.5% CO2 and 0.8% O2, which delivered a pH of 7.16±0.03 and 
an O2 partial pressure of 3.07±0.09 kPa. All solutions for use in the hypoxic hood were 
pre-equilibrated to hypoxia for 3 h. 
Care was taken to prevent access of oxygen to the hood during experimental procedures, 
by ensuring that adequate flushing of the access mailbox or hand ports with the 
appropriate hypoxic gas mixture was performed. All reactions were fully stopped (by 
centrifugation and aspiration of supernatants) prior to removal of any samples from the 
hood, to ensure that the results were not confounded by re-oxygenation.  All experimental 
procedures were performed in parallel in the hypoxic hood and outside the hood (ambient 
oxygen = ‘normoxia’) on the same neutrophil preparation.  
 
3.4 Preparation of cigarette smoke medium 
Research grade 3R4F cigarettes (Kentucky Tobacco Research Institute) were used to 
prepare the cigarette smoke medium (CSM). CSM was made by bubbling the smoke from 
3 cigarettes through 25 ml of IMDM in a 50 ml conical tube. The CSM was filtered 
through a 0.22 μm filter to remove large particles and to ensure sterility, and the pH 
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measured and adjusted when necessary (to pH 7.5). This solution was designated as 100% 
CSM, and 500 µl aliquots were stored at -20°C. Aliquots were defrosted and diluted in 
culture medium to yield concentrations specified for each experiment.  
 
3.5 Neutrophil extracellular reactive oxygen species production 
The superoxide dismutase (SOD)-inhibitable reduction of cytochrome C was used to 
measure extracellular superoxide anion (O2
-
) production. Cytochrome C is an electron-
transferring protein that contains a haem prosthetic group. The iron in the cytochrome 
alternates between a reduced ferrous (2
+
) state and an oxidized ferric (3
+
) state during 
electron transport. The color change induced by the reduction is quantified by measuring 
the optical density of the solution at 550 nm. The concentration of superoxide anion 
released was calculated by the Beer-Lambert Law: 
A = єcl, where 
A = absorbance, l = path length (1 cm, the width of the cuvettes used), c = concentration 
of the substance in mol
-1, and є = the molar absorption (or extinction) coefficient. 
Freshly isolated neutrophils were suspended in PBS
+
 at 11.1*10
6
/ml at 37°C under 
normoxic or hypoxic (0.8% O2 and 5% CO2) conditions, in a thermo-mixer shaking at 
450 rpm. Neutrophil aliquots of 90 µl in 2 ml Eppendorf tubes were primed with 
granulocyte macrophage colony stimulating factor (GM-CSF, R&D) 10 ng/ml, or treated 
with vehicle for 1 h. Next, pre-warmed cytochrome C (prepared with hypoxic or 
normoxic medium and kept at 37°C under hypoxic or normoxic conditions) was added 
(750 μl, 1.2 mg/ml final concentration). The cells were subsequently stimulated with 
either fMLP (100 nM, Sigma), or PMA (200 nM, Sigma) or vehicle for 10 min. Each 
reaction was performed in quadruplicate, and superoxide dismutase (SOD) 375 U (50 μl) 
included in one of each set of quadruplicates. Cells were pelleted and the supernatants 
transferred to fresh tubes before removal from the hypoxic hood. The supernatants were 
placed in cuvettes (200-1600 nm, Uvette, Eppendorf). The superoxide dismutase-
inhibitable reduction of cytochrome C was measured by assessing the optical density 
(OD) of the supernatants at 550 nm using a scanning spectrophotometer. The OD at 550 
nm was converted to nmol superoxide/ml using the extinction coefficient of cytochrome 
C (21*10
3
M
-1
cm
-1
). The values for the tube incorporating SOD (which converts O2
-
 to 
hydrogen peroxide) were subtracted from the corresponding triplicates.  
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3.6 Measurement of intracellular reactive oxygen species (ROS) production 
To determine the effects of CSM on intracellular ROS production the probe 5-(and-6)-
chloromethyl-2',7'-dichlorodihydrofluorescein diacetate, acetyl ester (CM-H2DC-FDA), 
abbreviated henceforth as DC-FDA, was used. This compound is non-fluorescent until 
the acetate groups are removed by intracellular esterases and oxidation occurs within the 
cell. Esterase cleavage of the lipophilic blocking groups yields a charged form of the dye 
that is much better retained by cells than is the parent compound. Once the probe is taken 
up into the cell, the cells can be fixed and oxidation of the probe can be detected by 
monitoring the increase in fluorescence using flow cytometry. As DC-FDA is susceptible 
to photo-oxidation, low-light conditions were used and the reaction tubes wrapped in foil.  
Freshly isolated neutrophils were re-suspended in HBSS (10
7/ml) and 500 μl aliquots 
transferred to Eppendorf tubes. DC-FDA (0.2 μM, 500 μl) was then added to cell 
suspension for 10 min (final volume 1 ml). The DC-FDA-loaded cells were spun down 
and the supernatant removed. Cells were re-suspended in 500 µl of HBSS and incubated 
for 10 min to allow for esterase cleavage of the acetate groups, rendering the dye sensitive 
to oxidation. The cells were spun down and re-suspended in HBSS (500 µl) with or 
without a range of CSM concentrations and incubated for 30 minutes. PMA (200 nM, 10 
min) was used as positive control. Aliquots (200 μl) of the cell suspension were added to 
a mix of 250 μl ice-cold optimised Cell FixTM and 250 μl PBS-. Samples were analysed 
immediately by flow cytometry (CANTOII, BD bioscience), using the FL-1 channel, 
gating on granulocytes by forward- and side-scatter properties, and the mean fluorescence 
of the individual samples was measured.  
 
3.7 Apoptosis assays 
To assess the effects of hypoxia/hypoxia mimetics on neutrophil apoptosis, purified cells 
were re-suspended at 5*10
6
 cells/ml in IMDM supplemented with 10% autologous serum 
and cultured at 37°C under normoxic conditions (with or without hypoxia mimetics) or 
hypoxic conditions, in Falcon Flexiwell 96-well low attachment plate inserts (135 µl cell 
suspension and 15 µl hypoxia mimetic).For morphologic assessment, neutrophils were 
harvested at 20 h by gently pipetting up and down 3 times, using cell saver tips. Cytospins 
were made by centrifugation of the samples in a Shandon 3 Cytocentrifuge, 3 min at 300 
rpm,and the resulting slides fixed in methanol (4 min) and stained with 
May/Grünwald/Giemsa (DiffQuick reagents, Reagena).  
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Figure 3.3: Different stages of neutrophil apoptosis 
Morphology of non-apopotitic, early apoptotic and late apoptotic neutrophils. A. 
Photomicrographs illustrating the different stages of neutrophils apoptosis. The cells were 
stained with May/Grünwald/Giemsa (100x magnification) B. Cartoons illustrating the 
nuclear morphological changes used in scoring slides. 
  
A   
1. Healthy Non-apoptotic 2. Early apoptotic  3. Late apoptotic  
   
B   
1. Non-apoptotic 2. Early apoptotic  3. Late apoptotic  
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Morphology was examined by oil-immersion light microscopy (100 x magnification, 
Olympus CX31) with. 300 cells per cytospin were counted. Apoptotic neutrophils have a 
distinct morphologic appearance with cell shrinkage, cytoplasmic vacuolation, and 
condensation of chromatin, leading to the loss of the normal multi-lobed nucleus (Figure 
3.3).  
 
3.8 Assessment of degranulation 
3.8.1  Assessment of the effect of hypoxia on secreted NE activity 
Freshly isolated neutrophils were re-suspended in normoxic or hypoxic IMDM 
(11.1*10
6
/ml). 270 µl aliquots were transferred to 2 ml Eppendorf tubes and incubated at 
37
ᴼ
C for 4 h under normoxic of hypoxic conditions. After 4 h the cells were primed with 
cytochalasin B (5 µg/ml, Sigma) for 5 min, GM-CSF (10 ng/ml) or vehicle for 30 min. 
The cells were subsequently stimulated with fMLP (100 nM) or vehicle for 10 min 
(Figure 3.4). Cells were pelleted and the supernatants were transferred to fresh tubes 
before removal from the hypoxic hood. Samples were frozen and stored at -80°C until 
further analysis. To check that the neutrophils were intact (and that extracellular NE had 
not been released by degranulation rather than by necrosis), aliquots (90 µl) were taken to 
make cytospins after stimulation. The cells were subsequently stained with 
May/Grünwald/Giemsa. Figure 3.5 shows representative photomicrographs of cytospins 
from 3 independent experiments (40x magification). The viability of the cells was also 
checked using trypan blue staining and was routinely >99%. 
 
3.8.2 Quantification of NE 
Assays available to quantify NE fall into 2 categories: those that measure the total amount 
of elastase released (including NE complexed with inhibitors such as alpha 1-antitrypsin  
(α1-AT), plus free NE) and those that quantify the amount of active elastase, based on 
enzymatic cleavage of a substrate. Total elastase is usually measured by ELISA-based 
assays, however such assays may not reflect accurately the capacity for tissue damage.  
Measurement of NE activity was hence performed using the EnChek® activity assay 
(Molecular Probes), which is based on the cleavage of DQ-Elastin. The non-fluorescent 
substrate is digested by NE to yield fluorescent fragments. The resulting increase in 
fluorescence can be monitored by a fluorescence multiwell plate reader. This assay was  
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Figure 3.4: Flow chart of typical neutrophil incubation, priming and stimulation 
protocol 
Freshly isolated neutrophils were suspended in normoxic or hypoxic IMDM 
(11.1*10
6
/ml).  270 µl aliquots were transferred to 2 ml Eppendorf tubes and incubated at 
37
ᴼ
C for 4 h under normoxic of hypoxic conditions (3 kPa O2 5% CO2).  After 4 h the 
cells were primed with cytochalasin B (5 µg/ml) for 5 minutes, or GM-CSF (10 ng/ml) or 
vehicle for 30 minutes.  The cells were subsequently stimulated with fMLP (100 nM) or 
vehicle for 10 min.  Cells were pelleted and the supernatant transferred to fresh tubes 
before removal from the hypoxic hood and further analysis.  
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Figure 3.5: Cytospins of resting and activated neutrophils incubated under 
normoxic and hypoxic conditions 
Neutrophils were re-suspended in hypoxic or normoxic IMDM at 11.1x10
6
/ml and 
incubated under normoxia or hypoxia (0.8% O2 and 5% CO2) at 37°C for 4 h.  The cells 
were then primed (GM-CSF 10 ng/ml, 30 min or CB 5µg/ml, 5 min) and then activated 
(fMLP 100 nM, 10 min). Cytospins were stained with May/Grünwald/Giemsa. Images are 
representative of 3 independent experiments (x40 magnification).  
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chosen because it is able to quantify active NE in supernatants, is sensitive and quick to 
perform, and can be used to measure multiple samples at low cost. For this assay, 100 µl 
of neutrophil supernatant (with 100 μL of 1x Reaction Buffer as a negative control, or 
100 μL of diluted porcine pancreatic elastase (0.2 U/mL) as a positive control) was 
combined with DQ elastin substrate diluted in 1x Reaction Buffer (final concentration of 
DQ elastin 25 µg/ml). The plate was then incubated in the dark, at room temperature (RT) 
for 30 min (optimal time point determined in pilot experiments), after which the 
absorption at 485/535 nm was read by a multi-well plate reader (PerkinElmer). The value 
derived from the no-enzyme control was subtracted from each sample to correct for 
background.  
 
3.8.3 Optimisation of the NE activity assay  
The number of cells per sample was titrated to optimise the signal–to-noise. As shown in  
Figure 3.6A, 3*10
6
 cells gave a near-maximal response, and this concentration was used 
therefore used in all subsequent studies (10
7
 cells per sample gave the maximum 
response, but adoption of this as standard would have limited the number of conditions 
that could be analysed in a single experiment). To study degranulation I used a priming 
agent GM-CSF (10 ng/ml) and subsequently an activating agent (fMLP 100 nM), as 
stimulation with GM-CSF or fMLP alone did not reliably induce any detectable 
degranulation. Cytochalasin B (Cyt B, 5 μg/ml), which disrupts actin filaments, is the 
most effective agent known to augment neutrophil degranulation, but I wished to assess 
and employ more physiological agonists; hence Cyt B was used as a positive control. 
Under conditions of hypoxia (but not ambient oxygen) GM-CSF (and also other priming 
agents such as PAF (1 μM)) augmented the fMLP-induced release of enzymatically active 
NE, although they were somewhat less effective than Cyt B (Figure 3.6B). GM-CSF 
priming was used in further experiments. This assay was performed using IMDM as the 
culture medium, because incubation in HBSS resulted in a high background signal in 
unstimulated negative controls; this was speculated to be secondary to the stress induced 
by lack of nutrients over the 4 h incubation period. Additionally, it was found that 
freezing the supernatants at -80°C and subsequent thawing had no significant effect on 
NE activity (Figure 3.6C), enabling samples to be stored and run in batches.  
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Figure 3.6: Optimising the neutrophil elastase activity assay  
Neutrophils were subject to normoxic or hypoxic incubation for 4 h and primed with 
cytochalasin B (5 µg/ml) or PAF (1 µM) for 5 min, or GM-CSF (10 ng/ml) or vehicle for 
30 min; they were then stimulated with fMLP (100 nM) or vehicle for 10 min. NE 
activity was quantified by the increased fluorescence caused by cleavage of DQ-Elastin. 
A. Effect of cell density on basal and stimulated (cytochalasin B and fMLP) NE 
production. B. Comparison of different priming agents C. Comparison of NE activity of 
fresh versus frozen supernatants from the same experiment. For A-C, results represent 
mean ± SEM, samples were run in triplicate, n=3.  
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3.8.4 Investigation of the mechanism of hypoxia-induced augmented neutrophil  
degranulation 
To investigate the specific role of hypoxia in neutrophil degranulation, a range of 
different inhibitors were used. The NE assay was used as a read-out of the effect of these 
compounds. Details regarding the compounds, and the concentrations used, are given in 
the relevant results sections and are summarised in Table 3.1.  
 
3.8.5  Quantification of myeloperoxidase 
This assay is based on the H2O2-dependent oxidation of o-dianisidine dihydrochloride 
(DMB) by MPO, leading to a colour change and hence a change of absorption at 460 nm. 
Freshly isolated neutrophils (11.1*10
6
/ml) in IMDM (270 µl aliquots) were subjected to 
normoxia or hypoxia at 37ᴼC for 4 h and stimulated exactly as documented in section 
3.8.1. Cells were pelleted, and the supernatants were transferred to fresh tubes before 
removal from the hypoxic hood. In addition, 3*10
6
 cells in 200 µl PBS
-
 were lysed with 
10% Triton X-100 (for assessment of total cellular MPO content). Lysed cells were spun 
down, and the supernatants transferred to a new tube. Supernatants were frozen at -80°C 
for subsequent analysis. Supernatants and lysates were de-frosted, and 50 µl aliquots 
transferred 1.25 µg/ml DMB in dH2O (50 μl) were added to each aliquot. The reaction 
mixtures were then incubated for exactly 15 min at 37°C. The reaction was stopped with 
50 µl of 0.1% sodium azide in dH2O, and the samples were placed on ice. 200 µl of each 
sample was transferred to a 96-well plate and absorption was read at 460 nm by a multi-
well plate reader (Biorad 680). MPO release (mean of triplicates) was expressed as a 
percentage of the total MPO present in Triton X-100-lysed cells.  
 
3.8.6 Quantification of lactoferrin release by ELISA 
Freshly isolated neutrophils (11.1*10
6
/ml) in IMDM (270 µl aliquots) were subjected to  
normoxia/hypoxia at 37
ᴼ
C for 4 h and stimulated exactly as documented in section 3.8.1.  
Cells were pelleted and the supernatants transferred to fresh tubes before removal from 
the hypoxic hood and freezing at -80°C. Pilot experiments demonstrated that a 500-fold 
dilution of the thawed supernatants was appropriate to bring the samples into the range 
measurable by a commercial solid-phase ELISA (enzyme-linked immunosorbent assay: 
Hycult). The plates supplied with the kit were pre-coated with capture antibody against 
human lactoferrin.  
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Table 3.1: Compounds used in neutrophil elastase activity assay 
The compounds shown in the table were obtained and used at the concentrations 
indicated; incubation times specified in the individual experiments. 
  
Compound Function 
Final 
concentration 
Company 
DMOG 
Competitive inhibitor of PHD 
enzymes 
1 μM Sigma 
DFO Iron chelator 1 μM Sigma 
Cobalt chloride 
Inhibits interaction between 
HIF1-α and VHL 
100 nM Sigma 
Cycloheximide 
Inhibits eukaryotic protein 
synthesis 
1 µg/ml Sigma 
EGTA 
 Calcium chelator (1:1 
stoichiometry) 
2 mM 
AnaSpec 
EGT group 
Thapsigargin 
Non competitive inhibitor of 
sarco/endoplasmic reticulum 
Ca
2+
 ATPases 
10-100 nM Sigma 
LY294002 Pan PI3Kinhibitor 10 µM CalBiochem 
IC87114 Selective  PI3Kδ inhibitor 3 µM Sigma 
AS605240 Selective  PI3Kγ inhibitor 3 µM Sigma 
U-73122 Inhibits the hydrolysis of PIP2 2 µM Sigma 
4-phenyl 3 
butenoic acid 
Inhibits PAM, an oxygen 
sensor 
1-500 µM Sigma 
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Samples (1:500 dilution, 100µl) and standards (0-100 ng/ml) were incubated in a 96-well 
plate. After an 1 h incubation at 37°C, the wells were washed 4 times with wash buffer 
(supplied with kit), and a biotinylated tracer antibody added (1:11 dilution, 100 µl, 1 h, 
22°C) which binds to the captured human lactoferrin, was added. After a further 4 washes 
with the wash buffer, streptavidin-peroxidase conjugate (which binds to the biotinylated 
tracer antibody; 1:23 dilution, 100 µl, 1 h, 22°C) was added. The peroxidase reacts with 
the subsequently added substrate, tetramethylbenzidine (TMB, 1:11 dilution, 100 µl, 30 
min in the dark, 22°C). This reaction was stopped by the addition of a stop solution 
(supplied by kit, contains 2% oxalic acid, 100 µl) and the absorbance at 450 nm measured 
with a spectrophotometer. A standard curve was obtained by plotting the absorbance 
(linear) versus the corresponding concentrations of the human lactoferrin standards (log). 
The concentration of lactoferrin present in the samples (which were run concurrently with 
the standards) was determined from the standard curve. 
 
3.8.7 Quantification of MMP-9 (gelatinase) release by ELISA 
To quantify the total amount of MMP-9 in the neutrophil supernatants, a DuoSet ELISA 
(R&D) kit was used according to the supplied protocol, with minor modifications to 
optimise detection of MMP-9 in neutrophil supernatants. Supernatants were prepared 
exactly as documented in section 3.8.1 were defrosted and serially diluted 500-fold. 
Instead of overnight coating of the plate with the capture antibody (mouse anti-human 
MMP-9, 2 µg/ml), the plate was coated for 2 h at 22°C. After 3 washes with PBS-Tween, 
non-specific binding was blocked by 2 h incubation with PBS
- 
BSA (1% BSA), and the 
plates were then washed thrice. Subsequently, the samples (1:500 dilution, 100 µl) and 
calibration curve standards (0-300 pg/ml, 100 µl) were added and incubated overnight to 
maximise binding of MMP-9 to the capture antibody. The supplied detection antibody 
(goat anti-human MMP-9, 100 ng/ml) was used (100 µl), but instead of streptavidin-HRP, 
extravidin alkaline phosphatase (1:400 dilution in the supplied diluent, Sigma) was used 
and the plate was incubated for 2 h, to improve the binding of the detection antibody to 
the captured MMP-9. This antibody reacts with 4-nitrophenyl phosphate disodium salt; 
using 4-nitrophenyl phosphate disodium salt (hexahydrate tablet, Sigma) in 
diethyanolamine buffer as substrate solution (100µl) eliminated the need for a stop 
solution and enabled the absorption to be read continuously at 405 nm by a multi-well 
plate reader (Biorad 680). This allowed me to determine the optimal “measurement time”. 
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The effect of these changes was assessed by repeated and comparative measurement of 
the calibration curve. To quantify MMP-9 in neutrophil derived samples, a standard curve 
was obtained by plotting the absorbance (linear) versus the corresponding concentrations 
of the human lactoferrin standards (log). The concentration of lactoferrin in the samples, 
which were run concurrently with the standards, was determined from the standard curve. 
 
3.8.8 Quantification of secreted MMP-9 activity by gelatin zymography 
Supernatants were prepared exactly as documented above (section 3.8.1). For this 
experiment a 10% polyacrylamide gel was cast, using 30% acrylamide/ bisacrylamide 
37.5:1 in 375 mM Tris pH 8.8, 0.1 % sodium dodecyl sulphate (SDS) and incorporating 2 
mg/ml of gelatin (Sigma). Polymerisation was accelerated by the addition of 0.05% 
freshly prepared ammonium persulphate (APS) and 0.1% Temed (N,n,n,n-tetramethyl-
ethylenediamine). Water-saturated butanol was layered on top of the resolving mixture to 
ensure a flat surface and exclude air. After the resolving gels had set (approximately 30 
min) the butanol was washed away and the stacking gel (5% acrylamide, 125 mM Tris pH 
6.8, 0.1 % SDS with APS and Temed (to accelerate polymerisation as above) was poured. 
A 10-well comb was inserted carefully into each stacking gel. Supernatants were 
defrosted and loaded (10 µl) onto the gel in a 1:1 dilution (in loading buffer). The gel was 
run at 150 V for 120 min in 1 x Tris Glycine SDS. Following electrophoresis, the proteins 
were re-natured by rinsing the gel in 2.5 % Triton X-100 (3 x 20 min) at RT. After 
rinsing, the gel was washed with MMP-9 incubation buffer (50 mM Tris-HCl (pH 7.6), 
150 mM NaCl and 5 mM CaCl2) made fresh on the day of the experiment (2 x 20 min) to 
remove the Triton-X. Subsequently MMP-9 incubation buffer was added and the gel 
incubated for 16 h at 37⁰C allowing the MMP-9 to digest the gelatin. Finally, the gel was 
stained with 0.4% Coomassie Blue R250 in 45% methanol, 10% acetic acid for 1 h prior 
to de-staining with 30% methanol/10% acetic acid until the bands where clearly visible 
(Figure 4.4B). The gel was photographed with a G:BOX gel imaging system (SynGene) 
and densitometry analysis of the bands performed with ImageJ.  
 
3.9 Western blot analysis of neutrophil granule protein content 
3.9.1  Preparation of cell lysates and protein extraction 
Western blot lysates were prepared by incubating freshly isolated neutrophils under 
normoxic or hypoxic conditions for 4 h in 6 well ultra-low attachment plates (Costar) at 
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37 °C, or by putting freshly isolated neutrophils on ice immediately. After 4 h the cells 
were collected in 15 ml Falcon tubes with the aid of a cell scraper (Corning). The cells 
were spun down at 310 g for 5 min at 4°C, washed with ice-cold PBS
-
, and resuspended 
in hypotonic lysis buffer (TRIS (pH 7.8, 10 mM), EDTA (1.5 mM), KCL (10 mM), DTT 
(500 µM), Na-orthovanadate (1 mM), tetramisole (2mM) in H2O) with protease inhibitors 
(1 tablet, Roche, 200 µl of lysis buffer per 20*10
6
 cells). Following vigorous vortexing 
for 15 sec, cells were placed on ice for 5 min, sonicated for 10 sec and returned to ice for 
15 min. Finally the insoluble fraction was spun down at 310 g for 5 min at 4°C and the 
supernatants transferred to new tubes 
 
3.9.2 Bicinchonic Acid (BCA) protein assay  
The BCA assay
387
 was used to determine the protein concentration of the lysates. This 
assay is based on the ability of proteins to reduce Cu
2+
 to Cu
+
 and on BCA to then chelate 
the Cu
+
, giving a purple coloration that can be quantified by spectophotometry (at 550 
nm). 10 µl of each sample was incubated with 200 µl of BCA solution  (BCA 10 ml + 
250 µl copper (II) sulphate (40:1)) for 30 min at 37°C in a 96-well plate, prior to analysis 
using an automated plate reader (Biorad 680). Samples were assayed in duplicate, and 
compared against standard curves prepared using pre-prepared BSA standards (0-1 
mg/ml). 
 
3.9.3 SDS-polyacrylamide gel electrophoresis 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was carried out using the Biorad 
Protean II system. Resolving gels were cast using Protogel (37.5:1 
Acrylamide:Bisacrylamide Stabilised Solution, National Diagnostics, Table 3.2). 
Polymerisation was accelerated by the addition of 0.05% freshly prepared APS and 0.1% 
Temed. Ethanol was layered on top of the resolving gel to ensure a flat surface and 
exclude air. After these gels had set (approximately 30 min) the ethanol was washed away 
and the stacking gels (Protogel with APS and Temed to accelerate polymerisation as 
above, Table 3.2) were poured. A 10-well comb was inserted carefully into each stacking 
gel. Samples (15 µg protein per sample, volume required determined by BCA protein 
assay as described above) were mixed in proportion with 6x sample buffer (60 mM Tris-
HCL, pH 68, 2% (v/w) SDS, 10% (v/v) glycerol, 5% (v/v) β-mercaptoethanol, 0.01% 
(w/v) bromophenol blue), heated for 5 min at 99°C, and allowed to cool to room 
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temperature before being loaded onto the gels, together with one lane for molecular 
weight markers (Precision Plus Protein™ Dual Color Standards, Biorad, CA, USA). The 
gel was run at 100 V through the stacking gel and at 150 V through the separation gel in 
1x running buffer (Tris-Glycine-SDS PAGE Buffer, National Diagnostics). 
 
3.9.4  Western blotting for MMP-9 
Following electrophoresis (dye front run to the bottom of the gel), the proteins were 
transferred to methanol pre-soaked polyvinylidene fluoride (PVDF) membrane using the 
Trans-blot system. Care was taken to ensure the membrane was moist at all times. Gel 
and membranes were sandwiched between 2 layers of Whatman 3M paper and placed in 
the tank containing transfer buffer (24 mM Trizma base, 193 mM glycine, 10% methanol) 
with a constant voltage of 75 V for 2 h. Following transfer, the two membranes were cut 
in two, determined by molecular weight markers, and blocked in freshly prepared in 5% 
Marvel dry milk powder (Nestle, France) in PBS-Tween (PBS-T: PBS
-
 with 0.1% Tween-
20, Sigma), for 1 h at room temperature, with constant agitation. The upper membranes 
were then incubated with a final concentration of 200 ng/ml anti-MMP-9 (rabbit 
polyclonal, Abcam), in freshly prepared 2.5% Marvel/PBS-T. The lower membrane 
portions were incubated with anti-β-actin (rabbit polyclonal, Cell Signaling, 1 in 5000) in 
freshly prepared 2.5% Marvel/PBS-T. Membranes were incubated overnight in primary 
antibody as indicated above at 4°C on a rocking platform. Membranes were washed thrice 
with PBS-T (10 min) and incubated with goat anti-mouse horseradish peroxidase (HRP)-
conjugated IgG (Dako, 1 in 10,000) or donkey anti-goat HRP-conjugated IgG (Santa 
Cruz, 1 in 5,000) in 2.5% Marvel/PBS-T. After a 1 h RT incubation, the membranes were 
finally washed thrice with PBS-T. HRP-tagged proteins were detected using the ECL 
(Enhanced Chemiluminescence) system (GE Healthcare). This detection method is based 
on the HRP-catalysed oxidation of luminol, resulting in light emission. Detection reagents 
1 and 2 were mixed (in equal volumes) and used to coat the membranes for 4 min. 
Membranes were then blotted dry, wrapped in clingfilm, and the resulting light was 
emission quantified by exposing to auto radiographic film in the dark for times ranging 
from 1 sec to 10 min. The films were scanned and densitometry analysis of the bands was 
performed using ImageJ. 
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Solutions Contents 
7.5 % gel 
(separation) 
10% gel 
(separation) 
4.5% gel 
(Stacking) 
Separation 
gel buffer 
see text 3.9 ml 3.9 ml - 
Stacking 
gel buffer 
see text - - 1.95 ml 
Proto gel 
(30%) 
37.5:1 Acrylamide 
to Bisacrylamide 
Stabilized Solution 
3.75 ml 5 ml 1 ml 
De-ionised 
water 
- 7.19 ml 5.74 ml 4.47 ml 
APS
#
 10% (w/v) APS 150 µl 150 µl 75 µl 
TEMED
#
 
Tetra-methyl-ethyl-
enediamine 
15 µl 15 µl 8 µl 
 
Table 3.2: Composition of SDS gels 
The table shows the reagents used for the SDS gels. Reagents indicated * were obtained 
from National Diagnostics, reagents designated 
#
 were obtained from Sigma. 
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3.10 Real-time PCR 
Real-time PCR (RT-PCR) experiments for assessment of BNIP3, MMP-9 and NE mRNA 
abundance were performed. Neutrophils were cultured at 5*10
6
 cells/ml in IMDM for 4 h 
under hypoxia or normoxia. Cell were gently scraped off the plates and pelleted by 
centrifugation (325 g, 10 min). Supernatants were discarded and the cell pellets 
transferred to 2 ml Eppendorf tubes, spun at 15,000 g for 5 sec, and the excess medium 
removed. Total RNA (1 μg), isolated with TRI-reagent (Sigma), was used for cDNA 
generation according to the manufacturer’s instructions (high capacity cDNA kit, Applied 
Biosystems). Relative gene expression was determined by qPCR (iCycler, Bio-Rad) using 
Sybr-green master-mix (Sigma) and relevant primers obtained from Qiagen. Relative 
gene expression was determined by correcting cycle threshold for the target gene against 
two housekeeping genes (Beta-2- microglobulin (β2M) and 18S ribosomal RNA (18S)). 
Relative gene expression (fold change) was expressed as 2-ΔΔCT.  
 
3.11 Assessment of the effect of hypoxia on kinase signaling 
To screen for kinases that might play a role in modulating degranulation, a human 
phospho-kinase antibody array (R&D systems) was used. It detects the relative site-
specific phosphorylation of 43 different kinases and related total proteins (Table 3.3). A 
nitrocellulose membrane is supplied with each capture antibody spotted on in duplicate,  
and the levels of phosphorylated protein in applied lysates can be assessed by the binding 
of phospho-specific antibodies and chemiluminescence detection. Neutrophils were 
incubated under normoxic or hypoxic conditions in ultra-low attachment 6 well plates 
(Costar) (to accommodate the large number of cells needed per condition) and activated 
as described previously, (section 3.8.1). After activation, the cells were collected in 15 ml 
Falcon tubes by gently scraping the cells off the plates with a cell scraper (Corning). The 
cells were spun down at 310 g for 5 min at 4°C. The cells were washed with ice cold 
PBS
-
 and resuspended at 1*10
6
/ml in the lysis buffer provided with the kit. The lysates 
were titurated to resuspend, rocked gently at 2-8°C for 30 minutes, clarified (14,000 g, 5 
min, 4°C), and the supernatants transferred to clean eppendorf tubes. Protein content was 
quantified using the BCA protein assay described in section 3.9.2.  
All kit reagents where brought to RT before use. Array buffer 1 (1 ml, Blocking Buffer) 
was added to each well of the supplied 8-well multi-dish. The membranes were placed in 
the array buffer, and incubated for 1 h on a rocking platform shaker. The lysates were   
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Kinase (phosphorylation site) 
Akt (S4873) Hck (Y411) PRAS40 (T246) 
Akt (T308) HSP27 (S78/S82) Pyk2 (Y402) 
AMPK alpha1 (T174) HSP60 
RSK1/2/3 
(S380/S386/S377) 
AMPK alpha2 (T172) 
JNK pan (T183/Y185, 
T221/Y223) 
Src (Y419) 
Beta-Catenin Lck (Y394) STAT2 (Y689) 
Chk-2 (T68) Lyn (Y397) STAT3 (S727) 
c-Jun (S63) MSK1/2 (S376/S360) STAT3 (Y705) 
CREB (S133) P27 (T198) STAT5a (Y694) 
EGF-R (Y1086) p38 alpha (T180/Y182) 
STAT5a/b 
(Y694/Y699) 
eNOS (S1177) p53 (S15) STAT5b (Y699) 
ERK 1/2 (T202/Y204, 
T185/Y187) 
p53 (S392) STAT6 (Y641) 
FAK (Y397) p53 (S46) TOR (S2448) 
Fgr (Y412) p70 S6 kinase (T421/S424) WNK-1 (T60) 
Fyn (Y420) PDGF R beta (Y751) Yes (Y426) 
GSK-3 alpha/beta 
(S21/S9) 
PLC gamma-1 (Y783) 
 
 
Table 3.3: Kinase array targets and phosphorylation sites 
Adapted from R&D website.   
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diluted with array buffer 1 to a final volume of 2 ml and 1 ml of diluted lysate was added 
per well; the membranes were incubated with the lysates overnight on a rocking platform 
at 2-8°C. The membranes were transferred to plastic containers with 20 ml of wash buffer 
(provided with the kit) and washed for 10 minutes (repeated for a total of three washes). 
After the wash steps the membranes were returned to the wells of the (cleaned) 8-well 
plate, containing 1 ml of the supplied antibody detection cocktail (diluted 1 in 5 in array 
buffer) and incubated on a rocking platform for 2 h at RT. Membranes were washed 
thrice and returned to the wells of the (freshly-cleaned) 8-well plate, containing 1 ml of 
diluted streptavidin-HRP (in array buffer, diluted according to dilution factor given on 
vial).  Following a 30 min incubation with streptavidin-HRP, another three wash steps 
were performed. Excess wash buffer was allowed to drain from the membrane by blotting 
the lower edge onto paper towels. The membranes were placed on the bottom sheet of the 
plastic sheet protector with the identification number facing up, with corresponding part 
A and B membranes end-to-end. Chemi-reagent mix supplied with the kit was used to 
coat the membranes for 1 minute.  Membranes were then blotted dry, wrapped in cling 
film, and the resulting light emission quantified by exposing to auto-radiographic film in 
the dark for times ranging from 1 sec to 10 min. The films were scanned and 
densitometric analysis of the signal was performed using ImageJ.   
 
3.12Assessment of hypoxia induced morphological changes 
3.12.1  Assessment of neutrophil morphology by electron microscopy 
Freshly isolated neutrophils were suspended in normoxic or hypoxic IMDM 
(11.1*10
6/ml, 270 μl aliquots) and incubated at 37°C for 4 h under normoxic of hypoxic 
conditions. After 4 h the cells were primed with cytochalasin B (5 µg/ml, Sigma) for 5 
min, GM-CSF (10 ng/ml) or vehicle for 30 min. The cells were subsequently stimulated 
with fMLP (100 nM) or vehicle for 10 min (Figure 2.4). Cells were pelleted, washed with 
1 ml of sterile 0.9% saline (Baxter) and fixed in 500 µl of 4% glutaraldehyde (containing 
0.1% (v/v) hydrogen peroxide and osmium tetroxide) for 2 h at 4⁰C. The cells were 
washed 4 times and finally suspended in 1 ml 0.9% saline. Cells were embedded in 
Spurr's resin. Dr Jeremy Skepper (Department of Physiology, Development and 
Neuroscience, University of Cambridge) completed sample preparation and took images 
(magnifications specified in the individual figures) of the cells using a CM 100 
transmission electron microscope (TEM: Philips).The images were scored for a range of 
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morphological changes, including shape (rounded, irregular or elongated), membrane 
ruffling (small microvilli, small/medium extensions, long extensions), clustering, 
presence of “empty vacuoles” (none, low or high) and granule density (low, medium or 
high). The result was an “activity score”, with a score of 6-8 indicating a quiescent cell, 
9-12 an activated cell and 13-17 a highly activated cell. The scoring system adapted from 
that of Mitchell et al.
388
, and is fully depicted in Figure 3.7. 
 
3.12.2 Assessment of neutrophil cytoskeletal remodeling by immuno-histochemistry 
Freshly isolated neutrophils were re-suspended in normoxic or hypoxic IMDM  
(3.5*10
6
/ml) and 270 µl aliquots transferred to 2 ml Eppendorf tubes to be incubated at 
37°C for 1 h under normoxic of hypoxic conditions. After 4 h the cells were stimulated 
with 30 µl fMLP (100 nM final concentration) or vehicle for 5 min. All subsequent steps 
were performed at RT (22°C) unless otherwise stated. The neutrophils were pelleted and 
the pellets were fixed by re-suspension in 200 µl of 4% paraformaldehyde (PFA), prior to 
removing samples from the hypoxic hood. Fixed neutrophils were washed thrice with 
PBS
-
, resuspended in 200 µl PBS
+
, and cytospins prepared. Before staining the 
neutrophils were permeabilised with 0.5% Triton X-100 in PBS for 10 min and washed 3 
times with PBS
-
. Non-specific staining was blocked with PBS-BSA (0.5% BSA, 30 min), 
after which the slides were washed 3 times with PBS
-
. The cells were stained with anti-
NE (goat polyclonal, Santa Cruz, 1:1,000) for 1 h, washed 3 times with PBS- and 
incubated with the secondary antibody (Alexa Fluor 488 – donkey anti-goat IgG, 1:1,000, 
Invitrogen) for 1 h in the dark, after which a further wash step was performed. Next the 
cells were stained for F-actin using rhodamine phalloidin (a high-affinity F-actin probe 
conjugated to the red-orange fluorescent dye, tetramethylrhodamine, Invitrogen) 1:200, 
30 min, in the dark, and washed thrice with PBS
-
. Finally, to prepare slides for 
microscopy, a DAPI containing mountant (Invitrogen) was dropped on to each sample, 
and cover slips were applied. The slides were kept on ice and in the dark prior to imaging 
with a Leica Sp5 confocal microscope. Representative images were taken in different 
areas of the well with the observer unblinded to the treatments.  
This protocol was developed by Cheng Chen, a Part 2 Medical Student at the University 
of Cambridge, who worked under my direct supervision during a 12-week lab project.  
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Figure 3.7: Scoring system of neutrophil images made by transmission electron 
microscopy (TEM) 
The images obtained by TEM were scored on a number of morphological criteria; 
including shape (rounded, irregular or elongated), membrane ruffling (A, small microvilli, 
small/medium extensions, long extensions), clustering (B), presence of “empty vacuoles” 
(C, none, low or high) and granule density (D, low, medium or high).  The result was an 
“activity score”, with a score of 6-8 indicating a quiescent cell, 9-12 an activated cell and 
13-17 a highly activated cell.   
 
  
Feature Score 
Shape rounded (1), irregular (2), elongated (3) 
Membrane ruffling 
small extensions(1), small/medium extensions (2), long 
extensions(3) 
Cell clustering no (1), yes (2) 
 Intracellular 
Vacuoles 
0-2 (1), 2-5 (2), 5> (3) 
Granule number  high (1), medium (2), low(3) 
D 
C 
B 
A 
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3.13 Human airway epithelial cell culture systems 
3.13.1 A549 cells 
A549 cells (a human lung adenocarcinoma cell line, ATCC) were initially used as a 
model cell-line to quantify neutrophil-mediated lung “epithelial” cell injury. The A549 
cells were cultured in 75 cm
2
 cell culture flasks in F-12K medium with 100 U/ml 
penicillin, 10 µg/ml streptomycin, 25 µg/ml amphotericin B (Invitrogen) and 10% fetal 
calf serum (FCS: GIBCO, Life Sciences). Cell aliquots were taken from nitrogen storage, 
defrosted and put into a flask with 15 ml F-12K medium. After 24 h the medium was 
replaced to remove any DMSO (dimethyl sulfoxide) present in the freezing solution. 
When the cell monolayers were confluent, the medium was removed and the cell layer 
washed with 10 ml of sterile PBS. The cells were then detached from the flask by 
incubation with 0.25% (v/v) trypsin/EDTA (Gibco) for 5 min at 37°C. Cells were viewed 
under an inverted microscope to ensure that they had rounded up and detached. Trypsin 
was inactivated by the addition of FCS-containing medium and the cells transferred into a 
15 ml Falcon tube, and spun at 1000 g, 5 min at 22⁰C. The pellet was re-suspended in 
fresh medium prior to counting on a haemocytometer. To maintain cell stocks, the cell 
suspension was diluted at a ratio of 1:10 or 1:20 and aliquotted into 75 cm
3
 tissue culture 
flasks and further stocks were frozen down.  
 
3.13.2 Immortalised human bronchial epithelial (iHBE) cells 
Immortalised human bronchial epithelial cells were a gift from Professor Gisli Jenkins 
(University of Nottingham). These cells were originally derived from normal human 
primary epithelial cells by Professor Jerry Shay, by transfection with cyclin-dependent 
kinase (Cdk) 4 and hTERT
389
. The iHBE cells were cultured in 75 cm
2
 cell culture flasks 
in keratinocyte serum-free media (500 ml, Fisher Scientific VX17005075) + 25 μg/ml 
bovine pituitary extract, 0.2 ng/ml rEGF, 250 ng/ml puromycin and 25 μg/ml G418. 
Puromycin and G418 are used for positive selection of the immortalised cells. Cell 
aliquots were taken from nitrogen storage, defrosted and put into a flask with 15 ml 
keratinocyte serum-free medium. After 1 day the medium was replaced to remove any 
DMSO present in the freezing solution. iHBE cells grew as a monolayer, adherent to the 
culture flask. When the cells were confluent, the medium was removed and the cell layer 
washed with 10 ml of sterile PBS
-
.  The cells were then detached from the flask by 
incubation with 10 ml 0.25% trypsin/EDTA solution for 5 min at 37 °C as above. Trypsin 
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was inactivated by the addition of 5 ml filter-sterilised FCS and the cells collected in a 15 
ml Falcon tube, and spun at 1000 g, 5 min at 22°C.  The pellet was re-suspended in fresh 
medium prior to counting on a haemocytometer, the cell suspension (diluted 1:10 - 1:20 
and aliquotted) into 75 cm
3
 tissue culture flasks and further stocks frozen down.  
 
3.13.3 Normal human bronchial epithelial (NHBE) cells 
Primary normal human bronchial epithelial (NHBE) cells were purchased from Lonza 
and cultured by Dr Robert A. Hirst (Senior Scientist, University of Leicester) as 
previously described
390
; Dr Hirst has extensive experience in culturing and working with 
these cells, and his input was vital as these cells are both expensive and extremely 
difficult to differentiate to ciliation.  NHBE cells were grown on collagen-coated (0.1%; 
Nutacon; Leimuiden, The Netherlands) 12-well tissue culture trays using bronchial 
epithelial growth media (BEGM; Lonza; Berkshire, England) for 2 to 7 days. The 
confluent non-ciliated basal cells were expanded into collagen-coated 80 cm
2
 flasks and 
the BEGM was replaced every 2 to 3 days. The basal cells were then seeded at 
approximately 10
5
 cells/cm
2
, on collagen-coated, 1.2 cm diameter, Transwell inserts 
(Corning) under BEGM for 2 days. After confluence was reached, the basal cell 
monolayer was fed on the basolateral side only with air-liquid interface media (ALI) 
medium comprising 50% BEGM and 50% Hi-glucose minimal essential medium with 
100 nM retinoic acid. The media was exchanged every 2 to 3 days and the apical surface 
mucus removed by gentle washing with phosphate-buffered saline (Figure 3.8). When 
cilia were observed (usually around 2 weeks after ALI culture
391
) on these cells, they 
were physically removed from the Transwell insert by gentle scraping with a spatula and 
the ciliated epithelium dissociated by gentle pipetting
392
. Dissociated ciliated epithelial 
cells were treated as described below (sections 3.14.4 & 3.14.6) to observe the effect of 
exposure to neutrophil supernatants.  
 
3.14 Assessment of damage to epithelial cell layers 
3.14.1 Poly-L-lysine coating of tissue culture plates 
For experiments using A549 and iHBE cells, tissue culture plates (see below) were coated 
with 0.001% (v/v) poly-L-lysine solution (Sigma) for 5 min. The poly-L-lysine solution 
was aspirated off the plates and the wells washed twice with sterile PBS
-
and air-dried 
prior to all experiments. 
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Figure 3.8: NHBE cell culture 
NHBE cells (Lonza) were grown on tissue culture trays in BEGM for 2-7 days. The 
confluent non-ciliated basal cells were expanded into collagen-coated 80 cm
2
 flasks and 
the BEGM was replaced every 2 to 3 days. The basal cells were then seeded at 
approximately 10
5
 cells/cm
2
 on a collagen-coated 1.2 cm diameter, clear Transwell  insert 
under BEGM for 2 days. After achieving confluence, the basal cell monolayer was fed on 
the basolateral side only with air-liquid interface. The media was exchanged every 2 to 3 
days and the apical surface mucus was removed by gentle washing with phosphate-
buffered saline. Ciliation occurred after approximately 2 weeks of ALI-culture and cells 
were used shortly thereafter.   
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3.14.2 MTT assay 
The MTT assay was used to determine the effect of neutrophil supernatants on A549 cell 
viability. 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) is 
processed in the mitochondria; mitochondrial dehydrogenases of viable cells cleave the 
tetrazolium ring, yielding purple formazan crystals,  which are insoluble in aqueous 
solution. The crystals are dissolved in isopropanol and the resulting purple solution is 
measured spectrophotometrically. A549 cells were plated onto 96-well plates (4*10
4
 
cells/well) and allowed to adhere overnight. 
The next day the medium was removed and the neutrophil supernatants (diluted 1in 2.5) 
or equivalent volume vehicle controls added. After 72 h incubation at 37°C (based on 
optimisation experiments using times of 12-120 h), the supernatants were removed and 
500 µg/ml of MTT in IMDM added for 2 h at 37⁰C. After incubation, the MTT solution 
was removed and the cells dissolved in 100 µl isopropanol.  The absorbance or the 
resulting solution was measured at 540 nm using a plate reader (Biorad). Toxicity of any 
treatment was expressed as absorbance at 540 nm versus that of medium controls. 
 
3.14.3 Immuno-histochemistry of cell layers  
A549/iHBEC cells were plated onto 96-well plates at a density of 8*10
4
 cells/well. The 
cells were incubated at 37°C overnight to adhere and form a confluent monolayer. The 
next day the medium was removed and the neutrophil supernatants (diluted 1 in 2.5) or 
diluent controls added. After 48 h at 37°C, the supernatants were removed, and the cell 
monolayers washed with PBS
-
 and fixed with 3.5% paraformaldahyde (PFA) for 20 min 
(RT) prior to two final washes with PBS
-
. NHBE cells in ALI culture were exposed to 
neutrophil supernatants (500 µl, 1:2 dilution) added to the basal side for 6 hours at 37⁰C. 
After this exposure the cells were gently scraped off the transwells and fixed in 4% PFA 
for 30 mins prior to washing twice with PBS.  Before staining, cytospins were made of 
the cell scrapings. All subsequent steps were performed at RT unless otherwise stated. 
Before staining the cells were permeabilised with 0.5% Triton-X in PBS
-
 for 10 min and 
washed twice with PBS
-
.Non-specific staining was blocked using PBS-BSA (0.5% BSA, 
30 min) and washed 3 times with PBS
-
 The cells were stained with anti-cleaved caspase 3 
(goat polyclonal, Santa Cruz, 1:1,000, Cell Signalling) for 1 h, washed twice with PBS
-
 
and incubated with secondary antibody (Alexa-Fluor 488 donkey anti-goat IgG, 1:1,000, 
Invitrogen) for 1 h prior to further washing steps. Rhodamine phalloidin (1:200, 
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Invitrogen) was then added to the wells to stain for F-actin (30 min), cells washed 3 times 
with PBS
-
 and finally a DAPI containing mountant (Invitrogen) was added.  
Figure 3.9 shows representative images of the A549, iHBE and NHBE cell layers stained 
in this fashion. The plates were kept on ice and in the dark prior to imaging with a Leica 
Sp5 confocal microscope. Three representative images were taken in different areas of the 
well, with care to avoid the edges of the wells. The observer was unblinded to the 
treatments.  
This protocol was developed by Cheng Chen, a Part 2 medical student at the University of 
Cambridge working under my supervision. 
 
3.14.4 Preparation of NHBE cells for electron microscopy analysis 
Cells were cultured as described above. When cilia were observed on the cultures, The 
wells were fixed by submerging the inserts in Sorensen phosphate-buffered (pH 7.4) 
glutaraldehyde (4% w/v). Dr Jeremy Skepper (Department of Physiology, Development 
and Neuroscience, University of Cambridge) completed sample preparation for electron 
microscopy analysis (as described in section 3.12.1) and took images of the cells using a 
FEI Verios 460 microscope. 
 
3.14.5 Assessment of cellular leakage by LDH assay 
The lactate dehydrogenase (LDH) assay (Sigma) measures membrane integrity by 
quantifying the release of cytoplasmic LDH into the medium. The assay is based on the 
reduction of NAD by LDH; reduced NAD (NADH) leads to the stoichiometric 
conversion of a tetrazolium dye, and the resulting compound is measured 
colourimetrically at 450 nm a multi-well plate reader (Biorad 680). Media samples (10 
µl) were taken from the basolateral side of a Transwell of NHBE cells exposed to 
neutrophil supernatants at t = 0, 1 h, 2 h, 4 h, 8 h, and 24 h. Samples or NADH standard 
(provided with the kit) were transferred to a 96-well plate and brought to a final volume 
of 50 µl with the supplied LDH assay buffer. Next, 50 µl of the provided reaction master 
mix was added, and the solution  mixed by pipetting up and down 4 times. During 
subsequent steps the plate was protected from light and incubated at 37°C. After 2 min, 
the initial measurement was made at 450 nm - (A450)initial. Subsequent measurements 
were made every 5  min for 1 h using a multi-well plate reader (Fluostar Optima plate 
reader, BMG Labtech) for 1 h; by this time the most active sample approximated to 
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Figure 3.9: Immunocytochemistry of A549, iHBEC and NHBE epithelial cells  
Three epithelial cell models were used to look at neutrophil mediated damage. A. A549 
cells. B. iHBEC’s and C. Primary HBEC’s (Lonza) grown to confluence in the 
recommended tissue culture media and stained with DAPI (nucleus: blue) and rhodamine 
phalloidin (actin: green), x40 magnification. The iHBEC’s and primary cells have a more 
uniform, cobblestone appearance compared with the A549 cells.  
3. Materials & Methods 
 
 
101 |  
 
or exceeded the end of the linear range of the standard curve. The measurement 
(A450)final used for calculating the released enzyme activity is the penultimate reading 
(when the final measurement of the most active sample falls within the linear range of the 
standard curve). All measurements were corrected for background. A standard curve was 
obtained by plotting the absorbance versus the corresponding concentrations of NADH 
standard. 
  
The change in absorbance was calculated by  
ΔA450 = (A450)final   - (A450)initial 
The LDH activity can then be calculated by  
LDH activity = (B x sample dilution factor) / (reaction time) x V 
B= Amount (nmol) of NADH generated between Tinitial and Tfinal 
Reaction Time = Tfinal –Tinitial  (minutes) 
V = sample volume (mL) added to wellLDH activity (mean of duplicates) was expressed 
as nmol/min/mL 
 
3.14.6  Analysis of ciliary function 
3.14.6.1  Assessment of ciliary beat frequency 
Ciliated cells were cultured as described above. The ciliated cell layers were gently 
scraped from the Transwell inserts, suspended in 500 µl of ALI medium per well and 
transferred to Eppendorf tubes. The cells were left to settle for 10 min, the medium was 
removed and the cells exposed to neutrophil supernatants (undiluted). Directly after 
exposure the cells were transferred onto a chamber-slide (Figure 3.10). Beating ciliated 
edges were recorded using a digital high-speed video camera (Kodak Ektapro Motion 
Analyser, Model 1012) at a rate of 500 frames per second (x 63 lens), using a shutter 
speed of 1 in 2,000. This allows video sequences to be recorded and played back at 
reduced frame rates or frame by frame.  Recordings of 4 different ciliated edges were 
taken every 30 min up to 2 h. The movies were subsequently analysed for ciliary beat 
frequency, ciliary dyskinesia and cell damage. For the ciliary beat frequency the movies 
were processed and cropped to the area of interest (ciliated cells) to eliminated 
background signal. They were then processed using CiliaFA
393
, a program developed by  
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Figure 3.10: Analysis of ciliary function 
Ciliated cultures were removed from the Transwell insert by gentle scraping with a 
spatula and transferred to Eppendorf tubes.  The cells were allowed to settle for 10 min 
after which the media was removed and the cells exposed to neutrophil supernatants.  
Directly after exposure the cells were transferred to a microscope chamber slide. Beating 
ciliated edges were recorded using a digital high speed video camera at a rate of 500 
frames per second (x63 magnification), using a shutter speed of 1 in 2000.  Recordings of 
4 different ciliated edges were made every 30 min for 2 h. The movies were subsequently 
analysed for ciliary beat frequency and ciliary dyskinesia. 
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Dr Claire M. Smith (Institute of Child Health, University College London). The program 
is based on Microsoft Excel and ImageJ and uses Fourier transformation to calculate the 
beat frequency (representative analysis sheet shown in the appendixes, section 8.3).  
 
3.14.6.2 Assessment of ciliary beat pattern 
Ciliary dyskinesia was assessed following an adapted version of a Standard Operating 
Procedure (SOP) for the determination of ciliary dyskinesia used for patient samples in 
the National Primary Ciliary Dyskinesia (PCD) service, Leicester (see appendix 3.2).  
1. Calculation of Immotility Index. 
In each movie the total number ciliated cells were counted, with a score of zero attributed 
to each immotile cilium. This process was repeated for each cell on 4 separate epithelial 
edges per condition. The Immotility Index is the percentage of zeros scored per edge per 
condition.  
2. Calculation of Dyskinesia Index. 
Dyskinetic cilia were defined as those with either no movement, or a slow or abnormal 
beat pattern. In each movie the total ciliated cells were counted, with dyskinetic cilia 
given a score of 1. This process was repeated for each cell on 4 separate epithelial edges 
per condition. The Dyskinesia Index is the percentage of 1’s scored per edge per 
condition.  
 
3.15 Statistical Analysis 
Data are reported as mean and SEM or SD from (n) independent experiments and 
analysed using Prism 5.0 software (GraphPad, San Diego, CA). A p value of 0.05 was 
considered significant. 
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4.  Hypoxia induces a more activated neutrophil phenotype  
4.1 Introduction 
It is well established that hypoxia modulates neutrophil function; published effects 
include delayed apoptosis
354,394
 and a reduced respiratory burst, resulting in impaired 
ROS-dependent killing of Staphylococus aureus
327
.  Previous work in our laboratory has 
shown that sustained and stable hypoxia (oxygen tension of the cell culture media ~3kPa) 
can be obtained using an InVivo400 hypoxic incubator (Ruskinn) delivering an 
atmosphere of 0.8% oxygen within the chamber. This oxygen tension is sufficient to 
stabilise HIF-1α in neutrophils incubated in tissue culture medium354 and is 
physiologically relevant (as shown by Peyssonnaux, C. et al.
309
 and others 
304,325,395,396
). 
Research undertaken by Peyssonnaux et al.
309
 has confirmed that hypoxic areas are 
present in normal skin epithelial basal cell layers; this was shown by staining tissues with 
Hypoxyprobe™-1 reagent (pimonidazole), which binds thiol groups in a redox-dependent 
fashion, with binding occurring only at oxygen tensions <10mm Hg or 1.3 kPa. 
Hypoxyprobe reactivity correlated to pronounced immunostaining for HIF-1α within the 
epithelial keratinocyte layer. In addition, Iannitti et al.
319
 showed that hypoxia is also 
present in the lungs of mice infected with the pathogenic fungus Aspergillus fumigatus, 
and in both the human and mouse cystic fibrosis (CF) airway.  
Since hypoxia is encountered by neutrophils in both the physiological and pathological 
settings, I wished to expand the preliminary observations made previously in our 
laboratory by Dr Naomi McGovern that hypoxia augments the release of NE. As well as 
playing a fundamental role in bacterial killing, degranulation has also been shown to 
contribute to neutrophil tissue migration
31
 and modulation of the immune response
133
.  
Furthermore, the products of neutrophil degranulation have been implicated in tissue 
destruction, in both a beneficial (promoting granuloma formation to limit the spread of 
mycobacterial pathogens: Taylor et al. 
397
 and a detrimental setting (for example, leading 
to matrix destruction and generating pro-inflammatory mediators like the neutrophil 
chemoattractant N-acetyl Pro-Gly-Pro (PGP)
206,398,399
). Although evidence of 
intravascular degranulation can be found in extreme clinical settings such as following 
cardiac arrest and septic shock
400,401
, degranulation occurs predominantly within tissues, 
at the site of infection or inflammation, either at the phagosomal membrane in response to 
pathogen ingestion (killing the engulfed organisms) or extracellularly at the plasma 
membrane in response to receptor-mediated activation (exposing the extracellular milieu  
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to potentially damaging proteases).  Several groups have found increased levels of NE in 
conditions that have been associated with hypoxia, for example in COPD sputum 
samples
402
 and in the circulation of rats after bowel ischemia-reperfusion injury
403
. Our 
previous observation
379
 that hypoxia augments NE release was preliminary made only by 
means of an ELISA, hence NE activity was not assessed. The distinction between protein 
detection and NE activity is of physiological relevance as neutrophils also release the 
protease inhibitor α1AT
404
; the ELISA for NE does not distinguish between active NE and 
NE complexed with α1AT.  
Furthermore, many granule-derived proteins in addition to NE contribute to both 
pathogen killing (for example, lactoferrin is directly bactericidal but also inhibits biofilm 
formation
405
) and tissue injury; for example, an MPO inhibitor halts disease progression 
in a mouse cigarette smoke exposure model of COPD
125
. To further investigate neutrophil 
degranulation I have focused on the hallmark proteins of each granule (section 1.3.1-
1.3.4): NE and also MPO from the azurophilic granules, lactoferrin from the specific 
granules, and MMP-9 from the gelatinase granules. 
 
The specific aims of the work presented in this chapter are: 
1. To establish whether hypoxia affects the release of any or all of the neutrophil 
granule sub-populations. 
2. To confirm that proteases released under hypoxic conditions display full 
biological activity. 
3. To determine whether cigarette smoke modulates the neutrophil degranulation 
response under normoxic and hypoxic conditions. 
4. To explore the effects of hypoxia on morphological features associated with 
neutrophil activation and priming. 
 
4.2 Confirmation of the neutrophil hypoxic response 
The CO2 levels in the InVivo400 chamber were titrated to maintain a stable, physiological 
pH in the culture media during experiments, to prevent acidosis from confounding the 
results. It should be noted that inflamed hypoxic tissues in vivo may also be acidotic with 
low nutrient availability; however the exploration of these parameters in the context of 
hypoxia was not thought to fall within the scope of this thesis. Accordingly, the O2 and 
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CO2  levels and pH of the culture media were tested regularly to ensure that stable 
readings were obtained throughout each experiment and for the entire duration of my 
experimental work (Normoxia: O2 = 21.65±0.49 kPa, CO2 = 4.30±0.28 kPa, pH = 
7.40±0.02. Hypoxia: O2 = 3.35±0.14 kPa , CO2 = 4.19±0.07 kPa , pH = 7.45±0.01 (section 
3.3.2, Figure 3.2). To confirm that I could isolate un-primed, fully responsive neutrophils 
and could recapitulate the previously published effects of hypoxia on neutrophil function, 
the ability of neutrophils to mount an oxidative burst was assessed under conditions of 
normoxia and hypoxia. Primed (GM-CSF, 10 ng/ml) and unprimed (vehicle treated) 
neutrophils were activated with fMLP (100 nM, G-protein coupled receptor-mediated 
activation), and the extracellular release of superoxide quantified using the superoxide 
dismutase-inhibitable reduction of cytochrome C. PMA (200 nM) was used as a maximal, 
receptor-independent method to achieve NADPH oxidase activation (PMA activates 
protein kinase C directly). Neutrophils were incubated under normoxic or hypoxic 
conditions for 1 h in PBS
+ 
and stimulated as described above (see also section 2.5). As 
shown in Figure 4.1A, GM-CSF-priming augmented the fMLP-stimulated respiratory 
burst substantially (approximately 6-fold up-regulation), whilst (as anticipated) hypoxia 
significantly impaired the production of superoxide anions. The normoxic primed and 
activated neutrophils produced 16.90±1.45 nmols O2
-
/10
6
 cells, while primed hypoxic 
neutrophils were only able to produce 5.09±1.03 nmols O2
-
/10
6
 cells on stimulation with 
fMLP. The inhibitory effect of hypoxia was also apparent upon stimulation with PMA, 
with the release of superoxide reduced from 22.50±0.95 nmols O2
-
/10
6
 cells under 
normoxia to 9.07±0.24 nmols O2
-
/10
6
 cells under hypoxic conditions.   
Another published effect of hypoxia on neutrophils is delayed apoptosis
354,394
. To 
recapitulate these data, freshly isolated neutrophils were re-suspended in normoxic or 
hypoxic media (with 10% serum, 5*10
6 
cells/ml) and incubated under normoxic or 
hypoxic conditions. After 20 h, cytospins were made and apoptosis assessed by cellular 
morphology (section 3.7). These data are depicted in Figure 4.1B and confirm that 
hypoxia promotes neutrophil survival by delaying apoptosis, consistent with the labs 
previous reports. These results show that the neutrophil isolation process employed yields 
un-primed and highly responsive cells, and that the hypoxic conditions modulated 
neutrophil function in a manner consistent with the published literature. Of note, 
McGovern et al.
327
 also demonstrated that hypoxia reduced the intracellular oxidative 
burst generated in response to particle ingestion, which is thought to be of direct 
relevance to bacterial killing, whilst the extracellular release of ROS has been linked to 
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Figure 4.1: Hypoxia alters neutrophil function  
A. Neutrophils (11.1*10
6
/ml) in PBS
+
 were incubated with GM-CSF (10 ng/ml) or 
vehicle under normoxic (filled bars) or hypoxic (0.8% O2 and 0.5% CO2, open bars) 
conditions for 1 h at 37°C. The cells were subsequently stimulated with either fMLP (100 
nM), PMA (200 nM) or vehicle for 10 min. Extracellular O2
-
 release was measured by the 
superoxide dismutase-inhibitable reduction of cytochrome C as described. Cells were 
pelleted and the supernatants transferred to fresh tubes before removal from the hypoxic 
hood prior to measuring the optical density at 550 nM using a scanning 
spectrophotometer. B. Neutrophils were re-suspended in hypoxic or normoxic IMDM at 
11.1*10
6
/ml. The cells were incubated under normoxia or hypoxia (0.8% O2 and 5% CO2) 
at 37°C for 20 h. Cytospins were prepared and stained with May/Grünwald/Giemsa. 
Morphology was examined by oil-immersion light microscopy.  Results represent mean ± 
SEM, A. n=5 experiments each performed in triplicate, B. n=8, experiments each 
performed in triplicate. *= p<0.05, *** = p<0.001 (Mann-Whitney test).  
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neutrophil-mediated tissue injury
406,407
.  The reduced intracellular respiratory burst under 
hypoxia was associated with impaired killing of Staph A, and re-oxygenation restored 
both ROS generation and killing. However, other mechanisms contribute to bacterial 
killing, and some bacteria including Escherichia coli and Streptococcus pneumoniae are 
killed independently of the NADPH oxidase respiratory burst
46,408
. Neutrophil granule 
proteins including serine proteases
129,409
 and lactoferrin
410
 contribute to bacterial killing, 
and NE and MMP-9 have been implicated in tissue injury. Hence I wished to investigate 
the effect of hypoxia on neutrophil degranulation. 
 
4.3
 
The effects of hypoxia on neutrophil degranulation 
4.3.1 The effects of hypoxia on azurophil granule protein release 
Since our preliminary data related to NE, and the considerable body of evidence 
implicating this protease in tissue injury
411–413
, I initially looked at NE activity released by 
neutrophils (section 3.8.2). Neutrophils were incubated under normoxic or hypoxic 
conditions at 37⁰C for 4 h, primed (GM-CSF, 10 ng/ml or Cytochalasin B (Cyt B) 5 
μg/ml, 30 min) and activated (fMLP 100 nM, 10 min) prior to measurement of NE 
activity in the supernatants. As shown in Figure 4.2A, there was little or no detectable NE 
activity present in the supernatants derived from un-stimulated cells under normal or 
hypoxic conditions.However, stimulation with the physiological priming agent GM-CSF 
and activation with fMLP did lead to detectable release of active NE, and importantly, 
this was significantly increased (almost sixfold) by hypoxia (10.4*10
3
±7.5*10
3 
Arbitrary 
units (AU) versus 61.2*10
3 
±12.4*10
3 
AU.). The combination of Cyt B and fMLP is 
normally regarded as a maximal (if non-physiological) stimulus for neutrophil 
degranuulation, but even the substantial NE release induced by this combination was 
further and significantly up-regulated under hypoxic conditions (increasing from 
173.4*10
3
±32.5*10
3 
AU. to 324.4*10
3
±24.3*10
3 
AU.).  
At the end of the assay, the neutrophils still excluded trypan blue, indicating that the NE 
release observed was not secondary to loss of membrane integrity or necrosis (data not 
shown). To determine whether this finding was specific for NE (perhaps reflecting 
increased expression of NE protein) or resulted from enhanced azurophil granule release, 
the liberation of a second azurophil granule protein, myeloperoxidase (MPO), was also 
assessed by means of the H202-dependent oxidation of o-dianisidine dihydrochloride 
(section 3.8.5). 
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Figure 4.2: Hypoxia augments the exocytosis of azurophil granules  
Neutrophils (11.1*10
6
/ml) in PBS
+
 were incubated under normoxic (filled bars) or 
hypoxic (0.8% O2 and 0.5% CO2, open bars) conditions for 4 h at 37°C.  The cells were 
primed (or not) with GM-CSF (10 ng/ml, 30 min) or Cyt B (5 µg/ml, 5 min) and activated 
with fMLP (100 nM, 10 min) or vehicle, and the supernatants assayed for granule protein 
activity. A. NE activity was measured by the increase in fluorescence caused by the 
cleavage of DQ-Elastin, n=10.  B. MPO activity was measured by the H202-dependent 
oxidation of o-dianisidine dihydrochloride (DMB) at 460 nm, n=8. The results represent 
mean ± SEM; all samples were run in triplicate. ** = p<0.01, *** = p<0.001 (Mann-
Whitney test).  
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Figure 4.2B shows that the release of active MPO closely paralleled that of NE. After 
stimulation with either GM-CSF plus fMLP or with Cyt B plus fMLP, MPO release was 
significantly augmented by hypoxia, increasing from 0.8%±0.56 of total cellular MPO to 
5.1%±1.18 with GM-CSF priming and from 10.8%±3.6 of total MPO to 46.1%±5.3 with 
Cyt B priming. During these experiments degranulation was measured in neutrophil 
supernatants only, the total amount of granule proteins in neutrophils after 4 hours of 
normoxia or hypoxia was not sampled. These results show that the release of both NE and 
MPO is increased by hypoxia, strongly suggesting that azurophil granule exocytosis is 
facilitated by these environmental conditions. To explore whether this effect was limited 
to the azurophilic granules, the effect of hypoxia on the release of gelatinase and specific 
granules was explored.  
 
4.3.2  The effects of hypoxia on specific granule protein release 
While the proteases present in the azurophil granules are of particular importance to 
bacterial killing, proteins stored in other granules also contribute to this function and to 
the potential of the migrating neutrophil to degrade matrix. Since hypoxia can augment 
the release of azurophil granules, which are considered to be the most resistant to 
extracellular mobilisation
68,70
, it was felt plausible that hypoxia might also facilitate the 
secretion of other neutrophil granule populations. 
Lactoferrin is a potent anti-microbial agent, which impairs bacterial growth by the 
sequestration of iron
109
, and is located principally in the specific granules. As shown in 
Figure 4.3A, the effect of hypoxia on the release of lactoferrin (measured by commercial 
ELISA as described in section 3.8.6) recapitulated the pattern seen with NE and MPO. 
Under normoxic conditions, there was minimal release of lactoferrin, but release was 
increased upon stimulation with GM-CSF and fMLP or Cyt B and fMLP. The release of 
lactoferrin was further augmented by hypoxia, from 391±82 ng/ml to 1331±407 ng/ml 
(GM-CSF/fMLP) or from 940±162 to 3286±663 ng/ml (Cyt B/fMLP). Since lactoferrin is 
not an enzyme, activity assays are not relevant in this context. 
 
4.3.3 The effects of hypoxia on gelatinase granule release 
The gelatinase granules are readily exocytosed, reflecting their function as a reservoir of 
matrix-degrading enzymes and membrane receptors to promote neutrophil extravasation 
and diapedesis
104–106
. 
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Figure 4.3: Hypoxia up-regulates the exocytosis of specific granules  
Neutrophils (11.1*10
6
/ml) in PBS
+
 were incubated under normoxic (filled bars) or 
hypoxic (0.8% O2 and 0.5% CO2, open bars) conditions for 4 h at 37°C. The cells were 
primed (or not) with GM-CSF (10 ng/ml, 30 min) or Cyt B (5 µg/ml, 5 min) and activated 
with fMLP (100 nM, 10 min) or vehicle, and the supernatants assayed for granule protein 
concentration. Lactoferrin release was measured by ELISA (Hycult). Results represent 
mean ± SEM from n=6 independent experiments; all samples were run in triplicate. * = 
p< 0.05, ** = p<0.01 (Mann-Whitney test).  
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Hypoxic enhancement of gelatinase granule release could lead to excessive matrix 
degradation and contribute to disease pathogenesis; for example, Vlahos and colleagues
67
 
demonstrated a dramatic up-regulation of MMP-9 in the BAL fluid of patients with 
COPD and noted a striking correlation with disease severity (21-fold increase in MMP-9 
activity in GOLD IV versus GOLD II disease).   
To confirm that hypoxia augments neutrophil gelatinase granule release, I assessed the 
liberation of matrix metalloproteinase-9 (MMP-9, neutrophil gelatinase B), an important 
component of the gelatinase granules. Total MMP-9 release was quantified by ELISA, 
and MMP-9 activity was assessed by gelatin zymography. The hypoxia-attributable 
increase in degranulation was recapitulated for MMP-9, as shown in Figure 4.4A. GM-
CSF priming induced a modest release of MMP-9 (37 ng/ml), which was significantly 
increased by hypoxia (4.4 fold, 165 ng/ml). Of note, under conditions of hypoxia, the 
fMLP-stimulated release of MMP-9 achieved by GM-CSF priming is almost equivalent 
to that seen with Cyt B (141 ng/ml versus, 218 ng/ml) consistent with the lower threshold 
for gelatinase granule release previously reported
75,233
. However MMP-9 release is only 
relevant in vivo if this protease is active and therefore capable of causing tissue damage, 
hence neutrophil supernatants were also subjected to gelatin zymography, Figure 4.4B/C. 
The basis of this assay it that active gelatinase should cleave the gelatin embedded within 
a polyacrylamide gel. Inclusion of EDTA (0.4 µM) to inhibit MMP's during the washing 
and incubation steps resulted in a blank gel, indicating that the bands shown in Figure 
4.4.C are produced by MMP digestion, not by other enzymes (data not shown). The 
representative zymogram and quantification of the bands by imageJ of n=3 experiments 
(Figure 4.4B) illustrates that active MMP-9 is released in a broadly similar pattern to that 
detected by ELISA. There is an increase in active MMP-9 released in response to GM-
CSF/fMLP from 10.5*10
3 
arbitary densitometric units (normoxia) to 22.4*10
3
 (hypoxia). 
There was no apparent difference between normoxia and hypoxia after Cyt B and fMLP 
stimulation, reflecting the results obtained using the ELISA assay. During these 
experiments degranulation was measured in neutrophil supernatants only, and the total 
amount of granule proteins in neutrophils after 4 hours of normoxia or hypoxia was not 
sampled. However electron microscopy data shown in Figure 4.8 indicates that there is no 
difference in total number of azurophil granules and data shown in Chapter 6, Figure 6.4 
shown that there is no increase in MMP-9 protein after a 4 hour incubation under 
normoxic or hypoxic conditions. 
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Figure 4.4: Hypoxia up-regulates the exocytosis of gelatinase granules  
Neutrophils (11.1*10
6
/ml) in PBS
+
 were incubated under normoxic (filled bars) or 
hypoxic (0.8% O2 and 0.5% CO2, open bars) conditions for 4 h at 37°C. The cells were 
primed (or not) with GM-CSF (10 ng/ml, 30 min) or Cyt B (5 µg/ml, 5 min) and activated 
with fMLP (100 nM, 10 min) or vehicle (Vehicle control= Veh C), and the supernatants 
were assayed for granule protein concentration/activity. A. MMP-9 release was measured 
by MMP-9 Duoset ELISA, samples were run in triplicate, n=5.  B. Quantification of 
MMP-9 activity by band analysis with ImageJ. Results represent mean ± SEM from an 
n=3 independent experiments, samples were run in triplicate. * = p< 0.05 (Mann-Whitney 
test) Numbers over bars relate to the lane numbers in C. C. Representative (of n=3)  
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Collectively, these results show that hypoxia augments exocytosis of multiple neutrophil 
granule populations following stimulation by physiological agonists, conferring the 
potential for increased tissue injury.  
 
4.4 The effects of cigarette smoke medium (CSM) on NE release 
Cigarette smoking is the most important risk factor for the development of COPD, and 
some papers have reported that cigarette smoke primes/activates neutrophils to induce a 
destructive phenotype. Mortaz et al
299
. and others have found that CSM induces the 
release of ROS
298
, IL-8, NE, MMP-2 and MMP-9 from neutrophils. Zappacosta et al.
297
 
also showed an up-regulation of fMLP receptors and CD11B/CD18 integrin expression 
on the cell surface, consistent with the mobilisation of secretory vesicles. Therefore I 
wished to investigate whether hypoxia and cigarette smoke have additive or even 
synergistic effects on neutrophil degranulation, since such an interaction could be highly 
relevant to the pathogenesis of COPD. Cigarette smoke medium (CSM) was prepared as 
described above in section 3.4. To confirm that the prepared CSM was capable of 
eliciting its recognised biological effects, such as induction of oxidative stress, the impact 
on intracellular neutrophil ROS production was quantified using the reagent DC-FDA, 
which becomes strongly fluorescent upon interaction with ROS. As shown in Figure 
4.5A, CSM induced a concentration-dependent increase in intracellular ROS production. 
This effect was most pronounced with concentrations of CSM above 25%; the effects of 
50% CSM were comparable to those of PMA (a maximal stimulus for the generation of 
intracellular ROS). Guided by the literature already cited and by the results above, the 
effect of CSM, alone or in combination with GM-CSF/fMLP, on normoxic and hypoxic 
neutrophil degranulation was investigated. As shown in Figure 4.5B, rather surprisingly 
25% CSM had no direct effect on the release of active NE, under either normoxia or 
hypoxia, and did not augment the effects of priming and/or stimulation with GM-CSF and 
fMLP. Even escalating the concentration of CSM to 50% did not augment these responses 
(figure 3.5B).  Incubation of cells with 75% CSM was toxic to the cells and induced 
substantial mixed apoptosis/necrosis under normoxia (Figure 4.6), whilst hypoxia seemd 
to ameliorate CSM-induced toxicity somewhat, as judged by light microscopy. 
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Figure 4.5: CSM induces ROS generation but does not affect NE release  
A. Neutrophils (5*10
6 
cells/sample) were suspended in HBSS ± DC-FDA (final 
concentration 0.1 µM) and incubated for 10 min prior to re-suspension in HBSS with or 
without 5, 25, 50, 75, 100% CSM. Following incubation at 37°C for 30 min, 100 µl 
aliquots were transferred to tubes containing optimised Cell Fix
TM
. The cells were then 
analysed by flow cytometry (n=2). B. Neutrophils were re-suspended (11.1*10
6
/ml) in 
normoxic (filled bars) or hypoxic (open bars) IMDM, with or without CSM (0-50 % as 
indicated), and incubated at 37°C for 4 h.  Cells were primed with GM-CSF (10 ng/ml, 30 
min) or Cyt B (5 µg/ml, 5 min) and activated with fMLP (100 nM, 10 min). NE activity 
was measured by the increase in fluorescence caused by the cleavage of DQ-Elastin. 
Results represent mean ± SD of n=2 independent experiments; all samples were run in 
triplicate.  
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Figure 4.6: High concentrations of CSM are toxic to neutrophils 
Neutrophils were re-suspended in hypoxic or normoxic IMDM (11.1*10
6
/ml) ± CSM (5-
50 %) incubated under normoxia or hypoxia (0.8% O2 and 5% CO2) at 37°C. After 4 
hours, aliquots (90 µl) were taken for cytospins and then stained with 
May/Grünwald/Giemsa. The images are representative photomicrographs of cytospins 
from 3 independent experiments (x40 magnification).  
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4.5The effects of hypoxia on neutrophil morphology 
The data for azurophil granule release (Figure 4.2) suggest that even with maximal 
stimulation there was incomplete neutrophil degranulation; to verify this I studied the 
morphology of neutrophils pre- and post-degranulation by electron microscopy. The 
ability for hypoxia to potentiate degranulation suggested that this signal may prime 
certain aspects of neutrophil function; as a consequence other features that might indicate 
augmented activation were also determined. Neutrophil shape-change is a feature of 
neutrophil priming/ activation, requiring changes in actin cytoskeleton conformation to 
facilitate migration. Furthermore, cytoskeletal remodelling plays an important role in 
degranulation. Hence Transmission Electron Microscopy (TEM) and confocal 
microscopy were used to evaluate neutrophil morphology and cytoskeletal organisation in 
the normoxic and hypoxic setting. 
 
4.5.1 TEM analysis of neutrophils morphology 
To study the effects of hypoxia on neutrophil morphology using TEM, the cells were 
incubated under normal or hypoxic conditions and activated as described above, then 
fixed (4% gluataraldehyde) and prepared for TEM (section 3.12.1). The images shown 
(Figure 4.7) were obtained by Dr Jeremy Skepper. Changes in cellular morphology were 
scored based on published observations made by Mitchell et al.
388
 and Hoffstein et al.
414
; 
the full scoring system is shown in Figure 3.7. Cells were scored (with the observer 
blinded to the experimental condition) for shape (rounded, irregular or elongated), 
membrane ruffling (microvilli, small/medium extensions, long extensions), clustering, 
presence of “empty vacuoles” (none, low or high) and granule density (low, medium or 
high). The result was an “activity score”, with 6-8 indicating a quiescent cell, 9-12 an 
activated cell and 13-17 a highly activated cell.  As shown in Figure 4.8A, a significant 
difference in activation status between normoxic and hypoxic cells was obtained in both 
un-stimulated neutrophils and in neutrophils stimulated with Cyt B/fMLP. Surprisingly, 
GM-CSF/fMLP-stimulated neutrophils under hypoxic conditions did not differ from 
comparable normoxic cells when assessed by this method. This may reflect either the cell 
processing for TEM in some way ‘blunting’ any differences or be an issue related to the 
scoring system itself. Hence further parameters were assessed using the TEM images. 
Upon activation the neutrophils surface becomes irregular with formation of microvilli, 
and the cell adopts a more polarised oval shape.  
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Figure 4.7: Effect of hypoxia on neutrophil morphology: TEM images 
Neutrophils were re-suspended in hypoxic (left panels) or normoxic (right panels) IMDM 
at 11.1*10
6
/ml and incubated under normoxia or hypoxia (0.8% O2 and 5% CO2) at 37°C 
for 4 h. The cells were primed with GM-CSF (10 ng/ml, 30 min) or Cyt B (5 µg/ml, 5 
min) and activated with fMLP (100 nM, 10 min). Cells were then fixed with 4% 
gluataraldehyde and processed for TEM by Dr Jeremy Skepper. Representative images of 
n=9-15 are shown; magnification = x3500.   
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The outline of each cell was therefore measured using ImageJ (n=9-10), and was found to 
increase upon activation; this increase was not greater for Cyt B-primed versus GM-CSF-
primed stimulated cells (Figure 4.8B). A statistically difference in circumference between 
normoxic and hypoxic conditions was seen only when cells were stimulated with 
CB/fMLP. This methodology may be affected if the cells are not sectioned in the same 
plane between conditions, although I attempted to compensate for this by choosing cells 
with the nucleus cut in a similar plane.   
Finally the number of azurophilic granules remaining within the cells was counted; these 
granules are electron dense and hence easy to identify. I predicted an inverse correlation 
with NE release. However, as shown (Figure 4.8C), only treatment with Cyt B/fMLP 
noticeable decreased the number of intracellular azurophilic granules remaining, versus 
unstimulated control cells.  This may reflect the fact that GM-CSF/fMLP treatment, even 
under conditions of hypoxia, results in the release of less than 10% of the total azurophil 
granule content (Figure 4.2B), and suggests that this methodology may not be sensitive 
enough to detect such minor changes in intracellular granule content.  
Although these data are not definitive, they do suggest that hypoxia promotes changes in 
neutrophil morphology. Since the actin cytoskeleton plays such a key role in shape 
change and in neutrophil degranulation, I chose to investigate more directly whether 
hypoxia might induce actin cytoskeletal remodelling. 
 
4.5.2 Cytoskeletal changes under hypoxic conditions 
Upon activation the neutrophil acquires a polarised morphology with an actin-rich 
lamellipodium (leading edge) and an elongated tail-like uropod at the rear end. This shape 
change facilitates rapid directional movement along a chemokine gradient (chemotaxis).  
Besides migration, actin re-organisation is also essential for the uptake of bacteria and the 
release of granule proteins
276,415
.   
Neutrophils were incubated under normal or hypoxic conditions for 4 h and stimulated 
with fMLP (100 nM) for 5 minutes prior to fixing and staining as described above 
(section 3.12.2). Under normoxic conditions, un-stimulated neutrophils displayed diffuse 
green F-actin staining, with slight polarisation apparent under hypoxia in the absence of 
other stimulation.  Upon activation with fMLP (100 nM) polarised actin staining, with the 
formation of actin ‘caps’ was detected. This fMLP-induced morphological change was 
substantially increased and apparent in a far higher proportion of cells under hypoxic 
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Figure 4.8: Effect of hypoxia neutrophil morphology: TEM quantification   
Neutrophils incubated under normoxia or hypoxia (0.8% O2 and 5% CO2) at 37°C for 4 h 
were primed (GM-CSF 10 ng/ml, 30 min or Cyt B 5 µg/ml, 5 min) and then activated 
with fMLP (100 nM, 10 min). Cells were fixed with 4% gluataraldehyde and processed 
for TEM. Representative EM images (from n=9-15) are shown in Figure 3.7 above. A. 
Cells were scored for morphology, clustering, granule density, membrane ruffling and 
vacuole formation to give a ‘cell activity’ score in arbitrary units (AU).  B. Cell 
circumference was measured by drawing around each cell margin and quantification with 
ImageJ. C. MPO
+ 
granule quantification by counting. For A-C, values are mean ± SEM, 
with 9 images analysed per condition. * = p< 0.05 (Mann-Whitney test).  
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Figure 4.9: Activation and hypoxia induce actin cytoskeletal remodelling 
Neutrophils were re-suspended in hypoxic or normoxic IMDM at 11.1*10
6
/ml and 
incubated under normoxia or hypoxia (0.8% O2 and 5% CO2) at 37°C for 4 h. The cells 
were stimulated with fMLP (100 nM) for 5 min, prior to fixing and permeabilisation. The 
cells were stained for the cell nucleus (DAPI, Blue), NE (goat IgG and Alexa Fluor 488–
donkey anti-goat IgG, red) and F-actin (rhodamine-phalloidin, green), magnification 
=x60. Representative images shown of n=3 independent experiments. 
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conditions as shown in Figure 4.9 (representative images from n=3 experiments)  
Cheng Chen, a 3
rd
 year Medical Student undertaking a 12-week project in the laboratory, 
performed these experiments under my direct supervision and with my assistance.  
 
4.6 Discussion 
Neutrophilic inflammation predominates in the COPD airway wall
63,64,416
, and an 
extensive body of evidence (from cell culture to murine models and finally to the 
susceptibility of human patients with α1AT deficiency to develop COPD) implicates NE 
as a key mediator of tissue damage and the relentless decline in lung function that 
occursin this disease. It is known that hypoxia can influence neutrophil function 
profoundly
327,354
. My results confirm and extend these observations; using a range of 
different techniques I have shown that hypoxia induces an altered neutrophil phenotype 
with an activated morphology, actin remodelling and - most importantly - increased 
degranulation. The increased degranulation response includes all the neutrophil granule 
types and leads to the enhanced release of NE, MPO, MMP-9 and lactoferrin; by 
implication the release other histiotoxic granule products such as cathepsins and 
proteinase-3 is highly likely to be also augmented by hypoxia. I have also shown that 
these liberated products are biologically active, and hence have the potential to cause 
significant tissue damage both in vitro and in vivo. There is no direct histological 
evidence of increased neutrophil degranulation present in areas of cellular damage in 
hypoxic tissue in the literature; however a substantial body of evidence links elevated 
levels of neutrophil granule proteins with the presence of tissue hypoxia.  The tumour 
microenvironment, for example, is profoundly hypoxic, as rapidly growing tumours 
outgrow their vascular supply.  Neutrophil granule proteins have been found to play a role 
in cancer; in particular NE has been implicated in tumour proliferation and metastasis. NE 
directly induced tumour cell proliferation in both human and mouse lung 
adenocarcinomas in part by gaining access to an endosomal compartment within tumour 
cells, where it degraded insulin receptor substrate-1 (IRS-1) and led to PI3K activation
417
. 
A NE inhibitor was found to prevent hepatic and lung metastasis in a mouse model 
involving intrasplenic injection of Lewis lung adenocarcinoma cells, partly by inhibition 
of neutrophil NET formation
418
.  In COPD, the airway wall may experience significant 
hypoxia, as evidenced by the presence of HIF in bronchial epithelial cells in biopsies 
from COPD patients but not in the biopsies of the healthy controls
419,420
; however it must 
be acknowledged that inflammation as well as hypoxia can lead to stabilisation of 
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HIF
363,421
. Polosukhin
419
 and colleagues also showed that HIF-1α expression was 
associated with areas of goblet cell hyperplasia (93.2 ± 3.9% of goblet cells were HIF-1α 
positive) whereas nuclear HIF-1α was not detected in individuals  
without COPD. This, combined with data from Stockley et al.
66
 and others including 
Vlahos et al.
67
 show that circulating NE and MMP-9 levels increase during exacerbations 
and that NE is related to disease severity in COPD supporting the hypothesis that hypoxia 
contributes to the enhanced neutrophil degranulation that is felt to be pathogenic in this 
condition.  
Although there has been no previous published study of the effects of hypoxia on 
neutrophil degranulation, some researchers have studied this phenomenon in other cell 
types. There is evidence that hypoxia can induce mast cell granule release
382,383
, although 
others have suggested that this in an indirect effect mediated by the release of MCP-1 by 
hypoxic alveolar macrophages
384
. Additionally, Pinskey et al.
385
 and others
386
 showed that 
hypoxia induces the exocytosis of endothelial cell Weibel-Palade bodies (WP-bodies), 
releasing von Willebrand factor (vWF) as well as increasing expression of the WP-body-
derived PMN adhesion molecule, P-selectin.  Pinskey et al.
385
 postulated that endothelial 
WP-body exocytosis occurs during hypothermic cardiac preservation, priming the 
vasculature to recruit PMNs during reperfusion. The two groups differed in their 
assessment of the length of hypoxic exposure required to induced WP body release; 
Pinskey et al.
385
 saw only a small increase in degranulation around 1 hour, with a more 
significant increase at 4 hours, whilst Goerge et al.
386
 found a very rapid degranulation 
response with a substantial difference between normoxic and hypoxic conditions as early 
as 5 minutes, maintained at 1 hour. Both groups use the same cell type and quantification 
method so the reason for this difference in the rate of degranulation is unclear. Of note, 
the kinetic pattern of degranulation reported by Pinskey et al.
385
 resembles previous data 
on hypoxic NE release from our laboratory
379
. 
Given the important role of cigarette smoke in the pathogenesis of COPD, and the fact 
that NE and other neutrophil-derived proteases may be important in mediating this effect, 
I explored the potential for cigarette smoke to synergise with hypoxia in augmenting 
neutrophil degranulation. No previous literature exploring the effect of CSM under 
hypoxic conditions was found, but a substantial amount of data exist reporting the effects 
of CSM on neutrophils under normoxia.  However, the results presented by different 
authors vary significantly. Different laboratories use different methods to prepare CSM, 
and some laboratories have used commercially available cigarettes rather than 
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standardised research cigarettes.  The quantification of the CSM and the concentration 
used by different laboratories is also substantially different, ranging from 1 cigarette per 5 
mls of medium to 1 cigarette per 20 mls of medium.  Since commercial preparations of 
cigarette smoke extract and condensate have also been reported to vary considerably, I 
prepared my own CSM using research grade cigarettes, and verified the activity of the 
CSM by demonstrating that it induced intracellular oxidative stress as predicted and in a 
concentration-dependent fashion. I also demonstrated that high (>50%) concentrations of  
CSM were directly toxic to neutrophils and induced necrosis/apoptosis. Although 
(interestingly) hypoxia largely prevented CSM-induced cell death, concentrations of CSM 
that were able to induce detectable intracellular oxidase activity had no effect on 
neutrophil viability/survival at 4 hours and hence were used to study degranulation. No 
effect on basal or stimulated NE secretion, either in ambient oxygen or hypoxic 
conditions was found.  These data contrast with those reported by Koethe et al.
296
, who 
showed a priming effect of CSM on neutrophils, leading to increased NE release 
following stimulation with fMLP, whilst Mortaz et al.
299
 and Overbeek et al.
300
 found that 
CSM induced the production of reactive oxygen species, IL-8, NE, MMP-2 and MMP-9 
directly.  However, both of these groups used a much longer incubation time (9 h) and a 
higher concentration of CSM than employed herein (smoke from 1 cigarette bubbled 
through medium in comparison to smoke from 3 cigarettes in 25 ml medium).  For the 
experiments involving hypoxia, the 4 h incubation period was deliberately selected as 
sufficient to induce maximal up-regulation of degranulation, but not sufficient to effect 
neutrophil survival (which might confound the results). As I could detect no effect of 
CSM on neutrophil degranulation in the time-frame relevant to my studies, I did not study 
this interaction further).  
To ensure that the enhanced release of granule proteins did not reflect a loss of cellular 
integrity, and to explore the effects of hypoxia on cellular features characteristic of 
priming and activation, I performed a detailed morphological analysis. Using TEM I have 
shown that the treatments I have used leave the cells fully intact, but that hypoxia induces 
a number of morphological changes, over and above those induced by activation alone. 
The scoring system I used was based on the observations of Mitchell et al.
388
, who show 
that activated neutrophils have a more elongated profile, and also observed more empty 
vacuoles; these are similar to the morphological changes I saw and which are depicted in 
Figure 4.7. In an attempt to obtain quantitative data on cellular morphology I analysed 
neutrophil circumference from the TEM images, using nuclear morphology to try to 
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ensure the selected cells had been cut in a similar plane (although this is still a potential 
source of error). In agreement with Mitchell et al.
388
, activation increased cellular 
circumference, perhaps by increasing the number of cellular protrusions; hypoxia alone 
had no significant effect on this index but did enhance the effect of Cyt B. A significant 
reduction in the number of intracellular electron-dense granules was detected only when 
neutrophils had been treated with Cyt B/fMLP under conditions of hypoxia; as shown in  
Figure 4.2, this is the only condition where >10% of total MPO was released from the 
cell, suggesting that the TEM quantification is not sufficiently sensitive to detect these 
smaller changes. I did not observe the peripheral granule redistribution reported by 
Rittner et al.
422
 in response to fMLP, perhaps reflecting the very high agonist 
concentrations used by this group (fMLP, 5µM). However, this set of experiments did 
confirm that the detection of increased extracellular granule proteins in response to 
hypoxic stimulation depicted in Figure 4.2-Figure 4.4 reflects the liberation of intact 
granules rather than non-specific cellular damage. 
The neutrophil cytoskeletal changes in response to hypoxia described in this thesis have 
not been, to my knowledge previously reported. Hypoxia has been shown to affect the 
actin cytoskeleton and induce shape change in neuronal cells
423
 and proximal renal 
tubular cells
424
 in culture, but the mechanism and consequences of these effects were not 
explored.  Working in our laboratory, Dr Naomi MCGovern did not detect hypoxia-
induced neutrophil shape change when using a FACS-based method, however by 
immunofluorescence microscopy I have shown a clear effect of hypoxia on the 
distribution of polymerised F-actin to cap-like structures. Since cytoskeletal 
rearrangements have been linked to degranulation
276,425
, this observation may provide a 
mechanistic insight into the hypoxic up-regulation of neutrophil degranulation. The 
mechanism of neutrophil degranulation under hypoxia and the possibility of enhanced 
degranulation leading to more epithelial cell damage are the focus of my subsequent 
chapters. 
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5.  The effect of hypoxia on neutrophil-induced damage to lung 
epithelial cells 
5.1 Introduction 
There is abundant evidence that neutrophil proteases can cause substantial tissue damage 
as exemplified by research into COPD. Factors contributing to the occurrence and 
progression of emphysema include chronic neutrophilic inflammation with protease/anti-
protease imbalance and oxidative stress in the alveolar environment, and lung epithelial 
cell apoptosis
426
; neutrophil-derived proteases can contribute to all of these processes
427
. 
Neutrophil elastase (NE) in particular has been shown to play an important role in the 
development of emphysema
127,133
; direct installation of purified NE (porcine pancreatic 
elastase of NE) into the lungs of mice is used as an animal of emphysema
133
, and mice 
deficient in NE are protected from cigarette smoke-induced emphysema
136
. NE has also 
been shown to cause mucous gland hyperplasia
210
 and enhance the secretion of 
mucus
180,428
, and incubation with elastase-positive but not elastase-negative  respiratory 
secretions led to a decrease in ciliary beat frequency of primary nasal epithelial cells
429
. 
Beside NE, both MPO
193,196
 and MMP-9 have been shown to promote inflammation and 
cause tissue injury
200,201
. Together, MMP-9 and NE are capable of degrading almost every 
extracellular matrix component including collagen, fibronectin, proteoglycans, heparin, 
and cross-linked fibrin
171
. MMP-9 has further been related to parenchymal destruction 
and lung function decline in subclinical and established emphysema
200,201
. Other studies 
have shown MMP-9 to be elevated in the sputum of patients with COPD in comparison to 
healthy control subjects, and MMP-9 levels were found to correlate with increased 
neutrophilia and decreased lung function
94,202,203
. MPO can cause oxidative stress in 
inflammatory settings and serum MPO levels have been shown to correlate with a decline 
in lung function
192
.  
Furthermore, neutrophil proteases can compromise local pulmonary immune responses; 
NE has been shown to cleave critical protein components of the bronchial defenses, such 
as the C3Bi opsonophagocytic receptor CR1
179
, immunoglobulin
180
 and SPLUNC1 (short 
palate, lung, and nasal epithelial clone 1
181
), which is thought to exert anti-microbial 
activity in the context of pulmonary pseudomonal infection
430
. MPO has been shown to 
up-regulate the inflammatory response directly; MPO internalised by endothelial cells 
leads to IL-6, IL-8 and ROS release with the potential for the perpetuation of 
inflammation and injury
195,196
.  
5. Results                       The effect of hypoxia on neutrophil-induced damage to lung epithelial cells  
 
 
129 |  
 
These data suggests an important role for neutrophil proteases in a range of lung diseases.  
In the light of the evidence summarised above, I wished to investigate the potential 
pathophysiological relevance of my finding that hypoxia substantially upregulates 
neutrophil degranulation. In order to do this, I explored the effects of supernatants 
collected from neutrophils cultured under normoxic or hypoxic conditions on lung 
epithelial cells in culture.  
These supernatants were generated by priming neutrophils (3*10
6
 cells per sample) with 
GM-CSF (10 ng/ml) and activating the cells with fMLP (100 nM) under normoxic or 
hypoxic conditions (0.8 % O2, 5% CO2, section 3.8.1). The amount of active NE in each 
neutrophil supernatant was quantified to counter any batch to batch variability and 
samples were stored for no longer then 6 weeks to ensure there was no time dependent 
loss of protease activity. Initial experiments were performed using the A549 lung 
adenocarcinoma cell line; I then progressed my findings to explore the effects on 
immortalised Normal Human Bronchial Epithelial Cells (iHBECs) and ultimately primary 
human bronchial epithelial cells grown in air-liquid interface (ALI) cultures.  
 
The specific aims of the work presented in this chapter are: 
1. To establish whether the hypoxic enhancement of neutrophil degranulation has the 
potential to damage A549 epithelial cell monolayers. 
2. To investigate the nature of the damage-inducing components of the neutrophil 
supernatants. 
3. To extend any relevant findings in A549 cells to cells which more closely 
resemble human bronchial epithelial cells in vivo. 
4. To explore the effects of normoxic and hypoxic neutrophil supernatants on ciliary 
function. 
 
5.2 The effect of hypoxia on neutrophil-induced damage to A549 cells  
For my initial experiments I used the A549 lung epithelial cell line. These cells are 
alveolar basal epithelial cells derived from a human lung adenocarcinoma; they are often 
used as a lung epithelial cell model
431,432
, having the advantages of being well-
characterised, readily available and easy to grow in the cell culture environment. The 
cells were used only at early passage number (up to 6 passages after defrosting) and were 
visually checked for signs of infection on a daily basis.  
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5.2.1  The effects of hypoxia on neutrophil induced toxicity to A549 cells 
To investigate the ability of neutrophil supernatants to cause damage to lung epithelial 
cell layers, A549 cells were plated onto poly-L-lysine coated plates (96-well plates, 
40,000 cells per well) and cultured overnight at 37 °C (5% CO2) in F-12K medium with 
antibiotic/antimycotic solution and 10% FCS overnight to obtain a fully confluent 
monolayer. The next day the cell layers were exposed to neutrophil supernatants (150 µl, 
1:2.5 dilution, 37°C) for 72 h (earlier time-points did not show significant cell damage 
visually, data not shown). To visualise cellular damage and delineate cell monolayer 
integrity, the A549 cell layers which had been exposed to neutrophil supernatants for 72 h 
were stained with the fluorescent dye 4',6-diamidino-2-fenylindool (DAPI) (which binds 
to chromatin) and 5-(and 6)-Carboxyfluorescein diacetate succinimidyl ester (CFSE), 
which is able to cross cell membranes and hence highlights the cytoplasm. As shown by 
the photomicrographs in Figure 5.1A, there was a striking difference in A549 monolayer 
integrity induced by supernatants derived from neutrophils activated (with GM-
CSF/fMLP) under normoxia versus those activated under hypoxia. Exposure to hypoxic 
activated neutrophil supernatants resulted in only a minimal remaining intact cell layer, 
whilst in the wells exposed to supernatants from normoxic neutrophils, a relatively intact 
cell layer is still present (Figure 5.1A, representative image from n=11 experiments). 
Since the supernatants from hypoxic neutrophils led to substantial disruption of 
monolayer integrity on visual inspection, the direct toxicity of the neutrophil supernatants 
was quantified more precisely by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide MTT assay. Experimental conditions were precisely as described above. After 
72 h, the supernatants were aspirated from the epithelial monolayers and the cells were 
incubated with MTT (100 µl, 500 µg/ml final concentration) in IMDM for 2 h at 37°C. 
The resultant purple formazan crystals, formed by the mitochondria of viable cells, were 
dissolved in isopropanol after a 2 h incubation and the absorbance measured at 540 nm. 
The absorbance of cells exposed to control media (IMDM) is used as 100% living cells 
(presence of an intact, fully confluent cell layer was confirmed by microscopy). The 
exposure of the cell layers to neutrophil supernatants led to reduced absorbance at 540 
nm, presented as percentage (%) of living cells. Figure 5.1B shows that the supernatants 
from normoxic neutrophils, even those activated by GM-CSF/fMLP, caused minimal 
(<10%) cell death. In contrast, even the supernatants from hypoxic unstimulated 
neutrophils induced substantial (39%) cell death, and this increased to 60% A549 cell 
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Figure 5.1: Hypoxic neutrophil supernatants compromise A549 cells survival 
A549 cells were cultured in Poly-L-Lysine coated 96-well plates (80,000 cells per well) 
to obtain a fully confluent cell layer, and were exposed to IMDM (Veh C) or supernatants 
(1:2.5 dilution) from neutrophils cultured and activated (GM-CSF/fMLP) under normoxic 
(filled bars) or hypoxic (open bars) conditions. After 72 h the cells were stained with 
cytoplasmic (CFSE) and nuclear (DAPI) dyes (A) or assessed for viability by MTT assay 
(B).  A. Immunocytochemistry microscopy images from a single representative 
experiment (of n=11) magnification = x20, B. MTT toxicity assay, n=11, each performed 
in triplicate. Values are mean ± SEM, *=p<0.05, **=p<0.01, ***=p<0.001.   
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death upon exposure to the supernatants from neutrophils activated by GM-CSF/fMLP 
under hypoxia. Toxicity was even more marked when supernatants from Cyt B/fMLP-
treated neutrophils were used, and again the effects were significantly enhanced by 
hypoxic versus normoxic neutrophil incubation. 
These preliminary experiments show that supernatants produced by hypoxic neutrophils 
can exert a highly damaging effect on A549 lung adenocarcinoma-derived epithelial cells. 
The following experiments were designed to explore this phenomenon in more detail. 
 
5.2.2 The effect of hypoxia on neutrophil-induced detachment of A549 cells    
Immunocytochemistry was used to interrogate the damage caused by the neutrophil 
supernatants in more detail and to explore the mechanism of A549 cell death, The A549 
cells were plated onto poly-L-lysine coated plates (96 well optical plates (Ibidi), 80,000 
cells per well) and incubated at 37°C overnight to obtain a fully confluent monolayer, 
before exposure to supernatants from normoxic and hypoxic neutrophils stimulated (or 
not) with GM-CSF/fMLP as above (150 µl, 1:2.5 dilution) for 48 h. After the incubation 
the supernatants were removed, the cell layers fixed with 3.5% PFA (20 min, 22°C) and 
stained for cleaved caspase 3 (anti-cleaved caspase 3 goat IgG antibody (1:1000 1 h, 
22°C) and Alexa Fluor 488–donkey anti-goat IgG, red (1:1000, 1 h, 22°C), F-actin 
(rhodamine-phalloidin, green, 1:200, 30 min, 22°C), nucleus (DAPI containing mountant, 
blue 22°C). Caspase 3 is activated via extrinsic (death ligand) and intrinsic 
(mitochondrial) pathways; cleavage and activation of caspase 3 irreversibly commits a 
cell to apoptosis and is therefore often used as a marker for early apoptosis
433,434
. 
For analysis three representative images were taken in different areas of the well, with 
care to avoid the edges of the wells. Exposure to hypoxic activated supernatants (Figure 
5.2A. panel hypoxia, GM/fMLP) led to a substantial increase in cleaved caspase 3 
staining, which was not seen upon exposure to normoxic supernatants (full set of images 
for all conditions are shown in the appendixes, section 8.3). 
Figure 5.2A (representative images from n=6 experiments) also shows that exposure to 
the hypoxic, but not the normoxic supernatants caused extensive cellular detachment from 
the tissue culture surface, in keeping with the data presented in Figure 5.1. The cell layer 
detachment seen on confocal images was quantified by measuring the "empty" areas 
using imageJ, and the data are represented as detached area as a percentage of total area. 
This quantification is shown in Figure 5.2B. No cellular detachment was induced by 
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Figure 5.2: Hypoxic neutrophil supernatants induce A549 cell detachment and 
apoptosis  
A549 cells were cultured in Poly-L-Lysine coated, 96 well plates to obtain a fully 
confluent cell layer. The cells were exposed to neutrophil supernatants (1:2.5 dilution) 
from neutrophils cultured and activated (GM-CSF/fMLP) under normoxic (filled bars) or 
hypoxic (open bars) conditions for 48 h before the before the cell layers were fixed with 
3.5% PFA and stained for F-actin (rhodamine-phalloidin, green), nucleus (DAPI, blue) 
and cleaved caspase 3 (goat IgG anti-cleaved caspase 3 antibody and Alexa Fluor 488–
donkey anti-goat IgG, red).  A. Representative images from n=6 experiments, x40. Full 
set of images is shown in appendix 8.3 B. Quantification of cell layer detachment 
measured by imageJ, shown as percentage of detachment of total area per field of view. 
n=6, each performed in triplicate, values are mean ± SEM, *=p<0.05, **=p<0.01.  
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supernatants from resting normoxic neutrophils, whilst supernatants from resting hypoxic 
neutrophils induced detachment of 15.5% of the total area. Damage to the epithelial cells 
layers increased upon exposure to supernatants from activated neutrophils; detachment of 
17.8% of the total area was observed with the application of supernatants generated by 
activation under normoxia, increasing to 67.7% detachment in response to analogous 
hypoxic supernatants. 
Together with the data from the MTT toxicity assay, these results show that neutrophil 
supernatants generated under hypoxic conditions can cause substantial damage to A549 
lung epithelial cell layers. However, it does not tell us whether the damage is protease- or 
even protein-dependent, or whether there is a contribution from other factors present in 
the neutrophil supernatants. This was further investigated as outlined below. 
 
5.2.3 Nature of the damaging agent in hypoxic neutrophil supernatants  
It has been shown that neutrophil proteases, especially NE, can cause cell damage and 
even cell death. For example NE applied to A549 cells induced concentration- and time-
dependent apoptosis; Nakajoh et al.
435
 showed that exposure to NE concentrations of 0.1 
U/ml or greater for 24 h significantly compromised A549 cell viability, supporting the 
hypothesis that neutrophil proteases in the lung have the capacity to cause epithelial cell 
damage locally. Importantly, this effect was inhibited by the addition of the serine 
protease inhibitor α1AT.  
To recapitulate this observation, A549 cell monolayers were exposed to increasing 
concentrations of porcine pancreatic elastase (PPE) and stained with a nucleic (DAPI) and 
a cytoplasmic (CFSE) dye exactly as described above. This resulted in epithelial cell layer 
damage (Figure 5.3A) visually indistinguishable from the damage induced by neutrophil 
supernatants and shown in Figure 5.1A. The MTT toxicity also showed a concentration-
dependent toxicity of PPE on the A549 cells (Figure 5.3B), with the concentration of 0.1 
U/ml PPE being the equivalent of the amount of NE present in the hypoxic, Cyt B/fMLP 
activated supernatants as measured by the NE activity assay.  
Thus hypoxic neutrophil supernatants in particular can damage lung epithelial cell layers, 
and this effect can be re-capitulated using purified PPE. However, these experiments do 
not prove that neutrophil-derived proteases, or even proteins, are responsible for this 
cellular toxicity. To investigate whether the damage is protein-dependent, the 
supernatants were boiled (10 min, 99⁰C) to denature any proteins present. A549 cell 
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Figure 5.3: Porcine pancreatic elastase recapitulates the damage caused by 
neutrophil supernatants 
A549 cells were cultured in Poly-L-Lysine coated 96-well plates to confluence. The cells 
were exposed to IMDM (Veh C) or porcine pancreatic elastase at the indicated 
concentrations for 72 h before staining of the cell layer (A) with a cytoplasmic dye 
(CFSE) and nucleic dye (DAPI) or determining the percentage of live cells by MTT assay 
(B). A. Representative images from n=1 experiment with triplicate wells, magnification = 
x20. B. MTT-assay data, n=1, each assay performed in triplicate. Values are mean ± 
SEM.  
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layers were cultured as before and exposed to the boiled and intact neutrophil 
supernatants (1:2.5 dilution) for 48 h. Boiling the supernatants abolished the damaging 
effects as illustrated in Figure 5.4A, confirming protein-dependence. The quantification 
of cell layer detachment is shown in Figure 5.4B and confirms complete protection is 
provided by protein denaturation.  To assess whether the cell injury was protease-
dependent, the physiological serine protease inhibitor α1-anti-trypsin (α1AT) was used. 
α1AT does not only inhibit NE but also a range of other proteases present in the 
neutrophil granules including cathepsin G and proteinase 3
436
. 
Neutrophil supernatants were pre-incubated with α1AT (10 min. 4.6-46 µg/ml) and the 
cell layers treated as described above. These concentrations were chosen based on the 
ability of α1AT to inhibit pure NE in a 2:1 ratio
437
. From data from McGovern et al.
379
 
and chapter 4, figure 4.3 it can be calculated that neutrophils primed stimulated with 
GM/fMLP released approximately 2 µg/ml of NE (from 1*10
6 
cells). As α1AT inhibits a 
range of proteases I used the inhibitor at a 2:1 ratio and higher. As shown in Figure 5.5A 
and B, α1AT decreased cell layer detachment in a concentration-dependent fashion. The 
highest concentration of α1AT reduced the damage induced by H-GM-CSF/fMLP from 
70.5% to 6.9 %, which is close to the baseline seen with vehicle alone.  The fact that 
α1AT concentrations of greater that 4.6 µg/ml were required to achieve significant 
protection may suggest that proteases other than NE may be involved in the cell 
damage/detachment caused by hypoxic supernatants.  
Data from the experiments shown in figures 4.3, 4.4 and 4.5 were performed with my 
assistance and under my direct supervision by Ms Cheng Chen, a third year Medical 
Student undertaking a 12-week project in the laboratory.  
 
5.3 The effect of hypoxia on neutrophil induced damage to immortalized primary 
bronchial epithelial cells.   
Using A549 cells I have shown that neutrophil supernatants, particularly those generated 
in a hypoxic environment can cause substantial damage. Although commonly cited as a 
model for lung epithelial cells in the literature, the A549 cell line is still a cancer cell line 
and may therefore have undergone substantial alterations in biochemical and functional 
properties. When compared to primary cells A549 cell morphology is very irregular in 
comparison to the more consistent cobblestone appearance of primary cells (Figure 3.9). 
To use cells which more closely resemble the endogenous lung epithelium, and to 
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Figure 5.4: A549 cell damage caused by neutrophil supernatants is protein-
dependent 
Confluent A549 cells monolayers in Poly-L-Lysine coated 96-well plates were exposed to 
IMDM (Veh C), (boiled, 5 min 99°C) or intact supernatants (1:2.5 dilution) from 
neutrophils cultured and activated (GMSCF/fMLP) as indicated under normoxic (filled 
bars) or hypoxic (open bars) conditions for 48 h. The cell layers were then fixed with 
3.5% PFA and stained for F-actin (rhodamine-phalloidin, green) and nucleus (DAPI, 
blue). A. Representative images of n=4, each performed in triplicate, magnification = 
x40. . Full set of images is shown in appendix 8.3. B. Quantification of cell layer 
detachment measured by imageJ, shown as percentage of detachment of total area per 
field of view. n=4, each performed in triplicate values are mean ± SEM, **=p<0.01.  
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Figure 5.5: A549 cell damage caused by neutrophil supernatants is protease-
dependent 
A549 cells were cultured in Poly-L-Lysine coated, 96 well plates to confluence. The 
neutrophil supernatants from cells cultured and activated (GM-CSF/fMLP) under 
normoxic (black bars) or hypoxic (open bars) were pre-incubated with α1AT (0, 4.6, 23 or 
46 µg/ml as indicated) for 10 min prior to application to the A549 cell layers. Following a 
48 h exposure, the cell layers were fixed with 3.5% PFA and stained for F-actin 
(rhodamine-phalloidin, green) and nucleus (DAPI, blue).  A. Representative images from 
1 of n=4 experiments, each performed in triplicate, magnification = x40, 46 μg/ml. . Full 
set of images is shown in appendix 8.3. B. Quantification of cell layer detachment 
measured by imageJ, shown as percentage of detachment of total area per field of view. 
n=3-8, values are mean ± SEM, *=p <0.05, **=p<0.01.   
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confirm that the damage to A549 cells caused by neutrophil supernatant is not due to a 
specific cell line-specific susceptibility, the immunocytochemistry  experiment performed 
with the A549 cells were repeated using immortalised human bronchial epithelial cells 
(iHBECs). These cells were originally derived in the laboratory of Professor Jerry Shay, 
and with his permission were gifted to us by Professor Gisli Jenkins (Nottingham 
Respiratory Research Unit, Nottingham City Hospital). 
They are normal primary epithelial cells immortalized by transfection with cyclin-
dependent kinase (Cdk) 4 and hTERT
389
. These cells do not have a cancer cell phenotype; 
they do not form colonies on agar plates and have an intact p53 checkpoint pathway.  
To assess the capacity of neutrophil supernatants to cause damage to the iHBEC's cell 
layers, the cells were cultured as described above (section 5.2.1) and exposed to 
neutrophil supernatants (1:2.5 dilution) for 48 h. After the exposure the cell layers were 
stained exactly as described above for F-actin (rhodamine-phalloidin, , 1:200, green) and 
nucleus (DAPI, blue) and detachment was quantified by measuring the "empty" areas 
with ImageJ (Figure 5.6). The results obtained from these experiments align closely with 
those seen with A549 cells; as shown in Figure 5.2 the supernatants from normoxic 
stimulated neutrophils induced some cell layer detachment, but this was approximately 
three-fold less than that seen with supernatants derived under hypoxic conditions (11.5% 
versus 29.3 % detachment).  
Together with the A549 cell data these results show that hypoxic neutrophils stimulated 
under hypoxic conditions display an augmented potential to cause significant damage to 
lung epithelial cells. To further place these results in a physiological context I wished to 
investigate the effect of neutrophil-derived supernatants on cells grown in air-liquid 
interface (ALI) cultures. 
 
5.4 The effect of hypoxia on neutrophil induced damage on ALI-cultures. 
Besides the structural damage found in the lungs of COPD patients, there is also an 
susceptibility to respiratory infections
438,439
, and a proportion of patients with COPD are 
colonised with potentially pathogenic organisms such as Haemophilus spp.
439
 and 
Moraxella catarrhalis
440
. The respiratory tract is lined with ciliated epithelial cells, which 
function as a ‘muco-ciliary escalator’ to move mucus and entrapped particles/organisms 
upwards and expel them from the lungs via the cough reflex. A delay of muco-ciliary 
clearance has been observed in chronic bronchitis due to a loss   
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Figure 5.6: Hypoxic neutrophil supernatants damage iHBE cells layers 
iHBE cells were cultured in Poly-L-Lysine coated 96-well plates to obtain a fully 
confluent cell layer. The cells were exposed to exposed to IMDM (grey bar) or  
neutrophil supernatants (1:2.5 dilution) from neutrophils cultured/activated under 
normoxic (black bars) or hypoxic (open bars) conditions for 48 h. The cell layers were 
then fixed with 3.5% PFA and stained for F-actin (rhodamine-phalloidin, green) and 
nucleus (DAPI, blue). A. Representative images from n=3 experiments, each performed 
in triplicate, x40 magnification. B. Quantification of cell layer detachment measured by 
imageJ, shown as percentage of detachment of total area per field of view. n=3, each 
performed in triplicate. Values are mean ± SEM.  
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of ciliated cells that have been replaced by goblet cells
441
,  also leading to mucus hyper-
secretion. The impaired mucus clearance may play a role in the first step of mucosal 
colonisation, and mucus hyper-secretion is associated with increased mortality related to 
infection
442
. Ciliary dysfunction has also been associated with an increased susceptibility 
to infection in other diseases like Primary Cilia Dyskinesia (PCD)
443
 and pulmonary 
nontuberculous mycobacterial disease
444
. 
Therefore I was interested to investigate whether exposure to neutrophil supernatants, and 
in particular those derived from hypoxic neutrophils, would affect ciliary function, in 
addition to exploring the effects of neutrophil supernatants on cells growing in conditions 
that more closely resemble the human airway environment than monolayer tissue 
cultures. Professor Chris O'Çallaghan (Portex Unit, Great Ormond Street Hospital and 
University of Leicester) runs a national diagnostic service for PCD, using a 3-dimensional 
culture system of primary ciliated bronchial epithelial cell layers. These cultures allow 
differentiation into goblet cells, basal cells and ciliated epithelial cells (Figure 5.7); this 
team have accrued extensive expertise in the assessment of ciliary function and structure 
using high-speed digital video microscopy. Furthermore, the use of an air-liquid interface 
(ALI) culture system more closely mimics the in vivo environment of alveolar epithelial 
cells which are exposed to inhaled air at their apical aspect, but are in contact with tissue 
fluid/pulmonary circulation basally
392,445
. To undertake the following experiments I 
worked in the PCD Centre, Department of Infection, Immunity and Inflammation at the 
University of Leicester, under the supervision of Dr Robert A. Hirst.  
 
5.4.1 The effect of hypoxia on neutrophil induced cell damage in ALI cultures.  
Primary HBECs were purchased from Lonza and cultured and differentiated into a 
polarised system incorporating basal, goblet and ciliated cells over a period of 
approximately 2 months as described in section 3.13.3. Cultures that failed to ciliate or 
which became infected were discarded. To confirm that the ALI-cultures (grown on 
Transwell
®
 inserts) did indeed incorporate ciliated epithelial cells, scanning electron 
microscopy (SEM) images were prepared from the cell layers. The ALI-cultures were 
exactly as described (section 3.14.4). Images were obtained by Dr Jeremy Skepper 
(Cambridge Advanced Imaging Centre, Department of Physiology, Development and 
Neuroscience, University of Cambridge).  
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Figure 5.7: Scanning electron microscopy of primary HBECs grown in ALI culture 
A. Representative scanning electron microscope image (of n=2) showing (black arrows) 
ciliated cells (A), basal cells (B), and mucus (C). The HBECs were grown on collagen-
coated 1.2 cm diameter Transwell
®
 inserts and transferred into ALI-cultures. Mature 
cultures with ciliated cells were fixed in the well with Sorensen phosphate-buffered (pH 
7.4) glutaraldehyde (4% v/w). Dr. Jeremy Skepper (Cambridge Advanced Imaging 
Centre) completed sample preparation for electronmicroscopy and took the images using 
a FEI Verios 460 microscope. B. Photomicrograph of section through HBECs growing in 
ALI culture. Black arrow indicate ciliated cells, white arrows indicate basal cells image 
imported from http://www.lonza.com/).  
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Figure 5.7 shows a representative SEM image of one of the ALI-culture NHBE cell 
layers(Figure 5.7B), demonstrating the presence of ciliated cells (A), basal cells (B) and 
mucus (C) and a photomicrograph of a section through HBECs growing ALI culture 
(Figure 5.7B, taken from Lonza website). 
The length of the culture period required, and the difficulties of obtaining full ciliation 
were a limiting factor in the number of experiments that could be undertaken in this 
section of work; to maximise the experimental outputs I used the same supernatant-
exposed cultures in a range of assays, which restricted the time-points I was able to 
analyse. Since ciliation is unique to this culture system, I prioritised experiments to study 
ciliary beat frequency (CBF) and co-ordination, hence other assays were restricted in 
number and scope. To map onto the data obtained for A549 and iHBEC submerged 
monolayer culture cells and investigate the effect of neutrophil supernatants on the 
integrity of these cells layers I employed immunocytochemistry and LDH assay (to assess 
cell damage by means of cellular leakage. 
Immunocytochemistry was used to look at cell damage and the induction of apoptosis, as 
previously undertaken using A549 cells and iHBEC's. The ALI cultures were exposed to 
neutrophil supernatants (500µl, 1:2 dilution) added to the basal side for 6 h at 37⁰C; this 
relatively short time period of exposure was dictated by the need to study ciliary motion. 
After exposure the cells were gently scraped of the transwells and fixed in 4% PFA for 30 
mins prior to washing twice with PBS. Before staining, cytospins were made of the cell 
scrapings. They were then stained for F-actin (rhodamine-phalloidin, 1:200 green), nuclei 
(DAPI, blue) and cleaved caspase 3 (anti-cleaved caspase 3 goat IgG antibody, 1:1000 
and Alexa Fluor 488 donkey anti-goat IgG, 1:1000, red). Representative images (of n=3 
stained edges imaged per condition, n=1 experiment) are shown in Figure 5.8. There is an 
increase in cleaved caspase 3 detection, even following this brief exposure to hypoxic 
activated supernatants relative to the normoxic equivalents. This is entirely consistent 
with the previous data obtained using A549 and iHBEC submerged monolayer cultures. 
No other significant signs of damage could be seen in the cell layer structure after this 
brief exposure. Although the immunocytochemistry data from ALI-culture primary cells 
align with my previous experiments, this data is only qualitative/semi-quantitative. In an 
attempt to obtain quantitative data to measure toxicity to ALI cultures induced by  
neutrophil supernatants, I used a commercial LDH assay, which can be undertaken on a 
small sample volume. Unfortunately, insufficient cells were available to undertake this  
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Figure 5.8: Hypoxic neutrophil supernatants induce apoptosis in ALI cultures 
ALI-cultures were cultured and matured as described above. The cells were exposed to 
neutrophil supernatants (1:2 dilution) generated from neutrophils cultured and activated 
(GMCSF/fMLP) under normoxic or hypoxic conditions for 6 h before the before the cell 
layers were fixed with 3.5% paraformaldehyde (4 h) and stained for F-actin (rhodamine-
phalloidin, green), nucleus (DAPI, blue) and cleaved caspase 3 (anti-cleaved caspase 3 
goat IgG antibody and Alexa Fluor 488 – donkey anti-goat IgG, red) as a marker of 
apoptosis.  Representative images of n=1 experiment performed in triplicate, 
magnification = x63. 
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assay on only one occasion, due to the difficulties inherent in maintaining and 
differentiating the primary HBECs in ALI culture conditions. ALI-cultures were exposed 
to neutrophil supernatants (1:2.5. dilution) on the basal side for 24 h at 37°C. 10 µl 
samples of the tissue culture media bathing the cells were removed at times t=0, 4, 8 and 
24 h and analysed for LDH activity (Figure 5.9). Consistent with my previous data sets, a 
time-dependent increase in LDH release (indicative of cellular damage) was seen upon 
exposure to the supernatants, especially those derived from the hypoxic, activated 
neutrophils; in these culture conditions , the released LDH activity more than tripled 
(from 16.9 to 50.2 nmol/min/ml). Statistical analysis could not be undertaken on these 
data since insufficient cells were available from subsequent ALI cultures to repeat this 
experiment. 
 
5.4.2 The effect of hypoxia on neutrophil induced ciliary dysfunction 
Ciliary dysfunction has been linked to increased susceptibility to infection; hence the 
effects of neutrophil supernatants on ciliary function (CBF and ciliary beat pattern) were 
assessed. The ALI cultures were gently scraped from the Transwell
®
 inserts, suspended in 
500 µl of ALI medium per well, and the cell suspension was divided into 2 Eppendorff 
tubes. Cells were left to settle for 10 min before the medium was removed and the cells 
were exposed to undiluted neutrophil supernatants.  Directly after exposure the cells were 
transferred onto a chamber-slide (Figure 3.10). Beating ciliated edges were recorded 
using a digital high-speed video camera (Kodak Ektapro Motion Analyser, Model 1012) 
at a rate of 500 frames per second (x 63 lens). Figure 5.10A shows single still images 
captured from representative movies (of n=3) of ciliated edges exposed to neutrophil 
supernatants for 2 h; the movies are included on a CD supplied with the thesis. They 
show that epithelial cell cilia are profoundly affected by the neutrophil supernatants, 
application of which resulted in a reduction of the number of normally beating cilia and 
cell swelling. These effects were most apparent when the ciliated edge was exposed to the 
hypoxic activated supernatants (not significant). The quantification of the ciliary beat 
frequency was done by ImageJ and ciliaFA  (programme developed by Dr. Claire Smith,  
university Collge London, Institute of Child Health, Smith et al.
393
). Fresh human 
respiratory tract cilia beat in a coordinated fashion at a frequency of approximately 10 to 
14 Hz446, and my readings were in agreement with this. Figure 5.10 shows that even 
exposure to supernatants from “resting” neutrophils cultured under normoxia reduced  
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Figure 5.9: Hypoxic neutrophil supernatants induce LDH release from ALI cultures 
ALI cultures of primary HBECs were maintained and matured exactly as described. The 
cells were exposed to supernatants (1:2.5 dilution) derived from neutrophils activated as 
indicated under normoxic (filled bars) or hypoxic (open bars) conditions, applied to the 
basal side (500 µl). 10µl samples were aspirated from the basal side at 0, 4, 8, and 24 h 
and analysed by commercial LDH assay according to the manufacturer’s instructions. 
Results represent a single experimental procedure with all samples run in duplicate. 
Values represent mean ± SEM. 
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Figure 5.10: Neutrophil supernatants do not affect ciliary beat frequency 
Primary HBECs grown in ALI culture were scraped from the Transwell
®
 inserts, 
transferred to a chamber slide and exposed to undiluted neutrophil supernatants for 2 h. 
Recordings were made at 0 and 2 h with a high-speed camera (500 fps). A. 
Representative still images from n=3 movies, magnification = x100. B. Ciliary beat 
frequency determined by analysis of n=3 movies with CiliaFA at t=2 h; fresh cells t=0 
hours. 
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CBF to 4.9Hz, and this effect was not more pronounced when supernatants from activated 
or hypoxic neutrophils were applied (ie the decrease in CBF did not correlate precisely  
with the enhanced degranulation products present in the hypoxic and activate cells). 
These results may suggest that either alternative (non granule-derived) components of the 
neutrophil supernatants are responsible for depressing CBF, or that maximal impairment 
of this function is seen even with the level of granule components release by resting 
normoxic neutrophils. Alternatively, the lack of a quantifiable effect of increasing 
protease content in the applied supernatants might be due to the fact that static cilia are 
not included in this calculation of beat frequency.   
To investigate the latter possibility, ciliary beat pattern per cell was scored, based on 
established clinical protocols used to diagnose patients with PCD. Dyskinetic cilia were 
scored (includes static cilia, score of 1) and the resultant Dyskinesia Index is the 
percentage of ‘1’s’ scored per edge per condition. The cells were also scored for static 
cilia (score of 0) and the Motility Index is the percentage of ‘0’s’ scored per edge per 
condition.  
As shown in Figure 5.11A-D, incorporating data from n=3 experiments using different 
batches of primary HBECs, there was a dramatic decrease in healthy cilia and a marked 
increase in static cilia on exposure to the neutrophil supernatants after just 1 h, the 
percentage of immotile cilia increased even further after 2 h. Although a trend towards a 
more pronounced effect with the hypoxic supernatants was observed, with no healthy 
cilia at all remaining after just a 1 h incubation, the differences between hypoxic versus 
normoxic supernatants did not reach statistical significance. This can in part be explained 
by the variability between different ALI cultures, but mostly reflects the considerable 
detrimental effect of the normoxic resting neutrophil supernatants alone, narrowing the 
window for a further effect of hypoxia to be observed.  
 
5.5 Discussion 
Neutrophil proteases have been implicated in mediating cell and tissue damage using a 
range of experimental methodologies; these range from cell culture systems to mouse 
models, and finally to the detection of increased proteases in the BALF derived from 
patients lung diseases such as COPD and ARDS 
193,196,200
. 
As sites of inflammation are profoundly hypoxic
314
 and hypoxia alters neutrophil 
function
327,354
, the impact of hypoxia on neutrophil function may have direct relevance to  
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Figure 5.11: Neutrophil supernatants induce ciliary dysfunction in ALI cultures 
Primary HBECs grown in ALI culture were scraped from the Transwell
®
 inserts, 
transferred to a chamber slide and exposed to undiluted neutrophil supernatants for 2 h. 
Recordings were made at t= 1 h and 2 h with a high-speed camera (500 fps). A&B. 
Ciliary beat pattern at t=1 h.  C&D. Ciliary beat pattern at t=2 h. Values represent mean ± 
SEM. 4 ciliated edges were examined per condition from n=3 experiments.   
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diseases of the lung and other organ systems. My discovery that hypoxia has a marked 
up-regulatory effect on neutrophil degranulation (as detailed in Chapter 4) suggests that 
hypoxia may promote neutrophil-mediated tissue injury. I therefore felt it was important 
to explore the effects of hypoxia on the ability of neutrophil-derived supernatants 
generated under conditions of normoxia and hypoxia to damage relevant target tissue. I 
chose to study lung epithelial cells as these are thought to be important targets in human 
neutrophil-mediated lung diseases.  
My results show that increased release of proteases in the context of hypoxia can cause 
substantial damage to lung epithelial cell monolayers grown in submerged or ALI 
conditions. The damage to A549 cells caused by supernatants from neutrophils activated 
under hypoxic conditions resembles data reported by Nakajoh et al.
435
 that elastase 
(extracted from purulent human sputum samples) induced a concentration dependent 
decrease in the viability of lung epithelial cell lines (both A549 cells and BEAS-2b cells), 
and also of primary human tracheal cells; they further noted a time-dependent increase in 
the detection of cleaved caspase 3, again re-capitulating my findings. Additionally, 
Venaille et al.
447
 demonstrated that neutrophil-derived proteases present in CF sputum 
samples (most likely NE and cathepsin G) led to epithelial cell damage and detachment 
(although these authors used amniotic rather than respiratory epithelial cells).  
Most published studies have focused on the damage caused by a single isolated protease 
such as NE; however this does not represent the physiological situation where a wide 
range of granule proteins and proteases are released in conjunction, and which can 
influence each other’s functions. For example; it has been shown that co-culture of 
MMP’s and NE results in the conversion of latent to active MMPs, thereby increasing the 
potential for tissue injury
448
. In agreement with the extensive range neutrophil 
degranulation products, and the likely damaging contribution of multiple rather than 
single factors present in neutrophil supernatants the damage to A549 cells could be 
mostly ameliorated by incubation with the more serine protease inhibitor α1AT.  
The primary HBEC cultures comprise a far more complex system, with polarised layers 
of basal, secretory and ciliated cells cultured on Transwell
®
 inserts, in the setting of an 
air-liquid interface, to more closely resemble the situation in the environment of the  
human lung. These ALI-cultures are challenging to undertake, with a requirement for 
approximately 6-8 weeks of culture in an air-liquid interface to obtain optimal ciliary 
growth and development (defined as visible cilia over > 10% of the surface area of the 
culture). The cells were purchased from Lonza, and the initial batch of cells grew far 
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better than subsequent batches; one attempt at ALI culture did not yield ciliated cells and 
a further batch of cells became infected; these cells had to be discarded. Further, higher 
passage number cells grew less vigorously in culture and did not yield sufficient cell 
numbers to repeat all of my initial experiments. Because of the limiting cell numbers, the 
time taken to culture to ciliation, and also the expense of this system, I was not able to 
refine my experimental conditions and had insufficient cells to repeat some of my initial 
assays in subsequent experimental runs. Ideally I would have wished to go on to dilute 
my neutrophil supernatants, to see whether I could delineate a greater effect of the 
hypoxic samples; with the conditions initially selected, the damage to the sensitive cilia 
was too great with the resting supernatants to see a differential effect with hypoxia. 
Further, it has been shown that CBF and ciliary beat pattern may be affected 
environmental factors such as pH and temperature
449,450
 to prevent temperature 
influencing the results the chamber-slides were kept in an incubator at 37°C (5% CO2) 
between time points and on a heated microscope stage during analysis. However we were 
not able to control for changes in pH; as the cells are on a chamber-slide in a small 
volume for 2 h, this could have affected basal CBF and ciliary beat pattern. 
The technique used for the above experiments required me to gently scrape the cells of 
the Transwell
®
 to obtain a suspension of cell “strips” that are used to analyse ciliary beat 
frequency and beat pattern. Thomas et al.
451
 determined with high speed digital video 
microscopy that the cilia on disrupted epithelial edges showed significantly reduced beat 
frequency and significantly increased dyskinesia compared with those on intact, 
undisrupted ciliated epithelial edges (13.4 for intact edges to 9.2 Hz for strips with 
isolated ciliated cells). With the first set of ALI-cultures analysed, mostly intact, 
undisrupted ciliated epithelial edges were obtained; unfortunately, subsequent sets of 
ALI-cultures were not as heavily ciliated and edges with a fewer and more isolated 
ciliated cells had to be used. Additionally exposure to the neutrophil supernatants induced 
visible cell damage, leading to smaller, damaged cell strips and making ciliary analysis 
increasingly challenging. The varying quality of the ALI cultures thus resulted in 
variability in the ciliary beat pattern analysis between experiments (Figure 5.10).  
Despite these experimental challenges, the results shown above are in broad agreement 
with published studies investigating the effects of neutrophil proteases on CBF and 
epithelial cell damage. Amitani et al.
209
, demonstrate that NE reduced CBF and disrupted 
the ultrastructure of human nasal ciliated respiratory epithelium, leading to cell 
detachment, cytoplasmic blebbing and mitochondrial damage, although the cilia 
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themselves remained intact. These studies suggest that NE and other neutrophil-derived 
granule products may contribute to the delayed mucociliary clearance and epithelial 
damage observed in patients with chronic bronchial infections in the setting of COPD and 
bronchiectasis. Furthermore, a single installation of elastase into rabbit lung led to goblet 
cell metaplasia and the formation atypical cilia. Although most data in the literature 
relates to NE, application of MMP-9 has also been shown to lead to detachment and 
detachment-induced cell death of airway epithelial cells by damaging components of the 
tight junction and the adherent junctions
452
. By targeting cell-cell junctions MMP-9 may 
disrupt the barrier function of the lung epithelium, allowing pathogens to gain access to 
the epithelial basolateral surface increasing infection efficiency. I have studied the effects 
of secreted neutrophil products by exposing the epithelial cell layers to neutrophil 
supernatants in an isolated cell culture system. It would be of interest to look at a more 
complex, interactive system or an in vivo model, as there is data showing that NE induced 
a 4.4 fold increase in neutrophil chemo attractant IL-8 release from A549 cells
453
. Both 
hypoxia and neutrophil granule products
133,195,196
 can induce an inflammatory phenotype 
in lung epithelial cells
320,321,323,324
 creating a complex feedback system potentially leading 
to more neutrophil recruitment and activation. This makes further investigation of the 
epithelial cell phenotype under conditions of normoxia/hypoxia and in the presence or 
absence of neutrophils an interesting progression of this research.  
In summary, I have demonstrated that enhanced neutrophil degranulation promoted by 
hypoxia imparts a greater capacity for these cells to damage delicate respiratory epithelial 
monolayers. This was seen in the A549 cancer cell line, in iHBECs and in primary 
HBECs grown in ALI culture conditions. Since inflammatory sites are characterised by 
hypoxia, preventing this hypoxic up-regulation of extracellular degranulation may limit 
neutrophil-mediated tissue damage in inflammatory diseases. To achieve this, a better 
insight into the mechanism of enhanced degranulation is required, and the signalling 
mechanisms that might underpin this effect are the focus of the experimental work 
presented in the next chapter. 
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6. The mechanism of augmented neutrophil degranulation under 
hypoxic conditions 
6.1 Introduction 
Neutrophils are exposed to a wide range of oxygen tensions even in health, from 13 kPa 
in the alveolar capillaries, through 5 kPa in mixed venous blood to oxygen levels as low 
as 0.5 kPA in the lymphoid organs
307
; this hypoxic exposure may be exacerbated and 
prolonged when neutrophils are recruited to sites of inflammation. Like other cells, 
neutrophils adapt to these changes in oxygen tension by stabilisation of HIF-1α, the near-
ubiquitous orchestrator of cellular hypoxic responses. HIF-1α migrates to the nucleus to 
form a heterodimer with HIF-1β, recruits the coactivators p300/CBP, and induces 
expression of its transcriptional targets via binding to upstream hypoxia-responsive 
elements (HREs). HREs are composite regulatory elements, comprising a conserved HIF-
binding sequence together with a highly variable (and poorly characterised) flanking 
sequence that modulates the transcriptional response. 
Changes in oxygen tension and HIF-1α stabilisation have profound effects on neutrophil 
function as described above (section 1.8.4 and section 4.3). However, the mechanism by 
which hypoxia modulates the degranulation response is currently unknown. Since HIF-1α 
is the master regulator of hypoxic responses, it is plausible that it also modifies the 
degranulation response. Peyssonnaux et al.
350
 suggested a role for HIF-1α in the 
production of neutrophil granule proteases; HIF-1α-null mouse neutrophils showed 
decreased enzymatic activity of NE and cathepsin G in comparison to WT neutrophils, 
while vHL-null neutrophils exhibited increased protease activity. However, mature 
circulating neutrophils have been shown to be transcriptionally inert with regard to 
granule proteins; no mRNA transcripts of neutrophil granule proteins could be found after 
neutrophil maturation
78,380
.  
As neutrophil granules are formed during maturation in the bone marrow, which is a 
hypoxic environment
454
, HIF-1α may well play a significant role in the transcriptional 
regulation of granule content proteins in early stages of neutrophil development. 
However, this mechanism may be less relevant in the context of mature peripheral blood 
neutrophils experiencing a relatively brief (4 h) hypoxic exposure. 
In addition to a direct effect of hypoxia on granule protein content, hypoxia could 
modulate the signal transduction pathways that control degranulation (section 1.8.5). The 
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short duration of hypoxic incubation required to entrain the enhanced degranulation 
response makes it unlikely (although not impossible) that increased expression of key 
signalling components such as PI3 kinase or PLC underpins this effect. There is little 
published data to suggest how hypoxia might modulate such signalling pathways in 
neutrophils or other relevant cell types, either via HIF1-α or by other means. Hence I 
wished to elucidate the mechanism of the augmented degranulation seen under hypoxic 
conditions. My initial focus was on HIF-1α; I then progressed to explore the role of the 
key regulators of neutrophil degranulation.  
The specific aims of the work presented in this chapter are as follows: 
1. To explore the role of HIF in the hypoxic enhancement of neutrophil 
degranulation by the use of hypoxia-mimetics and other compounds. 
2. To explore whether enhanced degranulation is dependent on de novo protein 
synthesis (of granule proteins or of other proteins). 
3. To investigate whether the hypoxic up-regulation of degranulation is dependent on 
tyrosine kinase, PLC/Ca
2+
 or PI3 kinase signalling pathways. 
 
6.1.1  Hypoxia and HIF-1α stabilizers delay neutrophil apoptosis 
It has been shown previously that hypoxia induces stabilisation of neutrophil HIF-1α at 
20 h
354
, that this is required to establish the increased lifespan of hypoxic neutrophils, and 
that HIF-1α stabilizers replicate this effect. Our laboratory previously has shown that 
hypoxia can induce stabilisation of HIF-1α and HIF-2α at earlier time points (including 4 
h, personal communication and published thesis Dr. L. Porter
455
). I was unable to replacte 
this data due experimental challenges with HIF-1α antibodies and the high number of 
cells needed. Since this is published data I did not spend significant amounts of time 
trying to replicate these findings. To confirm that I could recapitulate the established 
effects of HIF stabilizers, I measured the effect of dimethyloxalylglycine (DMOG), 
deferrioxamine mesylate (DFO) and cobalt chloride (CoCl2) on neutrophil apoptosis. All 
three compounds work by slightly different mechanisms (section 1.8.3.1), but all result in 
the stabilisation of HIF (both HIF-1α and HIF-2α). DMOG is a 2-oxoglutarate analogue 
that acts as a competitive inhibitor of PHDs and FIH. DFO is an iron chelator, and 
chelation of Fe
2+
 bound to the active site of PHDs inhibits its enzymatic activity. CoCl2 
also works as an iron chelator, but has also been reported to bind to the PAS domain,  
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Figure 6.1: Hypoxia and HIF stabilziers delay neutrophil apoptosis  
Neutrophils were re-suspended in hypoxic or normoxic IMDM at 11.1*10
6
/ml with or 
without DMOG (1 μM), DFO (1 μM), or CoCl2 (100 nM).  The cells were incubated 
under normoxia or hypoxia (0.8% O2 and 5% CO2) at 37°C for 20 h.  Cytospins were 
prepared and stained with May/Grünwald/Giemsa. Morphology was examined by oil-
immersion light microscopy. N≥5, results represent mean ± SEM, samples were analysed 
in triplicate. ** = p<0.01 *** = p<0.001 (Mann-Whitney test).   
 
6. Results                                              The mechanism of augmented degranulation under hypoxia  
 
 
157 |  
 
blocking HIF-1α-pVHL binding and thereby increasing HIF-1α stability. Neutrophils 
were cultured in 96 well plates (5*10
6
/ml in IMDM with 10% serum) under normoxic 
conditions with or without DMOG (1 µM), DFO (1 µM) or CoCl2 (100 nM), or under 
standard hypoxic conditions, for 20 h at 37°C. After these incubations, cytospins were 
prepared and the slides were stained with May/Grünwald/Giemsa. The percentage of 
apoptotic cells was determined based on the nuclear and cytoplasmic morphology, with 
the observer blinded to the incubation conditions. HIF-1α stabilizers DMOG and DFO 
could fully (and significantly) mimic the inhibition of neutrophil apoptosis observed at 
low oxygen tensions; however the effect of CoCl2 did not attain statistical significance 
(Figure 6.1).  These results are in agreement with data reported Mecklenburg et al.
377
. 
Neutrophil apoptosis was reduced from 48.6% at 20 h under normoxia to 31.7% after 20 
h of hypoxic exposure and the mimetics recapitulated the effect of true hypoxia; apoptosis 
was reduced to 26.8% (DFO) and 29.1% (DMOG) after incubation with the hypoxia-
mimetics DMOG and DFO.  
 
6.1.2  The effects of HIF-1α stabilizers on neutrophil degranulation 
As HIF-1α stabilizers can recapitulate the effects of hypoxia by stabilising HIF-1α, their 
ability to reproduce the effect of hypoxia on neutrophil degranulation was assessed. For 
this experiment neutrophils were re-suspended in normoxic (± DMOG (1 µM), DFO (1 
µM) or CoCl2 (100 nM)) or hypoxic IMDM (11.1*10
6
/ml), incubated under normoxic or 
hypoxic conditions for 4 h at 37°C and activated as described before. Neutrophil 
degranulation was assessed by active NE release, measured by activity assay. Unlike true 
hypoxia, none of the HIF-1αa stabilizers induced any increase in NE release, either in 
either resting or activated neutrophils (Figure 6.2). These results suggest that either the 
enhanced degranulation is not dependent on HIF-1α stabilisation, or that the hypoxia 
mimetics are less able to stabilise HIF-1α in the short 4 h timeframe than true hypoxic 
incubation. To further investigate the possible role of the transcription factor HIF-1α in 
the increased degranulation response I wished to determine whether there was increased 
abundance of granule constituent mRNA or expression of neutrophil granule proteins 
following a hypoxic incubation.  
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Figure 6.2: HIF-1α stabilizers do not recapitulate the hypoxic upregulation of NE 
release  
Neutrophils were re-suspended in hypoxic (open bars) or normoxic (filled bars) IMDM at 
11.1*10
6
/ml
 
with or without 1 μM DMOG (A) or DFO (B) or 100 nM CoCl2 (C) (hypoxia 
mimetics depicted by grey bars).  The cells were incubated under normoxia (including 
the cells with hypoxia-mimetcis) or hypoxia (0.8% O2 and 5% CO2) for 4 h at 37°C. 
The cells were then primed and activated (GM-CSF/fMLP). NE activity was measured in 
the supernatants by the increase in fluorescence caused by cleavage of DQ-Elastin.  A. 
Effect DMOG on NE release, n=5. B. Effect of DFO on NE release, n=6. C Effect of 
CoCl2 on NE release, n=5. Samples were run in duplicate. Results represent mean ± SEM. 
* = p< 0.05, ** = p<0.01 (Mann-Whitney test).   
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6.1.3 The effects of hypoxia on de-novo granule protein production 
6.1.3.1 The effects of hypoxia on granule protein transcription 
HIF exerts its functions mainly by inducing the transcription of a range of target proteins. 
As discussed (section 1.8.3.1 and Figure 1.10), under hypoxic conditions stabilised HIF-
1α translocates to the nucleus and binds to hypoxic response elements (HRE's) to 
influence gene transcription. To further investigate the role of HIF in neutrophil 
degranulation, Dr S. Farrow (GlaxoSmithKlein, Stevenage, Hertfordshire) performed a 
bioinformatics screen for hypoxic response elements (HRE's, which comprise a conserved 
HIF binding site A/GCGTG, plus highly variable and poorly understood flanking 
sequences
456
) in the upstream regulatory elements of key granule protein genes. Potential 
HRE's were identified in the promoter sequence of NE, MPO and MMP-9, but not in the 
promoter region of lactoferrin (see the appendixes, section 8.5). Although circulating 
peripheral blood neutrophils (as used in all of my experiments) are terminally 
differentiated, and no granule protein mRNA transcripts could be identified in a previous 
report 
78,380
, this study did not encompass hypoxia, hence it is still possible that HIF-1α 
induces de novo transcription of these genes in mature cells. Hypoxia up-regulates 
lactoferrin release as well as that of NE, MPO and MMP-9, but our understanding of 
HREs is incomplete, hence our failure to identify an HRE for lactoferrin does not 
preclude this mechanism. Hence qPCR was performed on RNA isolated from freshly 
isolated neutrophils and from neutrophils incubated under normal or hypoxic conditions 
(4 h, 37°C) identical to those used for the degranulation assays.  
As a positive control, 2 well-established HIF-1α targets were used to investigate whether 
hypoxia induced stabilisation of HIF-1α under the conditions documented; BCL2 and 
adenovirus E1B 19 kDa interacting protein (BNIP) is part of subfamily of BCL2 family 
proteins and plays a role in autophagy and apoptosis, and GLUT-1 is a glucose 
transporter
342,457
. As shown in Figure 6.3A, BNIP transcription was substantially induced 
by exposure of neutrophils to hypoxia for 4 h, but GLUT-1 transcription was not. This 
difference is likely to reflect the fact that BNIP is an early-hypoxic response gene whilst 
GLUT-1 is a late-hypoxic response gene. Using commercial primers (See the appendixes, 
section 8.6), mRNA transcripts for NE, MPO and MMP-9 were quantified (Figure 6.3A). 
No increase in mRNA abundance was detected for any of the granule proteins, indicating 
that hypoxia does not induce granule protein transcription in neutrophils.  
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Figure 6.3: Hypoxia does not increase transcription or translation of granule 
proteins 
A. Freshly isolated neutrophils were re-suspended in hypoxic or normoxic IMDM at 
11.1*10
6
/ml and incubated at 37°C for 4 h under normoxic (black bars) or hypoxic (0.8% 
O
2
, 5% CO2, open bars) conditions. RNA was extracted from freshly isolated neutrophils 
(grey bars) or neutrophils incubated under normoxic or hypoxic conditions and qPCR 
performed. Expression was normalised to β-actin. n=3 independent experiments, all 
samples run in duplicate. B. Neutrophils were re-suspended in normoxic (black bars) or 
hypoxic (open bars) IMDM at 11.1*10
6
/ml with or without cycloheximide (1 µg/ml). The 
cells were then primed and activated with GMCSF/fMLP as previously. NE activity in the 
supernatants was measured by the increase in fluorescence caused by the cleavage of DQ-
Elastin. Values represent mean ± SEM, samples were run in duplicate, n=5. * = p< 0.05, 
** = p<0.01 (Mann-Whitney test).   
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6.1.3.2 The effects hypoxia granule protein translation 
To investigate whether hypoxic incubation of neutrophils might to an increase in granule 
protein through increased translation, cycloheximide was used. Cycloheximide inhibits 
translation through inhibition of the elongation phase through binding to the E-site of the  
60S ribosomal unit and interfering with deacetylated tRNA. For this experiment freshly 
isolated neutrophils were re-suspended in normoxic or hypoxic IMDM (11.1*10
6
/ml) ± 
cycloheximide (1 µg/ml; a concentration previously established in our laboratory to 
inhibit translation in neutrophils without detectable toxicity), incubated under normoxic 
or hypoxic conditions (4 h, 37°C) and activated as described before. Figure 6.3B shows 
that incubation with cycloheximide had no significant effect on NE release from 
unstimulated or primed/stimulated cells under normoxic or hypoxic conditions. 
As a final confirmation that the enhanced release of granule proteins seen following 
hypoxic incubation is due to enhanced degranulation rather than to increased granule 
protein expression, the level of an exemplar granule protein (MMP-9) was assessed by 
Western blotting. Freshly isolated neutrophils were re-suspended in normoxic or hypoxic 
IMDM (5*10
6
/ml) and incubated under normoxic or hypoxic conditions for 4 h at 37°C. 
After incubation the cells were gently scraped off the plates, pelleted and lysed (200 µl 
ice-cold hypotonic lysis buffer with protease inhibitors (section 3.9.1). Lysates were 
prepared for Western Blot analysis exactly as described (section 3.9.1). Polyacrylamide 
gels were transferred to PVDF membranes, which were probed for MMP-9; β-actin 
staining was used to confirm equal protein loading. Incubation of neutrophils under for 4 
h led to a marked decrease in the detection of MMP-9 in comparison to protein levels 
seen in freshly isolated neutrophils (Figure 6.4); this reduction was more marked under 
hypoxic conditions, perhaps reflecting the increased basal release of MMP-9 under in this 
setting (Figure 6.4). An possible alternative explanation is that hypoxia leads to 
autophagic destruction of neutrophil granules. These results suggest that increased 
availability of granule proteins does not underlie their increased release following 
hypoxic incubation.  
 
6. Results                                              The mechanism of augmented degranulation under hypoxia  
 
 
162 |  
 
 
 
 
Figure 6.4: Granule MMP-9 protein content decreases under hypoxic conditions 
Neutrophils were analysed immediately (grey bars) or re-suspended in normoxic (filled 
bars) or hypoxic (open bars) IMDM at 11.1*10
6
/ml
 
and incubated under normoxia or 
hypoxia (0.8% O2 and 5% CO2) at 37°C for 4 h. Cells were gently scraped off the plate, 
pelleted and laced on ice immediately upon leaving the hypoxic hood. Lysates were 
prepared and corrected for protein content. Polyacrylamide gels were run and proteins 
transferred to PVDF membranes as described. The membranes were probed for MMP-9 
(rabbit polyclonal), and β-actin (rabbit polyclonal). A. Representative Western blot. B. 
Fold change of MMP-9, corrected for protein loading, densitometry analysis by ImageJ. 
n=3, values are mean ± SEM. * = p< 0.05 (paired T-test).   
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6.1.4 The effects of re-oxygenation on the hypoxic up-regulation of neutrophil 
degranulation 
Previous studies from our laboratory have shown that the hypoxic impairment of the 
neutrophil respiratory burst and bacterial killing is due to depletion of molecular oxygen 
(a substrate for the NADPH oxidase), since a brief period of re-oxygenation (15 min) 
restored these functions
327
. To see whether re-oxygenation would affect degranulation, 
neutrophils were subjected to normoxia or hypoxia as described before,and a set of 
samples was removed from the hypoxic hood after 4 h and re-oxygenated for 15 min  
before priming with GM-CSF (10 ng/ml) and activation with fMLP (100 nM). Figure 6.5 
shows that this re-oxygenation had no significant impact on the hypoxic up-regulation of 
NE release, suggesting that a lack of molecular oxygen does not underlie this effect, 
either directly or indirectly (via the effect on the NADPH oxidase).Taken together these 
experiments indicate that hypoxia does not induce the de novo synthesis of neutrophil 
granule protein by either transcription or translation, and that the hypoxic up-regulation of 
degranulation is not mediated by the canonical transcription factor HIF or by an NADPH 
oxidase-dependent mechanism. In view of this unexpected finding (HIF-mediated 
signalling underpins the vast majority of hypoxic responses) I decided to investigate the 
effects of hypoxia on both established and novel pathways with potential links to hypoxia 
that are implicated in the control of degranulation/secretory responses. 
 
6.2 The effects of hypoxia on degranulation signalling pathways 
The signalling pathways that regulated neutrophil degranulation are complex, and 
although some key players have been identified there are still gaps in our knowledge 
(section 1.6). As fMLP has been used as the stimulus to activate neutrophils in most of 
the experiments I have undertaken, I focused on GPCR-activated signalling pathways. 
Activation of GPCRs leads to the downstream phosphorylation and activation of a large 
range of proteins. To identify potential hypoxic targets an unbiased phospho-kinase array 
was performed. Additionally, key players in the GPCR-dependent degranulation pathway, 
including PI3K, PLC, and calcium flux, were assessed for their role in the augmented 
degranulation response seen under hypoxia. However, firstly I investigated a possible role 
for a novel oxygen-sensing pathway based on peptidoglycine monoxygenase (PAM). 
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Figure 6.5: Re-oxygenation does not affect the augmented degranulation response 
seen under hypoxia 
Neutrophils were re-suspended in hypoxic (open bars) or normoxic (black bars) IMDM at 
11.1*10
6
/ml. The cells were incubated under normoxia or hypoxia (0.8% O2 and 5% CO2) 
for 4 h at 37°C. After 4 h a set of samples were taken out of the hypoxic hood and re-
oxygenated (room air, normoxia) for 15 min (grey bars). The cells were then primed and 
activated with GM-CSF/fMLP as previously described. NE activity was measured by the 
increase in fluorescence caused by the cleavage of DQ-Elastin. n=4, all conditions 
analysed in duplicate. Results represent mean ± SEM, ** = p<0.01 (Mann-Whitney test). 
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6.2.1 The effects of peptidylglycine-monooxyenase on neutrophil degranulation 
I investigated a potential role for peptidylglycine-monooxyenase (PAM) in the hypoxic 
upregulation of neutrophil degranulation at the suggestion of Professor Peter Ratcliffe 
(University of Oxford), in the light of unpublished data generated by Dr Norma Masson. 
Using a bronchial carcinoid-derived cell line (H727) that exhibits rapid secretion of bio-
active peptides in response to hypoxia, Dr Masson has identified a novel HIF-independent 
secretory pathway. Peptidoglycine monoxygenase (PAM) was identified as a possible 
oxygen sensor in this setting, and PAM inhibition or knockdown by siRNA led to 
increased secretion of chromogranin A from the secretory granules of H727 cells 
(personal communication, Dr Norma Masson). Chromogranin A 
458
 and PAM can be 
found in neutrophils, therefore the effect of the PAM inhibitor 4-phenyl 3 butenoic acid  
(4p3-butenoic acid) on neutrophil degranulation was investigated. Freshly isolated 
neutrophils were re-suspended in normoxic or hypoxic medium (11.1*10
6
/ml) ± 4p3-
butenoic acid (1, 10, 100, 250 and 500 µM) for 4 h at 37 °C and activated as previously. 
Toxicity of 4p3-butenoic acid to neutrophils was assessed by trypan blue staining and by 
assessment of cell morphology with cytospins.  4p3-butenoic acidhad no significant effect 
on degranulation under normoxic or hypoxic conditions at any of the concentrations 
tested (Figure 6.6). Cell were 99% trypan blue negative even at the highest concentration 
of 4p3-butenoic acid, but inhibitor concentrations of 1mM or more resulted in a 
vacuolated morphology (data not shown). This experiment suggests that PAM is unlikely 
to underlie enhanced neutrophil degranulation seen in the hypoxic environment.  
 
6.2.2 The effects of hypoxia on kinase signalling 
To perform an unbiased screen for kinases/phosphoproteins that might be involved in 
degranulation under normal and hypoxic conditions, a human phospho-kinase antibody 
array (R&D Systems) was used. It detects the relative site-specific phosphorylation of 43 
kinases including MAP kinase, PI3K and Src family kinases (a full range of targets is 
given in Table 3.3). Each capture antibody is spotted in duplicate onto a nitrocellulose 
membrane, and levels of the phosphorylated proteins are assessed using phospho-specific 
antibodies and chemiluminescence detection. 
Freshly isolated neutrophils were re-suspended in normoxic or hypoxic medium 
(11.1*10
6
 cells/ml), incubated under normal or hypoxic conditions for 4 h (37°C) and 
primed with GM-CSF (10 ng/ml, 30 min) and activated with fMLP (100 nm, 10 min).  
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Figure 6.6: PAM does not influence neutrophil degranulation 
Neutrophils were re-suspended in hypoxic (open bars) or normoxic (black bars) IMDM at 
11.1*10
6
/ml
 
with or without the PAM inhibitor 4p3-butenoic acid at the indicated 
concentrations (1, 10, 100, 250, 500 µM). The cells were incubated under normoxia or 
hypoxia (0.8% O2 and 5% CO2) for 4 h at 37°C. The cells were then primed and activated 
with GMCSF/fMLP as previously described. NE activity was measured by the increase in 
fluorescence caused by the cleavage of DQ-Elastin. n=2 experiments, all samples 
analysed in duplicate. Results represent mean ± StDev.   
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Figure 6.7: Phospho-kinase array performed under normoxia and hypoxia 
Neutrophils were re-suspended in hypoxic (open bars) or normoxic (black bars) IMDM at 
11.1*10
6
/ml
 
and incubated under normoxia or hypoxia (0.8% O2 and 5% CO2) for 4 h at 
37°C. The cells were then primed and activated as described (section 2.8). Neutrophils 
were pelleted and lysed. Lysates were adjusted for protein concentration and the phospho-
kinase array was run according to the manufacturer’s instruction. Samples were run in 
singlicate, n=2. Results represent mean ± StDev.  
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After activation, the cells were gently scraped off the plates, placed on ice and lysed 
immediately using the lysis buffer provided. The resulting samples were adjusted for 
protein content (BCA protein assay) and the kinase array was undertaken according to the 
manufacturer's instructions (as detailed in section 3.11). The resulting dot-blots were 
quantified using ImageJ.  
Figure 6.7 and Appendix 8.7 show the proteins demonstrating differential 
phosphorylation levels in different conditions, grouped by pathway. Figure 6.7A shows 
the Src family kinases, which have been shown to play a role in degranulation. There was 
a trend towards increased phosphorylation of Src, Hck and Fyn in unstimulated cells after  
hypoxic exposure, but upon priming this difference disappeared; after subsequent 
activation with fMLP, phosphorylation of these tyrosine kinases was in fact reduced 
under conditions of hypoxia, although non of the detected changes attained 
statisticalsignificance. Figure 6.7B shows the results obtained for kinases involved in the 
PI3K/PLC/AKT pathway. At the single time point studied, there were no significant 
differences in the phosphorylation of PLCγ, Akt or cJun between normoxic- and hypoxic-
incubated cells. Likewise, a wide range of other proteins/kinases in the array (not known 
to be relevant to the degranulation response) did not show significant differences or even 
consistent trends towards increased or decreased phosphorylation following hypoxic 
incubation (appendix 8.7).   
Thus the results of the unbiased phospho-kinase array did not identify novel signalling 
pathways that might be relevant to the hypoxic uplift of neutrophil degranulation. 
Therefore, in subsequent experiments, I undertook a more detailed analysis of the known 
key signalling elements that influence degranulation downstream of GPCRs. Gβγ 
subunits released upon GPCR ligation in neutrophils directly trigger two key signal 
transduction cascades in parallel, namely the activation of PLCβ with resultant calcium 
flux, and the stimulation of PI3-kinases (PI3Ks) γ and δ, leading to PIP3 accumulation, 
Akt phosphorylation and activation of small GTPases (section 1.6).   
 
6.2.3 The effects of phospholipase C (PLC) inhibition on the hypoxic uplift of 
neutrophil degranulation   
GPCR ligation induces the activation of PLCβ, which mediates the hydrolysis of PIP2 to 
generate inositol 1,4,5-trisphosphate (IP3), in turn leading to the release of intracellular 
Ca
2+
 from the endoplasmic reticulum. PIP2 hydrolysis also yields diacylglycerol and 
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results in the activation conventional protein kinase C (PKC) isoforms. Ca
2+
 flux in 
particular has been strongly linked to degranulation
233
. U-73122 is a phospholipase C and 
A2 inhibitor, which prevents the PLC-dependent hydrolysis of PIP2 to IP3 and DAG. To 
enable me to dissect out the known immediate effects of fMLP (rapid but transient 
activation of PLC) from any PLC-dependent signal that was generated earlier during the 
hypoxic incubation period, U-73122 (2 µM) was added either at the start of the 4 h 
incubation or just 10 minutes prior to activation with fMLP. The concentration used was 
determined via a dose response curve (data not shown) to be the optimal concentration 
without inducing cell toxicity and aligns with concentrations used in the literature.
459,460 
The incubation and stimulation conditions were exactly as described previously, and 
degranulation was assessed by the detection NE (activity assay) and of MMP-9 (DUO-set 
ELISA) into the supernatants. As shown in Figure 6.8A, addition of the PLC inhibitor just 
prior to fMLP activation had an inhibitory effect on the release of both NE and MMP-9. 
Elastase release decreased from 52.1.2*10
3 
arbitrary units (AU) to 1.7*10
3
 AU under 
normoxia and from 114.2*10
3
 AU to 30.5*10
3
 AU under hypoxic conditions; however, 
this data also shows that the significant hypoxic uplift of NE release (from 1.7*10
3
 AU to 
30.5*10
3
 AU) remains when fMLP-dependent PLC activation is prevented, despite the 
much lower baseline value (Figure 6.8A). The effect on MMP-9 release was similar in 
this setting, decreasing from 64.0 ng/ml to 10.7 ng/ml under normoxia and from 221.2 
ng/ml to 90.5 ng/ml under hypoxic conditions (Figure 6.8A); thus again, a significant 
hypoxic uplift was preserved. Of note, PLC inhibition from the start of the 
hypoxic/normoxic incubation had a more marked suppressive effect on degranulation 
(Figure 6.8B), and in this setting there was no longer a significant difference between the 
normoxic and hypoxic cells, although a trend towards increased hypoxic degranulation 
was still present (2.8*10
3 
AU under normoxic conditions in comparison to 15.5*10
3 
AU 
under hypoxic conditions). These results suggested that PLC activation may comprise 
part of the hypoxia-mediated signal to augment degranulation responses, and prompted 
me to explore the role of Ca
2+
 flux in this setting. 
 
6.2.4 The effects of modulating intracellular Ca2+ transients on the hypoxic uplift of 
neutrophil degranulation   
Due to the limitations of working within the hypoxic hood, it was not possible to perform 
direct measurements of intracellular Ca
2+
 flux in real time in hypoxic neutrophils, and  
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Figure 6.8: Role of phospholipase C activation in the hypoxic augmentation of 
degranulation 
Neutrophils were re-suspended in hypoxic (open bars) or normoxic (black bars) IMDM at 
11.1*10
6
/ml. The cells were incubated under normoxia or hypoxia (0.8% O2 and 5% CO2) 
at 37°C for 4 h. The cells were then primed with GM-CSF (10 ng/ml) for 30 minand 
stimulated with fMLP 100nM.  The PLC inhibitor (U-73122 2 µM) was added either 10 
min prior to activation with fMLP (A and B) or from the outset of the incubation (C). 
Cells were pelleted and the supernatants were assessed for NE activity by the cleavage of 
DQ-Elastin (A and C) or for MMP-9 release by ELISA (C). A: n=4, B: n=4 C: n=3. 
Values represent mean ± SEM, samples were run in triplicate, * = p< 0.05 (Mann-
Whitney test). 
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because of concerns regarding the confounding effects of re-oxygenation, these studies 
were not undertaken on cells made hypoxic and then removed from the hypoxic 
incubator. Activation of GPCRs is known to lead to a biphasic increase in intracellular 
calcium; the first phase is due to Ca
2+
 release from IP3-sensitive, intracellular stores such 
as the endoplasmic reticulum (ER), whilst the second phase is secondary to Ca
2+
 influx 
from the extracellular fluid/media
235
. To assess the role of calcium flux via both routes 
under hypoxic as well as normoxic conditions, EGTA and thapsigargin were used. EGTA 
chelates divalent cations, and when compared to EDTA it is more selective for calcium 
rather than magnesium. EGTA chelates calcium in a 1:1 ratio, and since there is 1.5 mM 
Ca
2+
present in IMDM, EGTA was added at a concentration of 2 mM. Freshly isolated 
neutrophils were re-suspended in normoxic or hypoxic IMDM (11.1*10
6 
cells/ml) ±  
EGTA (2 mM), incubated under normoxic or hypoxic conditions for 4 h (37°C) and 
stimulated as described before. Degranulation was quantified by the detection of NE 
(activity assay) and MMP-9 (DUO-set ELISA) in the supernatants. Depletion of 
extracellular calcium with EGTA had no effect on the (minor) release of granule proteins 
from unstimulated neutrophils under normoxia or hypoxia (Figure 5.9). However, 
extracellular calcium depletion significantly reduced the release of NE (Figure 6.9A) and 
MMP-9 (Figure 6.9B) under both normoxic and hypoxic conditions (from 64.4*10
3
AU to 
16.8*10
3
AU under normoxic condition
 
and from 124.3*10
3 
to 60.6*10
3
AU under hypoxic 
conditions). NE release was affected irrespective of oxygenation conditions, and a 
significant increased (3.6. fold) in NE release was still seen with hypoxic incubation in 
the presence of EGTA (from 16.8*10
3
AU under normoxic condition
 
to 60.6*10
3 
under 
hypoxic conditions) For MMP-9, the results were less reproducible, but the trend was 
similar. Inclusion of EGTA reduced the detection of MMP-9 in the cellular supernatant 
whether normoxic or hypoxic incubation was employed, but the variation in release 
between experiments meant that EGTA-dependent differences did not reach statistical 
significance. Since these results suggested that modulation of the extracellular influx of 
calcium does not fully explain the effects of hypoxia on neutrophil degranulation, I 
proceeded to explore the effects of thapsigargin. Thapsigargin releases calcium from 
intracellular stores to induce an intracellular calcium spike. Freshly isolated neutrophils 
were re-suspended in normoxic or hypoxic IMDM (11.1*10
6
 cells/ml), incubated under 
normoxic or hypoxic conditions for 4 h (37°C) and primed with GM-CSF (10 ng/ml) 
before incubation with thapsigargin (10, 50 or 100 nM) and immediate addition of fMLP 
(100 nM).   
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Figure 6.9: Role of calcium influx in the hypoxic augmentation of neutrophil 
degranulation 
EGTA (2mM) was added to the media used in these experiments 10 min before re-
suspension. Neutrophils were re-suspended in hypoxic (open bars) or normoxic (black 
bars) IMDM ± EGTA at 11.1*10
6
/ml. The cells were incubated under normoxia or 
hypoxia (0.8% O2 and 5% CO2) at 37°C for 4 h. The cells were then primed and activated 
with GMCSF and fMLP as described. Cells were pelleted and the supernatant transferred 
to fresh tubes before removal from hypoxic hood for further analysis. A. NE activity was 
measured by the increase in fluorescence caused by the cleavage of DQ-Elastin. B. MMP-
9 release was measured by MMP-9 ELISA.  Values represent mean ± SEM, samples were 
run in triplicate, n=4. * = p< 0.05 (Mann-Whitney test).   
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After 10 min supernatants were collected and assessed for NE and MMP-9. Both MMP-9 
and NE release was significantly increased (Figure 6.10). Thapsigargin did not augment 
or diminish the hypoxic upregulation of GMCS/fMLP-stimulated NE release, which 
remained constant (approximately twofold) at all thapsigargin concentrations examined 
(normoxia versus hypoxia, no thapsigargin: 10.8*10
3 
AU increasing to 20.0*10
3
 AU; 
normoxia versus hypoxia, 100 nM thapsigargin: 17.1*10
3 
AU increasing to 36.9*10
3 
AU; 
see Figure 6.10A). In the absence of thapsigargin, MMP-9 release was upregulated 2.8 
fold under hypoxic conditions (from 100.6 ng/ml to 275.4 ng/ml). In unstimulated cells, 
thapsigargin had little effect on NE release, but induced marked MMP-9 release (figure 
5.10B), an effect more marked when neutrophils were hypoxic.  Thapsigargin increased 
MMP-9 release from primed and stimulated cells, but again had a more pronounced effect 
when the incubation was normoxic rather than hypoxic;in the presence of 100 nM 
thapsigargin, there was no significant hypoxic uplift in MMP-9 release (figure 6.10B). 
This difference between NE and MMP-9 in response to thapsigargin may reflect the 
known differential sensitivity of the 2 granule populations (azurophilic and gelatinase) to 
Ca
2+
-induced release. 
Thus modulation of Ca
2+
-flux appeared to have little impact on the hypoxic up-regulation 
of NE release, although a probable contributory role was detected for the liberation of 
MMP-9. In view of this, I went on to explore the role of PI3K in the hypoxic up-
regulation of azurophilic granule release. 
 
6.2.5 The effects of PI3K inhibition on the hypoxic uplift of neutrophil degranulation 
The PI3K pathway (see section 1.5.2) plays a key role in GPCR signalling and is one of 
the earliest kinases to be activated upon receptor ligation. PI3K activation induces the 
production of phosphatidylinositol (4,5)-bisphosphate (PIP3) from phosphatidylinositol 
(4,5)-bisphosphate (PIP2)
221
. PIP3 is an important messenger is plays a role in a range of 
cell processes including neutrophil polarisation and degranulation. PI3Kγ and PI3Kδ are 
expressed predominantly in leukocytes and are key to a number of neutrophil functions 
such as the oxidative burst
461
 and chemotaxis
462. PI3Kγ is the principal isoform activated 
on ligation of GPCRs and has been implicated in the control of neutrophil 
degranulation
463
. To investigate the role of PI3K signalling in degranulation under 
hypoxic conditions, 3 different inhibitors were used; LY294002 (10 µM), which is a pan- 
PI3K inhibitor, AS605240 (3 µM), a selective PI3Kγ-isoform inhibitor and  
6. Results                                              The mechanism of augmented degranulation under hypoxia  
 
 
174 |  
 
 
Figure 6.10: Role of calcium release from intracellular stores in the hypoxic 
augmentation of neutrophil degranulation 
Neutrophils were re-suspended in hypoxic (open bars) or normoxic (black bars) IMDM at 
11.1*10
6
/ml. The cells were incubated under normoxia or hypoxia (0.8 % O2 and 5% 
CO2) at 37°C for 4 h. The cells were primed with GM-CSF (10 ng/ml) for 30 min. 
Thapsigargin (10, 50 or 100 nM) was then added before the cells were activated with 
fMLP (100 nM) for 10 min.  Cells were pelleted and the supernatant transferred to fresh 
tubes before removal from hypoxic hood for further analysis. A. NE activity was 
measured by the increase in fluorescence caused by the cleavage of DQ-Elastin. Values 
represent mean ± SEM, samples were run in triplicate, n=5. B. MMP-9 release was 
measured by MMP-9 ELISA. Values represent mean ± SEM, samples were run in 
triplicate, n=4. * = p< 0.05, ** = p<0.01 (Mann-Whitney test).   
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IC87114 (3 µM), a selective PI3Kδ-isoform inhibitor. These PI3K inhibitors are 
frequently used in our lab and have been shown be active at the used concentrations
464,465
 
for example by inhibiting  neutrophil apoptosis and inhibition of AKT phosphorylation 
The inhibitors were added either at the start of the 4 h incubation or 10 minutes prior to 
fMLP; this was to enable me to dissect out the known effects of fMLP (rapid but transient 
accumulation of PIP3) from any PI3K-dependent signal that was generated earlier during 
the hypoxic incubation period. The incubation and stimulation conditions were exactly as 
described previously, and degranulation was assessed by supernatant NE activity. In the 
unprimed/unstimulated cells, neither the pan- nor the isoform-selective inhibitors 
modulated degranulation in a significant fashion, whether the cells were maintained under 
conditions of normoxia or hypoxia (Figure 6.11). In the setting of normoxic culture, 
addition of LY294002 just prior to GPCR ligation by fMLP (figure 5.12A) had a 
significant impact on degranulation: NE release was reduced from 61.3*10
3
 AU to 
11.9*10
3
 AU; the PI3Kγ inhibitor has a very similar effect (reduction to 19.6*103 AU), 
whilst the PI3Kδ inhibitor had little effect (reduction only to 51.7*103 AU). Under 
hypoxic conditions the same pattern was seen; both LY294002 and AS605240 decreased 
NE release (from 128.9*10
3 
AU to 52.1*10
3 
AU with LY294002 and to 52.2*10
3 
AU with 
AS605240). Interestingly, the hypoxic uplift remained approximately the same; 2.3 fold 
without inhibitors and approximately 2.5 fold with inhibitors. Importantly, when the pan- 
PI3K inhibitor and the PI3Kγ inhibitor were added at the beginning of the normoxic or 
hypoxic incubation they suppressed NE release to baseline, and completely eliminated the 
augmented NE release induced by hypoxia (from 87.8*10
3 
AU to 3.9*10
3 
AU with the 
pan-PI3K inhibitor and to 3.2*10
3
AU with the PI3Kγ inhibitor under normoxic condition 
and from 193.5*10
3
AU to 9.0*10
3
AU with the pan-PI3K inhibitor and 4.5*10
3 
AU with 
the PI3Kγ inhibitor under hypoxic conditions). In contrast, the isoform-selective PI3Kδ 
inhibitor had a less marked effect on degranulation and did not eliminate the hypoxic 
uplift of NE release (NE release was reduced from 87.8*10
3
AU to 32.5*10
3
AU under 
normoxic condition
 
and from 193.5*10
3
AU to 108.0*10
3
AU under hypoxic conditions).  
Together the data presented in this chapter show that the augmented degranulation seen 
under hypoxic conditions in not HIF- or protein synthesis-dependent. Investigation of key 
molecules of degranulation signalling pathways indicated a key role for PI3Kγ in the 
enhanced release of NE seen with hypoxic incubation; a probable role was also identified 
for PLC-dependent Ca
2+
 flux, contributing in particular to the hypoxia-mediated release 
of MMP-9.  
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Figure 6.11: Role of PI3K signalling in the hypoxic augmentation of NE release 
Neutrophils were re-suspended in hypoxic (open bars) or normoxic (black bars) IMDM at 
11.1*10
6
/ml. Inhibitors (pan-PI3K inhibitor Ly294002 10μM, PI3Kγ inhibitor AS605240, 
3μM or PI3Kδ inhibitor IC87114, 3μM) were added just prior to fMLP stimulation (A) 
or from the outset of the incubation (B). The cells were incubated under normoxia or 
hypoxia (0.8% O2 and 5% CO2) at 37°C for 4 h, then primed (GM-CSF, 10 ng/ml, 30 
min) and activated (fMLP. 100 nM, 10 min). Neutrophils were pelleted and the 
supernatants transferred to fresh tubes before removal from the hypoxic hood. NE activity 
was measured by the increase in fluorescence caused by the cleavage of DQ-Elastin. 
Values represent mean ± SEM, samples were prepared in duplicate, n=3-5. # is the 
significant decrease in NE release after inhibitor treatment in comparison with the 
activated normoxic or hypoxic neutrophils. * or # = p< 0.05, ** or ## = p<0.01(Mann-
Whitney test).  
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6.3 Discussion 
Since neutrophil degranulation products have been implicated in the pathogenesis of 
many diseases, and hypoxic augmentation of degranulation in the inflammatory 
environment is biologically plausible, identification of the signalling mechanism by 
which this effect is established may be of therapeutic relevance. HIF-1α can modulate 
protein transcription of a large range of target proteins; there is some evidence that it 
modulates neutrophil granule protein production, at least during development in the 
hypoxic environment of the bone marrow.  
We therefore hypothesised that hypoxic stabilisation of HIF-1α induces de novo granule 
protein synthesis, leading to enhanced release of granule proteins on stimulation 
following such hypoxic exposure. My initial experimental focus was therefore directed to 
investigate this hypothesis.Consistent with the hypothesis, putative HRE’s were identified 
in the promoter regions of MMP-9, MPO and NE. The timeframe of hypoxic incubation 
(4 h) is very brief to induce an effect via protein synthesis, but of note, transcription of 
BNIP was markedly up-regulated (almost 30-fold) at this time point. However, to our 
surprise, HIF-stabilisation by HIF stabilizers did not lead to increased degranulation. 
Since it was possible that HIF stabilizers might stabilise HIF-1α to a lesser extent or with 
different kinetics to hypoxia, I also quantified the effects of hypoxia on mRNA and 
protein levels of selected granule proteins. Hypoxia did not increase transcript or protein 
levels (in fact, neutrophil MMP-9 protein was diminished by hypoxia).  
To exclude a role for HIF-1α in modulating the levels of other relevant signalling 
proteins, I explored the effect of cycloheximide, and found that this compound did not 
diminish the hypoxic up-regulation of NE release. Together these data suggest that the 
effect of hypoxia on degranulation is not mediated by HIF-1α, at least via its role as a 
transcription factor. Ideally I would have liked to study the stabilisation of HIF-1α in 
neutrophil lysates directly by Western blotting, and compared the effects of true hypoxia 
with those of the hypoxia-mimetics. However, detection of HIF-1α in neutrophils is 
technically challenging and requires large numbers of cells
354
; attempts to undertake these 
experiments, even with the assistance of Dr Andrew Cowburn (who works in the 
laboratory of Professor Randall Johnson, Department of Physiology, University of 
Cambridge) did not consistently detect HIF-1α in hypoxic neutrophil lysates. It would be 
of interest to pursue these experiments in the future, particularly if better detection 
reagents became available. 
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The signalling pathways regulating neutrophil degranulation are surprisingly poorly 
understood, considering the importance of degranulation to innate immunity and to 
disease pathogenesis. Rather than simply focusing on the pathways previously identified 
to be relevant in degranulation response, I wished to perform an unbiased screening 
assay, to ensure I did not miss novel signalling pathways engaged by the combination of 
hypoxia, priming and stimulation. Since protein phosphorylation events are critical in a 
range of neutrophil functions, a phospho-kinase array was used as an initial screen for 
hypoxic targets. However, it is important to note that this methodology has significant 
limitations. Firstly, although a large number of target proteins can be studied, only a 
single time-point can be examined for each experimental run; since phosphorylation 
events are transient, this may limit the sensitivity of detection. Secondly, the 
reproducibility of the findings was found to be low (Figure 6.7), and the arrays are costly, 
making it difficult to identify statistically significant results. Thirdly, many proteins are 
phosphorylated on multiple sites, and studying a single phosphorylation target may not be 
an ideal readout of activation status. As discussed in more detail below, I did not find 
significant results using this assay even with targets known to be involved in signalling 
degranulation, and did not identify pathways subsequently shown to be relevant in the 
hypoxic up-regulation of degranulation.  
Src family kinases are known to play an important role in neutrophil degranulation, 
especially in integrin-dependent signalling
231,232
. Src-dependent pathways can activate 
Rac2 in parallel with PI3-kinase, and hence could impact on cytoskeletal re-arrangements 
in degranulation
466
; of note, I found that hypoxia induced neutrophil cytoskeletal 
remodelling (section 4.5.2). Furthermore, Src-pathways and PI3K have been shown to be 
activated in the context of hypoxia/reperfusion
467–469
. Unfortunately, I did not find any 
detectable increase in the phosphorylation of Src-family kinases in response to 
priming/stimulation with GM-CSF/fMLP, and even CytB/fMLP had only a marginal 
effect (Figure 6.7A). This suggests that the phospho-kinase array did not adequately 
interrogate this pathway under the conditions studied; hence the apparent reduction in 
Src-family kinase phosphorylation seen on stimulation in the context of hypoxia (Figure 
6.7A) likely reflects the limitations of this assay alluded to above. A slight increase in 
AKT phosphorylation was seen in response to treatment with GM-CSF/fMLP, as would 
be expected; this response appeared to be diminished in the setting of hypoxia (figure 
5.7B). However, in the light of the finding that activation of the PI3K pathway seems to 
highly relevant to the hypoxic augmentation of NE release (section 6.2.5), this finding of 
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reduced AKT phosphorylation does not seem biologically plausible, and again suggests 
that the phospho-kinase assay is not sufficiently sensitive to pick up known or unknown 
relevant pathways under the selected experimental conditions. This assay was hence not 
pursued any further. 
There has been no previous published study specifically exploring the effects of hypoxia 
on neutrophil degranulation, although some data sets have been published in other 
contexts that suggest hypoxia can modulate signalling pathways that regulate 
degranulation in other cell types. In certain settings, hypoxia has been shown to activate 
p42/44 MAPK (e.g in PC12 cells
358
), p38MAPK (human neutrophils
356
) and also PI3K  
(in mouse microglial cells
470
)  and in ras-transformed NIH3T3 cells
471
, PKC and Src 
family kinases (in rat cardiac myocytes
359
). A key finding reported in this chapter is that 
inhibition of PI3K, and specifically of PI3Kγ, could prevent degranulation under both 
normoxic and hypoxic conditions. It is important the note that the full effect of PI3K 
inhibition on the hypoxic up-regulation of degranulation occurred only when the 
inhibitors were present from the outset of the hypoxic incubation, and not when they were 
added prior to the addition of fMLP. This suggests that their effect on degranulation is not 
simply due to the inhibition of the established fMLP-induced activation of PI3Kγ and 
PI3Kδ isoforms461, but instead implies that a PI3K-dependent signal is entrained prior to 
the addition of fMLP during the preceding hypoxic incubation period. At present the 
nature and timing of this signal are unclear and future studies will focus on delineating 
these responses in more detail. It would also be of considerable interest to explore the 
mechanism by which hypoxia modulates PI3K activation. 
 The literature detailing the effects of hypoxia on PI3Kactivation is surprisingly limited, 
and is mainly derived from cancer cell lines such as HeLa cells. Alvarez-Tejado et 
al.
472,473
 found activation of the PI3-kinase/Akt signalling pathway after 4 h of hypoxic 
incubation in rat pheochromocytoma PC12 cells, which could be prevented by 
cycloheximide or actinomycin D, suggesting de novo protein synthesis was required to 
mediate this effect. A later paper by the same group showed that activation of PI3-
kinase/Akt was downstream of HIF-1α. Clearly, this does not align with my findings in 
neutrophils. Perhaps more in keeping with my results, Mottet et al.
474
 saw a biphasic 
response to hypoxia in HepG2 cells with an initial PI3K dependent HIF-1α stabilisation at 
5 h; by 16 h hypoxic exposure PI3K activation was no longer detectable and GSK3β 
activation led to depletion of HIF. Kilic-Eren et al.
475
 also found that PI3K acted upstream 
of HIF-1α, since LY294002 reduced the detection and DNA binding activity of this 
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transcription factor. Finally, Kim et al.
469
 showed that hypoxia and CoCl2 induced IL-8 
mRNA and protein expression via activation of the PI3K/Akt and p38 MAPK signalling 
pathways. Since my data suggest that the hypoxic up-regulation is independent of HIF-
mediated transcriptional activity, these published studies do not shed a light on the 
mechanism of this effect and further underscore the need for future studies. 
Similarly, a limited amount of data exists to support a role for hypoxia in modulating PLC 
activity, IP3 accumulation and intracellular calcium concentrations. Yadav et al.
476
 
reported that acute hypoxia significantly enhanced PLC activity in mouse pulmonary 
arteries smooth muscle cells (PASMCs), by increasing mitochondrial complex III Rieske  
iron-sulfur protein (RISP)-dependent mitochondrial ROS production in complex III. The 
resultant IP3 production and Ca
2+
 release were found to play an important role in hypoxic 
contractile responses in PASMCs. As for PI3K signalling, inhibition of PLC from the 
outset of the hypoxic incubation period had a greater suppressive effect than addition of 
the inhibitors prior to stimulation with fMLP. Given the fact that both PLC and PI3K 
signalling seem to be up-regulated by hypoxia in this context, it would be of considerable 
interest to measure the effects of hypoxia on membrane phospholipid content, and in 
particular on the levels of PIP2, which is the substrate for both of these enzymes. 
It would also be of interest to explore whether the formation of DAG and the activation of 
PKC isoforms was modified in the setting of hypoxia. A further line of enquiry is to 
explore the downstream effectors of PI3K/PLC signalling and how they interface with the 
degranulation machinery. Downstream effectors of PI3K include a range of kinases like 
Akt, but also adaptor proteins and regulators of small GTPases including Rac and Rho. 
Recently, Shuang Ma et al. 
378
 found that hypoxia increased cell polarisation in response 
to fMLP in HL-60 cells (a neutrophil like cell line), which concurs with my data (section 
4.5.2, Figure 4.9) that hypoxia induces the formation of an F-actin leading edge. It could 
be speculated that hypoxia modulates degranulation via a PI3-kinase/PLC-dependent 
effect on small GTPases to modulate F-actin distribution, or the fusion and docking stage 
of degranulation (discussed in more detail in section 1.6.5). The GTPase Rac plays an 
important role in F-actin polarisation
261,477
 and the release of azurophil granules 
83,264
. 
Furthermore, research by Dooley et al.
478
 indicated an additional role for Rac2 in the 
release of MMP-2/-9 from macrophages and neutrophils.  
Other Rho-family GTPases may also be involved in aspects of neutrophil degranulation, 
since different granule populations have partially distinctive regulatory pathways. Rac1 
and Rac2 have been shown to play distinct role in antigen stimulated mast cell exocytosis; 
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Rac1-mediates membrane ruffling and Rac2-mediates calcium influx in this setting
265
. 
Additionally, Rab family GTPases have been implicated in vesicle transport and 
docking
277,278
, Rab3, Rab4 and Rab5 co-localise with neutrophil granules
280
. Hypoxia has 
been shown to modulate a range of Rab family GTPases, it can activate Rab11
479
, 
increase Rab20 expression
480
 and increases Rab4 dependent trafficking in cancer cells
481
. 
This makes hypoxic modulation of degranulation through Rab GTPases a possibility.  
Thus although I have identified a role for PI3Kand PLC in mediating the hypoxic uplift of  
neutrophil degranulation, several important questions remain. Firstly, how might 
hypoxias affect these signalling molecules, and is this a cell-specific or a more ubiquitous 
phenomenon? Secondly, what are the kinetics of this response? Thirdly, what are the 
downstream effectors and how do they interface with the degranulation machinery in the 
neutrophil? Exploring these questions will form the basis of a further exciting research 
project. 
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7.  Discussion 
7.1 Overview 
Neutrophils are the ‘rapid response’ frontline troops of the innate immune system. 
Circulating neutrophils sense tissue injury and/or invading microbial pathogens by means 
of membrane receptors that recognise products of tissue injury, chemoattractants, and 
microbial compounds, which ‘flag’ the affected tissue or organ as requiring their 
attention. Neutrophils arrive early (within minutes) during acute inflammatory responses, 
and represent the most abundant immune cells in the inflamed tissues for many hours. In 
their capacity as first responders, the primary role of these professional phagocytes is to 
kill invading pathogens. To kill ingested microbes they can deploy the phagocyte 
NADPH oxidase and an array of proteolytic enzymes and antimicrobial peptides 
contained in membrane-encapsulated granules; the products of both systems are 
discharged into the phagosome
36
. This potent anti-microbial armamentarium is what 
makes the neutrophil an effective frontline defensive cell. Paradoxically, these same 
antimicrobial responses can, under pathological circumstances, lead to considerable host 
tissue injury in a form of unintended “collateral damage”. In such circumstances, 
neutrophil-derived antimicrobial compounds may be released into the extracellular space 
in excess quantities, resulting in inflammatory tissue injury. Although neutrophils can 
emigrate from the vasculature without causing injury, there is abundant evidence in vitro 
and in vivo experimental models that an intense influx of neutrophils may incite 
pathological inflammation in a range of organs and may contribute to the pathogenesis of 
conditions such as acute lung injury
149
, inflammatory bowel disease
482
, nephritis
117
, 
arthritis
56
, ischemia-reperfusion injury
93
, myocardial infarction
483
, and stroke
483
.  
To understand this transition toward a maladaptive inflammatory state, it is essential to 
consider the physiological properties of the environment in which the recruited 
neutrophils must operate, and to recapitulate those conditions when studying neutrophil 
function in the laboratory. As previously discussed, inflammatory sites are often 
profoundly hypoxic, yet most studies of neutrophil function are undertaken in ambient 
oxygen tensions that do not reflect the pathological setting in which these cells routinely 
operate. Tissue damage is a feature of infection and although it can be beneficial on a 
small scale, larger scale damage is detrimental and contributes to the pathogenesis of a 
wide range of inflammatory diseases. Neutrophil proteases can cleave almost any 
extracellular matrix component and have been closely linked to tissue damage in, for 
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example, COPD. The effect of hypoxia on neutrophil function is highly relevant to this 
disease, as the neutrophil the most abundant inflammatory cell present in the bronchial 
wall and lumen of patients with COPD
63,64,416,484
, the COPD lung is a hypoxic 
environment
485,486
, and HIF-1α immunostaining has been detected specifically in COPD 
airways. Whilst HIF-1α can be stabilized by inflammatory stimuli as well as hypoxia, our 
laboratory has recently found direct evidence that the inflamed airways are hypoxic by 
means of demonstrating Hypoxyprobe™ staining in the IL-13 transgenic mouse, which 
displays spontaneous airway inflammation (Dr Andrew Cowburn, personal 
communication). 
It is known that hypoxia can influence neutrophil function profoundly, with delayed 
neutrophil apoptosis and reduced killing of pathogenic bacteria such as Staphylococcus 
aureus 
327,379
. My results confirm and extend these observations, and suggest that the 
phenotype of a neutrophil in a hypoxic environment may be highly destructive, with not 
only impaired capacity to kill pathogens but also enhanced potential to damage the 
surrounding tissues.  
 
7.2 Experimental challenges  
Inconsistency of data between different studies of neutrophil function has arisen in some 
cases from the different isolation methods used. Neutrophil priming can alter neutrophil 
function and has been shown to be a consequence of exposure to temperature changes and 
certain chemicals used during the isolation process
487,488. The Percoll™-gradient method 
used to generate the results reported in this thesis is very gentle and induces minimal 
priming
487
, as exemplified by near-undetectable levels of basal shape-change and of 
fMLP-induced superoxide release. Any neutrophil preparation that yielded basally primed 
cells was discarded. All of my experiments were performed on primary human 
neutrophils freshly isolated from the peripheral blood of healthy, un-medicated human 
volunteers. I used a short hypoxic exposure (4 h) as these cells are terminally 
differentiated and have a short life span; importantly, hypoxia dramatically increases 
neutrophil longevity, and the survival curves for normoxic and hypoxic neutrophils start 
to diverge after 6 h
377
, hence the selection of a 4h incubation period rather than a longer 
hypoxic exposure.   
Hypoxia alters neutrophil function, but re-oxygenation also has profound effects
489–491
. 
Some groups may have investigated the effect of hypoxia on neutrophil function after 
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inadvertent re-oxygenation or have simply taken cells out of hypoxic chambers to 
undertake functional assays, which can profoundly affect the results obtained. Therefore 
the oxygen levels in the hypoxic hood were carefully monitored, and the oxygen tension 
of tissue culture medium was also monitored using a blood gas analyser. Great care was 
taken to avoid re-oxygenation during the experiments performed; any reactions were fully 
stopped, prior to removal of samples and all experiments were performed under normoxic 
conditions outside of the hood in parallel.  The InVivo400 hypoxic hood used throughout 
the thesis was over 5 years old at the beginning of my studies, and unfortunately 
developed faults on several occasions, which were detected by the means described 
above; again, all such experiments were discarded. 
To determine the capacity of hypoxic neutrophils to induce tissue injury I studied the 
effect of neutrophil supernatants on cultured respiratory epithelia. Although I initially 
used A549 cells, I was concerned that this lung cancer-derived cell line would not 
necessarily reflect the characteristics of true bronchial epithelial cells. I extended my 
observations using iHBEC cells, and the results I obtained with these cells were 
reassuringly very similar. My experiments with primary HBECs were limited by the 
difficulty and expense of growing these cells to a ciliated morphology in ALI culture 
systems, but the data I obtained by microscopy studies and LDH release supported an 
increased toxicity secondary to exposure to hypoxic neutrophil supernatants. I geared 
these experiments to gather data on the impact on ciliary function, but unfortunately, all 
of the supernatants used (including those from unstimulated neutrophils) had a profound 
impact on CBF and ciliary co-ordination. It is possible that some component of the 
neutrophil medium (DMEM) was toxic to the ciliated cells, but this was felt to be unlikely 
by Dr Rob Hirst (University of Leicester, personal communication); there is very little 
protein in control medium (1, lane A). It seems more likely that ciliary function is more 
sensitive to disturbance than the other indicators of damage I have studied (loss of 
membrane integrity, activation of caspase 3, cell death and detatchment) and that future 
studies should use more diluted supernatants. 
 
7.3 Discussion of results 
In the work presented in this thesis I have shown that hypoxia markedly increases the 
liberation of (active) neutrophil granule proteins including elastase and MPO from the 
azurophilic granules, lactoferrin from the specific granules and MMP-9 from the  
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gelatinase granules. These are exemplar granule contents and the liberation of the whole 
spectrum of granule proteins will, by implication, also be released in parallel. 
Intriguingly, in collaboration with Dr Wei Li, a structural biologist working in the 
Department of Medicine, I have also shown that certain cytoplasmic proteins (including 
the S100 family) are liberated in particular from hypoxic primed and stimulated 
neutrophils (Figure 7.1). Since these cells treated in this fasion show a marked increased 
in longevity the release of cytoplasmic proteins does not reflect impaired membrane 
integrity, and the mechanism and consequences of this phenomenon are currently unclear 
but warrant further investigation. 
 In keeping with my finding that hypoxic neutrophil supernatants contain increased active 
degranulation products, these supernatants caused substantially more damage to lung 
epithelial cell layers than did supernatants from neutrophils cultured under normoxic 
conditions; this damage was protein- and protease-dependent. Preliminary inhibitor 
studies suggest that the damage to epithelial cells was not secondary to a single protease 
or protein but reflected a combinatorial effect of the ‘toxic soup’ of released products. 
Again of interest, preliminary data obtained in collaboration with Dr Wei Li has 
suggested that hypoxic but not normoxic neutrophil supernatants can cleave the 
endogenous circulating vascular protective factor BMP-9, and that this effect is mediated 
specifically by NE (Figure 7.2). Thus while certain aspects of tissue injury may reflect the 
action of multiple neutrophil products and hence necessitate inhibition of degranulation to 
suppress the resulting damage, other damaging consequences of enhanced degranulation 
may be more amenable to specific inhibitors such as those for NE. This may have 
relevance to the endothelial dysfunction (both pulmonary and systemic) associated with 
COPD, and this observation is the basis for an MRC Research Training Fellowship 
awarded to Dr Katharine Lodge. 
I have shown that the increased granule protease release by neutrophils under hypoxic 
conditions can damage to lung epithelial cells in a tissue culture setting, even when the 
supernatants are diluted. Whilst it is difficult to equate the addition of neutrophil 
supernatants to the in vivo pathological setting, the fact that neutrophil products have been 
shown to contribute to injury in disease makes this hypoxic uplift a biologically plausible 
mechanism for promoting such damage. I have progressed my findings from submerged 
cultures of a cancer-cell line to ALI cultures of primary HBECS, with similar results. In 
the future it would be of value to explore the effects of direct neutrophil-epithelial  
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Figure 7.1: Superntants from normoxic and hypoxic neutrophils contain cytoplasic 
proteins 
Neutrophil supernatants were run on a polyacrylamide gel, stained with Coomassie stain, 
and bands identified by mass spectrometry by Dr Wei Li.  Lanes: A. Control medium (no 
neutrophils) B. Normoxic unstimulated neutrophils C. Hypoxic unstimulated neutorphils.  
3. Normoxic neutrophils stimulated with GMCSF/fMLP. 4. Hypoxic neutrophils 
stimulated with GMCSF/fMLP. Proteins: 1. Lactoferrin 2. Neutrophil lipocalin 3. 
Myeloperoxidase 4. Chain A, Human Cathepsin G 5. Lysozyme 6. Keratin 7. Calprotectin 
8. Protein S100-A9. 9. Protein S100-A8. 
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                                               A 
 
                                         B 
 
Figure 7.2: BMP-9 is cleaved following exposure to hypoxic neutrophil supernatants 
BMP-9 was incubated with PBS or supernatants activated under hypoxic conditions in the 
absence or presence of protease inhibitors. Exposure to hypoxic supernatants induced 
cleavage of recombinant BMP-9 that was inhibited by α1AT or the elastase inhibitor 
sivelestat. A. Representative example (of n=3) SDS-PAGE. Lanes: PBS only (no 
supernatant); hypoxic activated supernantants in the presence of no protease inhibitor (no 
PI), α1AT and sivelestat. B. Quantification of n=3 experiments using ImageJ. SDS-PAGE 
was undertaken by Dr Wei Li.  
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interactions under conditions of hypoxia, to establish the number of neutrophils and the 
degree of hypoxia required to lead to significant cellular injury and death. 
Surprisingly, the mechanism of hypoxia-augmented degranulation was found to be 
independent of the transcription factor HIF-1α (the ‘master-regulator’ of hypoxic 
responses); thus, hypoxia did not increase mRNA transcript or protein abundance of the 
major granule components, and HIF stabilizershypoxia mimetics failed to recapitulate the 
degranulation phenotype. If HIF signalling does not underpin the enhanced secretory 
phenotype demonstrated by hypoxic neutrophils, what might be the alternative 
mechanisms? It is possible that hypoxia somehow works as a priming agent, amplifying 
signals or increasing the cells sensitivity to priming agents. The classical manifestation of 
neutrophil priming (enhanced ROS generation) cannot be seen using my experimental 
conditions; indeed the oxidative burst is suppressed due to the lack of substrate 
(molecular oxygen). Priming is known to augment degranulation
227
, however the effect of 
hypoxia is additive with that of GMCSF at full priming doses, suggesting an alternative 
mechanism may be operative. Although I see alterations in the neutrophil cytoskeleton 
under hypoxic conditions (see below), previous work in our laboratory has not identified 
a major change in the cell surface markers CD11b and CD62L, nor an enhancement in IL-
8 secretion
327
, both features that would be expected in the setting of neutrophil priming. 
These features suggest that hypoxia does not simply ‘prime’ neutrophils in the 
conventional manner of cytokine priming.  
Since I demonstrated a global hyper-secretory effect rather than an effect on individual 
proteins, I then examined the signalling pathways regulating neutrophil degranulation. An 
unbiased phospho-kinase screen did not reveal any novel targets, but for the reasons 
discussed (section 6.3) this methodology was not felt to be optimal, and it would be 
pertinent to pursue the effects of hypoxia on neutrophils using newly emerging techniques 
such as RNAseq or more extended phospho-proteomics studies. Since such studies were 
outside the remit of my PhD thesis, I instead focussed on the effects of hypoxia on 
signalling pathways already known to regulate neutrophil secretory function. Since 
inhibition of either PI3K or PLC is known to limit degranulation responses
224,225,229
, I 
needed to demonstrate that the inhibitors had an additional effect that was specific to the 
hypoxic up-regulation rather than simply preventing all fMLP-mediated stimulation; I did 
this by comparing the impact of inhibitor addition at the beginning of the hypoxic 
incubation with that of delayed addition of inhibitors immediately prior to stimulation 
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with fMLP. Delayed inhibitor addition reduced degranulation under normoxia and 
hypoxia equally, such that the fold up-regulation of NE release entrained by hypoxia was 
preserved; however this uplift was largely abolished when the inhibitors were added prior 
to the hypoxic incubation. This implies that hypoxia activates PI3K/PLC signalling 
pathways and that the signals so generated mediate the subsequent augmented release of 
neutrophil granule contents stimulated by further priming/activation events. The 
mechanism by which hypoxia might influence PI3K/PLC signalling is unknown at 
present; the fact that cycloheximide is without impact suggests that increased 
enzyme/lipid kinase levels are unlikely to be responsible, although it is possible that 
hypoxia could stabilise these proteins independent of protein synthesis. Another 
possibility is that hypoxia might alter the lipid content of plasma membranes and increase 
the availability or accessibility of PIP2, the substrate of both PLC and PI3K. 
Although the inhibition of PLC markedly attenuated degranulation under both normoxic 
and hypoxic conditions, manipulation of calcium signalling did not precisely recapitulate 
the impact of PLC inhibition on NE release, suggesting that other downstream effectors 
such as PKC activation may be relevant. Manipulation of calcium flux had a greater 
impact on MMP-9 release, in keeping with the known calcium-sensitivity of this 
response. Since PI3K activation leads to the downstream activation of a large range of 
signalling molecules via PIP3 it is possible that hypoxia modulates multiple degranulation 
pathways in parallel to Ca
2+
 signalling.  
Hypoxia has been shown to affect the actin cytoskeleton and induce shape change in 
neuronal cells
423
 and proximal renal tubular cells
424
 in culture. In our laboratory, Dr 
Linsey Porter has demonstrated that hypoxia induced more shape-change in fMLP 
activated neutrophils (Dr Linsey Porter, personal communication) and I have shown a 
clear effect of hypoxia on the distribution of polymerised F-actin to cap-like structures. 
Since cytoskeletal re-arrangements have been linked to degranulation
276,425
 this 
observation may provide a mechanistic insight into the hypoxic up-regulation of 
neutrophil degranulation. Downstream signalling molecules that play a role in 
cytoskeletal re-organisation include the small GTPases Rac and Rho, and importantly 
Rac2 has been shown to play a role in the release of azurophil granules
83,264,478
. 
Furthermore, Rac2 has been shown to be a downstream effector of PI3K in human 
neutrophils
492,493
, and Rac1-dependent cytoskeletal re-organisation has been reported to 
occur in hypoxic endothelial cells
494
; thus activation of Rac could plausibly link the 
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hypoxic regulation of PI3K activity with actin re-distribution and degranulation. To 
pursue this possible link, I undertook some preliminary experiments to study the 
activation of Rac in the setting of hypoxia using a G-LISA method. These experiments 
were technically challenging, in part because peak activation of Rac in fMLP-stimulated 
neutrophils occurs at only 10s
495
; however, the G-LISA methodology was not sufficiently 
sensitive to detect Rac activation in fMLP-stimulated neutrophils even at this early time 
point. The alternative methodology to detect Rac activation is a complex ‘pull-down’ 
assay that was not felt to be achievable within the confines of the hypoxic hood without 
considerable work to adapt the method to this environment. Additionally, Rab family 
GTPases have been implicated in vesicle transport and docking
277,278
, Rab3, Rab4 and 
Rab5 co-localise with neutrophil granules
280
 and hypoxia has been shown to modulate a 
range of Rab family GTPases
479–481
. Hence exporing Rab localisation during normoxic 
and hypoxic incubation by immunofluorescence analysis, with co-staining of the relevant 
granule populations, would also be of interest in future studies. 
What might be the translational potential of this work? New light on the destructive 
potential of the neutrophil at inflammatory sites may inform therapeutic strategies in 
neutrophil-mediated disease. My work suggests that either anti-protease strategies or 
perhaps inhibitors of PI3Kγ may be worth exploring in diseases where neutrophilic 
inflammation occurs in a hypoxic environment. An example of the application of anti-
protease therapy can already be found in a small subset of patients with COPD. Current 
therapy for ‘usual’ smoking-related COPD is largely symptomatic496, with only long term 
oxygen therapy shown to increase life expectancy
497
. In contrast, in the setting of COPD 
associate with deficiency of the protease inhibitor α1AT, augmentation therapy with 
α1AT has been shown to both ameliorate lung function decline498,499 and reduce the 
frequency and severity of pulmonary exacerbations
500,501
. However, this treatment 
requires weekly intravenous infusions of human plasma-derived α1AT, is licensed only 
for the small proportion (~2%) of patients who have α1AT deficiency, and is not 
available in all countries. Whilst α1AT augmentation therapy in usual COPD (without 
α1AT deficiency) inhibits NE and prevents elastin degradation502 both systemically and in 
the lung, early (short duration) trials of AZD9668, an orally available NE inhibitor, had 
no impact on respiratory symptomatology or lung function in patients with COPD
503,504
. 
Sivelestat, another neutrophil inhibitor, has been used in clinical situations, the benefits of 
such interventions have been somewhat disappointing; sivelestat did have a beneficial 
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effect on the pulmonary function of ARDS patients with systemic inflammatory response 
syndrome (SIRS)
505
 but was not associated with decreased mortality
137
. These latter 
studies are wholly in keeping with my observations that hypoxic neutrophils release a 
broader range of granule proteases aside from NE. These trials, together with my 
experimental results, underscore the potential utility of combating/preventing the release 
of the whole spectrum of neutrophil-derived proteases, and emphasise the need for orally 
active or inhaled compounds that can prevent local neutrophil degranulation.  
My finding that PI3Kγ is instrumental in signalling the hypoxic uplift of degranulation is 
particularly exciting, since small molecule inhibitors of this lipid kinase (and of PI3Kγ) 
are entering the clinical domain. Inhibition of the signalling event that results in 
degranulation is an attractive prospect as it would prevent the release of all granule 
contents rather than just neutralise a subset of proteases. Studies using PI3Kγ knockout 
mice have suggested that inhibition of this isoform may be advantageous in a range of 
inflammatory conditions including acute pancreatitis
506
, acute lung injury
507
, 
inflammatory bowel disease
508
 and ischaemia-reperfusion injury
509,510
. However, any 
advantage would need to be weighed against the risk of impaired innate immune function, 
as PI3Kγ is important in mediating neutrophil recruitment and the oxidative burst461,269, 
particularly in the setting of treatment for a chronic disease. In respiratory diseases such 
as COPD, topical application of such medications might ameliorate such potential risks. 
 
7.4 Future research avenues  
I have shown that hypoxia induces a destructive neutrophil phenotype, with increased 
release of multiple histotoxic proteases. This may contribute to tissue injury and disease 
pathogenesis in a range of clinically important conditions. Hypoxia induces a global 
hyper-secretory state; hence targeting individual proteases such as NE alone is unlikely to 
be sufficient when hypoxia and inflammation co-exist. It therefore seems relevant to 
further characterise the extent of this phenomenon and to uncover more about the 
mechanisms leading to the establishment of the destructive neutrophil phenotype 
engendered by hypoxia, in the hope that such information might identify additional 
pathways/mechanisms as targets. 
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7.4.1  Elucidating the mechanism of augmented degranulation under hypoxia 
To target the capacity of hypoxia to up-regulate agonist-stimulated neutrophil 
degranulation in a therapeutic setting, we need to identify the biochemical signals(s) and 
mechanisms that underpin it. I would like to extend our observations to encompass a 
broader range of oxygen tensions/agonists, quantitate the phosphorylation of AKT under 
conditions of hypoxic stimulation, explore the role of the PIP3 and other signalling 
molecules downstream of PI3K activation, and perform an unbiased screen of the 
neutrophil transcriptome and lipidome under conditions of normoxia and hypoxia, with 
the aim of identifying novel effectors and potential therapeutic targets. I would also wish 
to explore the capacity of hypoxia to modulate degranulation neutrophils obtained from 
PI3Kγ, PI3Kδ and PLC knockout mice. Clearly, this work is not within the remit of my 
thesis and will be further explored by other laboratory members in future projects. 
To put the increased degranulation under hypoxic condition into a broader, physiological 
window, it would be valuable to study the effects of a wider set of mediators relevant to 
COPD and other inflammatory diseases. For the experiments in this thesis the neutrophil 
were primed/activated with GM-CSF and fMLP; it would be of value to extend the 
observations by studying the effects of inflammatory cytokines and chemokines such as 
LPS, TNF, IL-1β, leukotriene B4, IL-6 and IL-8 on neutrophil degranulation in the 
context of hypoxic incubation. It would also be relevant to explore the effect of lesser 
(and greater) degrees of hypoxia, and in particular such levels as may be present in the 
systemic setting of lung diseases such as COPD.  
To reach the plasma membrane or the membrane of the phagolysosome, a granule must 
negotiate the sub-cortical actin filament network; Cytochalasin B inhibits actin 
polymerisation and the formation of actin filament networks, and is a potent stimulus for 
neutrophil degranulation. Hypoxia augments neutrophil shape change and induces 
dramatic redistribution of the sub-cortical actin network to a focal ‘cap’ Figure 4.9), 
which I predict will allow unrestricted granule mobilisation to the ‘non-capped’ areas of 
the neutrophil surface. In view of these results, it would be useful to study whether 
hypoxia alters granule distribution in “resting” and activated cells. Mitchell et al. (2008) 
have already shown the formation of an actin cap and granule re-distribution in neutrophil 
activated with fMLP, and I anticipate that hypoxia will augment this effect.  
Additionally, elucidating the role of agents that modulate cytoskeletal function including 
the small GTPase families Rac, CDC42, and Rho in the augmented degranulation under 
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hypoxia would be informative. The final step of exocytosis involves the mutual 
recognition of secretory granules and target membranes, which is postulated to involve a 
set of intracellular receptors that guide the docking and fusion of granules. SNAP-
SNARE proteins, which play a role in the docking and fusion stage of degranulation, are 
candidates for hypoxic modulation. Syntaxin 4, SNAP-23, VAMP-1, VAMP-2 and 
VAMP-7
84
 have all been shown to associate with granules and hypoxia has been shown to 
modulate SNAP/SNARE function
511,512
. 
 
7.4.2 The effects of hypoxia on neutrophil function in an epithelial cell system  
The impaired ciliary function induced by neutrophil supernatants warrants further 
research. Primary ciliated epithelial cells are expensive and are challenging to culture. 
The Condliffe/Chilvers laboratory has recently obtained iHBEC’s, and these can ciliate 
when grown at air-liquid interface; this may provide a more accessible alternative system 
to take these observations forwards; alternative sources of material include mouse 
tracheal cells and even human nasal scrapings or bronchial biopsies. The experiments 
undertaken in this thesis were performed on ALI-cultures scraped off the Transwell
®
 to 
enable us to use multiple conditions per well. Looking at intact ALI-cultures would 
provide us with a way to analyse ciliary function without the added stress of disrupting 
the cell layers or the time spend on the chamber-slide. Additionally it would be beneficial 
to look at neutrophil function under hypoxia in a more complex system, perhaps with 
intact neutrophils rather than supernatants. This would allow us look at the interplay 
between the epithelial cell layers and neutrophils. As hypoxia has been shown to induce 
an inflammatory phenotype in endothelial cells it is possible that neutrophil-epithelial cell 
interactions induces a more activated neutrophil phenotype and augment degranulation, 
and that augmented secretion from damaged epithelial cells might signal further 
neutrophil recruitment.  
 
7.4.3 Translational studies  
It would be very valuable to determine the relevance of the in vitro data presented in this 
thesis to the effects of systemic and tissue hypoxia on neutrophil function in vivo.  The 
Condliffe/Chilvers laboratory has demonstrated previously that peripheral blood 
neutrophils obtained from patients experiencing an acute exacerbation of COPD display 
delayed apoptosis relative to healthy controls, and that this phenomenon is transient and 
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normalizes on recovery
464
, consistent with a previous report that COPD neutrophils 
isolated during exacerbation are basally primed and display abnormal chemotactic 
responses
513
. Furthermore, we have obtained preliminary data that the supernatants from 
hypoxic neutrophils cleave the vascular quiescence factor bone morphogenetic protein-9 
(BMP-9) in a NE-dependent fashion, which resonates with the known increase in 
circulating NE activity during COPD exacerbations
514
 and the endothelial dysfunction 
observed in stable COPD
515
.  
We hope to further explore the role of BMP-9 cleavage in the endothelial dysfunction in 
both the pulmonary and systemic circulation in patients with COPD by a number of 
approaches:  
1.  By correlating circulating NE levels, BMP-9 levels, and estimated pulmonary artery 
pressures in patients with stable and exacerbating COPD.  
2. By challenging healthy volunteers with nebulised LPS (to mimic a COPD 
exacerbation) with or without co-incident hypoxia (achieved by reducing inspired O2 
levels).  
3. By hypoxic challenge of COPD patients. 
The effects of such challenges on circulating and lung neutrophil degranulation could be 
measured in addition to the effects on circulating NE and BMP in both healthy volunteers 
and COPD patients.  
 
7.5 Final summary and conclusions 
To develop new therapies for the treatment of persistent infection and prolonged 
inflammation a better understanding of how neutrophils function in physiologically 
relevant oxygen levels is required. In this thesis I have extended our knowledge of 
neutrophil function under hypoxic conditions and shown that hypoxia profoundly 
augments the release of (active) granule proteins from all granule populations. My results 
suggest that the phenotype of a neutrophil in a hypoxic environment may be highly 
destructive, with not only impaired capacity to kill pathogens
327
 but also enhanced 
potential to damage the surrounding tissues. I have demonstrated that hypoxic neutrophil 
supernatants have the apacity to damage respiratory epithelial cells reflecting the effects 
of not just one but of multiple proteases. In a disease setting such as COPD (Figure 7.3) I 
propose that cigarette smoke and pathogens can induce 
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Figure 7.3: Neutrophil function in healthy and chronic obstructivepulmonary 
disease (COPD) airways 
Healthy airways are protected from infection by the innate immune system; bacteria are 
cleared by the mucociliary escalator, by the action of antibacterial peptides, and by 
resident phagocytes. Pathogens that evade these first-line defenses are ingested and killed 
by recruited neutrophils, which then undergo apoptosis and efferocytosis, controlling 
infection and limiting inflammation. In the COPD airway, cigarette smoke exposure may 
damage local defenses, with impairment of the mucociliary system and the phagocytic 
capacity of alveolar macrophages. Cigarette smoke and pathogens trigger the release of 
chemoattractants, promoting the recruitment of neutrophils and other inflammatory cells. 
Although there is increased neutrophil infiltration, local or systemic hypoxia impairs 
bacterial killing and increase the release of proteases, resulting in further mucociliary 
dysfunction and cellular and tissue injury. The proinflammatory state is perpetuated by 
increased neutrophil lifespan secondary to hypoxia and inflammatory cytokines. The 
increased release of NE further result in increased cleavage of BMP-9 which in health is 
an endogenous vascular quiescence factor. ECM = extracellular matrix, BMP-9 = bone 
morphogenetic protein. (Adapted from Hoenderdos & Condliffe.
516
).  
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neutrophil inflammation resulting in inflammation and local hypoxia. Cytokines and 
hypoxia synergize to alter neutrophil function as demonstrated, with impaired bacterial 
killing (impaired oxidative burst), increased lifespan (HIF-1α and NF-κB) and the 
enhanced release of multiple proteases (PI3Kγ/PLC). These proteases have the capacity to 
degrade ECM, generating further recruitment signals, and to promote airway epithelial 
cell apoptosis and mucociliary dysfunction.  
Thus a vicious cycle of injury, further further inflammation and hypoxia may be 
perpetuated. Finally, in the light of the data obtained in collaboration with Dr. Li Wei, I 
speculate that systemic neutrophil priming, coupled with hypoxia, may induce endothelial 
cell dysfunction due to an increased cleavage of BMP-9 by NE (Figure 7.3). Whilst this 
hypothesis is ‘personalised’ to COPD, the inflammation and hypoxia co-exist at most 
inflammatory sites and the same paradigm may apply to other diseases in the lung and 
elsewhere. 
Although HIF modulates many neutrophil functions under hypoxic conditions, I have 
shown that the augmented granules release is largely independent of transcriptional 
regulation, implying that it is predominantly HIF-independent. Instead, hypoxia 
influences the PLC/PI3K pathway (Figure 7.4, green). Inhibition of either of these 
signaling molecules profoundly suppresses degranulation, and abolishes the hypoxic 
uplift. Although inhibition of  Ca
2+
 flux (Figure 7.4, red) did not prevent the augmented 
release of NE found under hypoxic conditions, it is possible that hypoxia modulates 
pathways in parallel to Ca
2+ 
signaling through PI3K and PIP3. Possible targets (Figure 
7.4, blue) include PKC and also Rac2. 
I hope that the data I have generated and presented in this thesis will lead to further work 
to elucidate the mechanism of hypoxia-augmented neutrophil degranulation, and 
ultimately that greater understanding of this process may lead to improved treatments for 
a range of inflammatory disease. 
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Figure 7.4: Neutrophil signalling pathways involved in the augmented degranulation 
under hypoxic conditions 
Hypoxia influences both the PI3Kand the PLC signalling pathway (green text) to promote 
the release of neutrophil granules. Activation of PLCβ leads to Ca2+ influx and 
intracellular Ca
2+
 release from the endoplasmic reticulum, which did not play a role the in 
hypoxia-augmented release of azurophilic granules (red text) but did promote gelatinase 
granule release. Activation of PI3Kγ induces the production of PIP3 by phosphorylation 
of PIP2.  Through PIP3 signalling, hypoxia can modulate a range of targets, include Rac2 
(which modulates cytoskeletal pathways) and RAB family GPTases, which play a role in 
granule fusion and docking. Green: modified by hypoxia, Red: not modified by hypoxia, 
Blue: possibly modified by hypoxia. 
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8. Appendixes 
8.1: Elastase targets 
Cytokines/chemokines Receptors 
Target Biological function Target Biological function 
Chemerin, IL-8 
(CXCL8)  
Modulation of cytokine 
half-life time,  activation 
of chemotaxis  
TLR4  
Modulation of cytokine 
half-life time, , 
activation of chemotaxis  
IL-6, TNF-a, 
IL-2 EGF  
Modulation of cytokine 
half-life time  
PAR-1, 2 and 3  
Inactivation, modulation 
of response, apoptosis  
SDF1 
(CXCL12) 
MIP1 (CCL3)  
Modulation of cytokine 
half-life time, inhibition 
of chemotaxis  
IL-2R, TNF-RII  
 Inhibiting cellular 
response and 
prolongation of cytokine 
half-life time  
G-CSF  Growth inhibition  CD88 (C5aR)  
Inhibition of chemotaxis, 
feedback mechanism  
Integrins/others CD35 (C3b/C4b R)  
Inhibition of 
complement signaling  
Target Biological function CD87(urokinase R)  
Modulation of cell 
migration  
ICAM-1, 
Vascular 
endothelium 
cadherin  
Modulation of adhesion  GCSF-R  Growth inhibition  
Proepithelin  Wound healing  CD43, CD16  Modulation of adhesion  
TGF-B  
binding 
protein  
Enhanced growth factor 
availability  
CD14  
Inhibition of LPS-
mediated cell activation  
 IGF binding 
protein  
Enhanced growth factor 
availability  
CD2,4 and 8  
Impairment of T 
lymphocytes  
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8.2: HIF targets 
HIF targets 
Energy metabolism Vaso-motor regulation 
• Glucose transporter-1 
• Hexokinase-2 
• 6-Phosphofructo-1-kinase L 
• Glyceraldehyde-3-phosphate 
dehydrogenase  
• Aldolase A 
• Enolase 1 
• Phosphoglycerate kinase-1 
• Lactate dehydrogenase A 
• 6-phosphofructo-2-kinase 
• Carbonic anhydrase-9 
• PFKB3 
• Endothelin-1 
• Adrenomedullin  
• Tyrosine hydroxylase 
• Α1β-adrenergic receptor 
• Inducible nitric-oxide synthase  
• Endothelial nitric-oxide synthase  
• Haem oxygenase  
• Atrial natriuretic peptide 
Oxygen transport Matrix and barrier function 
• Erythropoirtin  
• Transferrin  
• Transferrin receptor 
• Ceruloplasmi  
• Procollagen prolyl hydroxylase-
α1 
• Interstinal trefoil factor 
• Ecto-5’-nucleotidase  
Angiogenic Signalling Cell migration 
• Vascular endothelial growth factor A 
• Endothelial-gland-derived vascular  
endothelial         growth factor  
• vascularendothelial growth factor  
receptor-1 
• Plasminogen activator inhibitor -1  
• Chemokine recepor CXCR4 
• C-Met  
Growth and apoptosis Transcriptional regulation 
• Insulin-like grwoth factor binding 
protein-1 
• NIP3 
• Endoglin  
• Wilms’tumor supresso α-Fetoprotein  
• Calcitonin receptor like receptor  
• DEC1 and DEC2 
• ETS1 
• P35srj  
Virus related Others 
• Retrotransposon VL30  
• Multidrug-resistance P-
glycoprotein  
• Leptin  
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8.3 Hypoxic neutrophil supernatants induce A549 cell detachment and apoptosis 
 
Figure 8.3: Hypoxic supernatants induce A549 cell detachment and apoptosis 
A549 cells were cultured in Poly-L-Lysine coated, 96 well plates to obtain a fully confluent cell 
layer. The cells were exposed to neutrophil supernatants (1:2.5 dilution) from neutrophils 
cultured/activated under normoxic or hypoxic conditions for 48 hours before the before the cell 
layers were fixed with 3.5% PFA and stained for F-actin (rhodamine-phalloidin, green), nucleus 
(DAPI, blue) and cleaved caspase 3 (goat IgG anti-cleaved caspase 3 antibody and Alexa Fluor 
488 – donkey anti-goat IgG, red).  A. Representative images from n=3-6 experiments, x40.:  
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8.4 Ciliary function 
8.4.1 Ciliary beat frequency 
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8.4.2 Standard Operating Procedure for the determination of ciliary dyskinesia 
Using the 100x oil immersion lens find a minimum 50μm length of continuous ciliated 
epithelium. Align the epithelial strip horizontally in the middle of the screen. Place the acetate 
grid over the screen so that cilia are present in each of the 10μm sectors. See below: 
 
1. Calculation of Immotility Index. 
In each grid 2 ciliary beat frequency readings are measured. When there is no movement a zero 
is scored which is an immotile cilia. This is repeated for each 10 μm section on 10 separate 
epithelial strips per patient. The Immotility Index is the percentage of zeros scored per 10 
ciliated strips per patient. Number of zeros per 100 readings (total number of readings per 
patient) ≈ percent).  
2. Calculation of Dyskinesia Index. 
10 individual edges per patient are visualised in the grid and a percentage of each edge where 
there is dyskinetic cilia is determined. The overall Dyskinesia Index is the average +/- standard 
deviation of each percentage of 10 measurements.  
e.g. 
strip 1  10%   strip 6  50% 
strip 2  15%   strip 7  10% 
strip 3  10%    strip 8  15% 
strip 4  12%   strip 9  30% 
strip 5  60%    strip 10     20%   23.2+17.1 
10μm 
Screen 
Acetate grid 
Ciliated epithelial 
strip 
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8.5 HRE’s in the promoter regions of neutrophil granule proteins 
HIF1A:ARNT (Human, Mouse, Rat)  
  
ARNT (Mouse)  ARNT:AHR (Mouse)  
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8.6 Primer sequences of primers used in section 5.1.3.1 
BNIP 
 
GLUT1 
 
Elastase 
 
MMP-9 
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8.7 Phospho-kinase array 
 
 
Figure 8. 7: Phospho-kinase array performed under normoxia and hypoxia 
Neutrophils were re-suspended in hypoxic (open bars) or normoxic (black bars) IMDM at 
11.1*10
6
/ml
 
and incubated under normoxia or hypoxia (0.8% O2 and 5% CO2) for 4 h at 
37°C. The cells were then primed and activated as described (section 2.8). Neutrophils 
were pelleted and lysed. Lysates were adjusted for protein concentration and the phospho-
kinase array was run according to the manufacturer’s instruction. Samples were run in 
singlicate, n=2. Results represent mean ± StDev. 
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8.8 Publications arising from this thesis 
8.8.1  Papers 
The Neutrophil in Chronic Obstructive Pulmonary Disease. Too Little, Too Late or 
Too Much, Too Soon? K. Hoenderdos, A.M. Condliffe, Am J. Respir. Cell. Mol. Biol. 
Vol. 48, Iss. 5, pp 531–539, May 2013 
 
The Effect of Hypoxia on neutrophil degranulation, K. Hoenderdos, C Cheng, R.A. 
Hirst*, C. O’Callaghan**, ER. Chilvers, A.M. Condliffe, Department of Medicine, 
University of Cambridge Addenbrooke’s Hospital, Cambridge, UK, *Department of 
Infection, Immunity and Inflammation, University of Leicester, Leicester, UK, 
**University College London, Institute of Child Health, London, UK. manuscript in prep.  
 
Neutrophil- and redox-dependent proteolysis of BMP9 and the potential role in the 
pathogenesis of pulmonary arterial hypertension, W. Li
a
, Z. Wei
a
, K. Hoenderdos
a
, R. 
T. Zamanian
b
, I. Nikolic
c
, R. M. Salmon
a
, P. D. Upton
a
, P. B. Yu
c
, M. Rabinovitch
b
, A. 
M. Condliffe
a
, E. R. Chilvers
a
, N. W. Morrell
a
, 
a
Department of Medicine, University of 
Cambridge, UK, 
b
Stanford University School of Medicine, USA, 
c
Department of 
Medicine, Harvard Medical School, Boston, Massachusetts, USA, manuscript in prep.  
 
8.8.2 Abstracts 
The Effects of Hypoxia on Neutrophil Elastase Release, poster presentation, Keystone 
meeting, February 2012, Advances in Hypoxic Signalling: From Bench to Bedside, 
Banff, Alberta Canada 
 
The Effects of Hypoxia on Neutrophil degranulation, poster presentation, Department 
of Medicine Research day, 2012, Cambridge, UK 
 
The Effects of Hypoxia on Neutrophil Degranulation, poster presentation, British 
Thoracic Society winter meeting, December 2012, London, UK   
 
The Effects of Hypoxia on Neutrophil Degranulation, poster presentation, European 
Society for Clinical Immunology meeting, April 2013, Albufeira, Portugal.  
 
The effects of Hypoxia on Neutrophil Mediated Tissue Damage, oral presentation, 
Cambridge Immunology PhD and Postdoc Day, Cambridge, UK 
 
The Effects of Hypoxia on Neutrophil Degranulation, poster presentation, School of 
Clinical Medicine Research Day, Cambridge, UK. 
 
The effects of Hypoxia on Neutrophil Mediated Tissue Damage in the Lung, oral 
presentation Department of Medicine Research day, November 2013, London, UK   
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The effects of Hypoxia on Neutrophil Mediated Tissue Damage in the Lung, oral 
presentation British Thoracic Society winter meeting, December 2013, London, UK   
 
The Effects of Hypoxia on Neutrophil Degranulation, poster presentation, European 
Society for Clinical Immunology meeting, April 2014, Utrecht, The Netherlands.  
 
The Effects of Hypoxia on Neutrophil Degranulation, poster presentation, The 
Neutrophil Conference, May 2014, Montreal, Canada.  
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